Vous êtes sur la page 1sur 305

Substances that may be used in Listed medicines in Australia

December 2007

Therapeutic Goods Administration

About the Therapeutic Goods Administration (TGA)

The TGA relies on the public, healthcare professionals and industry to report problems with medicines or medical devices. The TGA investigates reports received by it to determine any necessary regulatory action. To report a problem with a medicine or medical device, please see the information on the TGA website.

The TGA administers the Therapeutic Goods Act 1989 (the Act), applying a risk management approach designed to ensure therapeutic goods supplied in Australia meet acceptable standards of quality, safety and efficacy (performance), when necessary.

The work of the TGA is based on applying scientific and clinical expertise to decision-making, to ensure that the benefits to consumers outweigh any risks associated with the use of medicines and medical devices.

The TGA is a division of the Australian Government Department of Health and Ageing, and is responsible for regulating medicines and medical devices.

Copyright Commonwealth of Australia 2011

This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part may be reproduced by any process without prior written permission from the Commonwealth. Requests and inquiries concerning reproduction and rights should be addressed to the Commonwealth Copyright Administration, Attorney Generals Department, National Circuit, Barton ACT 2600 or posted at http://www.ag.gov.au/cca

Substances that may be used in Listed medicines in Australia December 2007

Page 2 of 305

Therapeutic Goods Administration

Substances that may be used in Listed medicines in Australia

The following substances are eligible for use in medicines Listed on the Australian Register of Therapeutic Goods for supply in Australia. The list includes the approved role of the substance (ie. active, excipient, and/or component), and any restrictions and conditions that apply to the substance when used in Listed medicines.

Please note substances marked as components (C) are not approved as substances for use in their own right and can only be used in conjunction with an approved source. For example, iodine is not approved as a substance in its own right but is permitted when expressed as a component of Fucus vesiculosus (Kelp), which is known to naturally contain iodine.

A glossary of abbreviations is provided at the end of the document. For further information on Coded Warnings, refer to the following web page: https://www.ebs.tga.gov.au.

Please note this list does not include substances that may be used as homoeopathic preparations. The Office of Complementary Medicines is currently conducting a review of homoeopathic substance permitted in Listed medicines, and this document will be updated upon completion of the review.

Some substances are permitted as food excipients only. These substances (e.g. apple, pear) refer only to edible substances fit for human consumption as a food. Only certain preparations are permitted for most food excipients: fresh dry or powdered plant material and fresh, dried or concentrated juices. Juice preparations may only be named where the fresh plant part has a high water content. For further details, refer to the Introduction to the Herbal Substances AAN list in the TGA Approved Terminology for Medicines: http://www.tga.gov.au/industry/medicines-approved-terminology.htm.

For further information on conditions related to provisional ingredients (PRVs), refer to the Australian Regulatory Guidelines for OTC Medicines: http://www.tga.gov.au/industry/otc-argom.htm.

This list was updated on 12 December 2007 and is subject to change from time to time as new substances are approved for use in Listed medicines. Importantly, as a result of a safety concern, substances may be subject to new restrictions or may be removed from the list.

Substances that may be used in Listed medicines in Australia December 2007

Page 3 of 305

Therapeutic Goods Administration

Ingredient

1-Dodecanol

Use E E C E E E E E C C

Restrictions

1-Methylheptyl isostearate 1,1,1-Trichloroethane 1,2-Hexanediol 1,3-Butylene glycol 2-Ethoxyethanol

10-Hydroxy-2-decenoic acid

Approved for topical use only.

PRV may only be used as an excipient in topical preparations.

Product must contain 25% or less of designated solvents as defined in Part 1 of the SUSMP. Approved for topical use only. Concentration must not exceed 1%. Approved for topical use only.

2-Amino-2-methyl-1-propanol

(2S,3R,4S)-4-Hydroxyisoleucine (of Trigonella foenum-graecum) 4-Hydroxyisoleucine (of Trigonella foenum-graecum) 4-Methylbenzylidene camphor Abelmoschus moschatus Abies balsamea Abies nigra Abies pectinata

Concentration must not exceed 0.016%. Residual solvent limit is 1.6 mg per MDD.

A, E A, E A, E A, E

Sunscreen active permitted only in topical products. Concentration must not exceed 4%. Native species if exporting this product please contact the DSEWPC.

Substances that may be used in Listed medicines in Australia December 2007

Page 4 of 305

Therapeutic Goods Administration

Ingredient

Abies sibirica

Use A, E A A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E C

Restrictions If the plant part is seed, the MRDD must contain 1 mg or less of the equivalent dry seed. If any other plant part, it is listable without restriction. May be a native species if exporting this product please contact the DSEWPC.

Abrus cantoniensis Absidia ramosa Acacia Abutilon avicennae Acacia arabica

Acacia baileyana Acacia catechu Acacia dealbata Acacia senegal

Acacia longifolia Acalypha indica

Native species if exporting this product (excluding oil) please contact the DSEWPC. Native species if exporting this product please contact the DSEWPC.

Acanthopanax gracilistylus Acanthus mollis

Substances that may be used in Listed medicines in Australia December 2007

Acemannan (of Aloe barbadensis)

Page 5 of 305

Therapeutic Goods Administration

Ingredient

Acer campestre Acer negundo

Use A, E A, E A, E A, E E E E E E E E E E A, E

Restrictions

Acer saccharinum Acer saccharum Acerola

Acesulfame potassium Acetanisole Acetic acid

Only Malpighia punicifolia fruit flesh is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Approved for topical use only.

Acetic acid glacial Acetone

Concentration must not exceed 0.5%. Concentration of acetic acid from all ingredients must not exceed 80%. Residual solvent limit is 50 mg per MDD. Concentration must not exceed 0.5%. Concentration of acetic acid from all ingredients must not exceed 80%. Residual solvent limit is 50 mg per MDD. Concentration should not exceed 0.5%. Residual solvent limit is 50 mg per MDD. Product must contain 25% or less of designated solvents as defined in Part 1 of the SUSMP. Approved for topical use only. Concentration must not exceed 0.01%. Approved for topical use only. Concentration must not exceed 0.5%. PRV may only be used as an excipient in topical preparations. When used as an active in oral or sublingual products, the label must include the statement VIT.

Acetomenaphthone Acetyl dipeptide-1 cetyl ester Acetyl glucosamine Acetyl hexapeptide-3

Substances that may be used in Listed medicines in Australia December 2007

Page 6 of 305

Therapeutic Goods Administration

Ingredient

Acetyl trifluoromethylphenyl valylglycine Acetylated lanolin Acetylated lanolin alcohol Acetylcysteine

Use E E E E E

Restrictions

Approved for topical use only. Concentration must not exceed 0.5%. Approved for topical use only. Approved for topical use only.

Acetylated monoglycerides

Acetyllevocarnitine hydrochloride Achillea millefolium Achillea moschata Achillea ptarmica

A, E A, E A, E A, E A, E A, E A, E E E

Approved for topical use only. Concentration must not exceed 0.001%.

Achyranthes aspera Achyranthes fauriei Acid green 25 Acid red 33

Achyranthes bidentata

May be a native species if exporting this product please contact the DSEWPC.

Substances that may be used in Listed medicines in Australia December 2007

Aconitum carmichaelii

Colour permitted only in topical preparations.

Colour permitted only in topical preparations.

Concentration of equivalent dry herbal material must not exceed 10 mg/Kg or 10 mg/L or 0.001%.

Page 7 of 305

Therapeutic Goods Administration

Ingredient

Aconitum ferox

Use A A A C

Restrictions

Aconitum kusnezoffi Aconitum napellus Acrylamide

Concentration of equivalent dry herbal material must not exceed 10 mg/Kg or 10 mg/L or 0.001%. Concentration of equivalent dry herbal material must not exceed 10 mg/Kg or 10 mg/L or 0.001%. Concentration of equivalent dry herbal material must not exceed 10 mg/Kg or 10 mg/L or 0.001%.

Acrothecium arenarium Acrylamides copolymer Acrylates copolymer

A, E E E E E E E E E

Acrylamide/sodium acryloyldimethyltaurate copolymer Acrylates/acrylamide copolymer Acrylates/c10-30 alkyl acrylate crosspolymer Acrylates/dimethicone acrylate/ethylhexyl acrylate copolymer

Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only.

Approved for topical use only. Concentration must not exceed 1.7%.

Acrylates/C12-22 alkyl methacrylate copolymer Acrylates/dimethicone copolymer

Approved for topical use only. Concentration must not exceed 5%. PRV may only be used as an excipient in topical preparations.

Approved for topical use only. Concentration must not exceed 0.3%.
Page 8 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Acrylates/octylacrylamide copolymer Acrylates/steareth-20 methacrylate copolymer Actaea pachypoda Actaea spicata

Use E E

Restrictions

Approved for topical use only.

Actinidia chinensis

A, E A, E A, E A A A A A A A A A

Approved for topical use only. Concentration must not exceed 0.1%.

Ademetionine disulfate ditosylate dihydrate Ademetionine disulfate tosylate

(S)-S-Adenosylmethionine is a mandatory component of this ingredient (see separate entry). (S)-S-Adenosylmethionine is a mandatory component of this ingredient (see separate entry). (S)-S-Adenosylmethionine is a mandatory component of this ingredient (see separate entry). (S)-S-Adenosylmethionine is a mandatory component of this ingredient (see separate entry). (S)-S-Adenosylmethionine is a mandatory component of this ingredient (see separate entry). (S)-S-Adenosylmethionine is a mandatory component of this ingredient (see separate entry). (S)-S-Adenosylmethionine is a mandatory component of this ingredient (see separate entry). (S)-S-Adenosylmethionine is a mandatory component of this ingredient (see separate entry). (S)-S-Adenosylmethionine is a mandatory component of this ingredient (see separate entry).

Ademetionine disulfate tritosylate dihydrate

Ademetionine hexasulfate dihydrate

Ademetionine hexatosylate dihydrate Ademetionine pentasulfate dihydrate Ademetionine tetrasulfate dihydrate

Ademetionine pentatosylate dihydrate Ademetionine tetratosylate dihydrate

Substances that may be used in Listed medicines in Australia December 2007

Page 9 of 305

Therapeutic Goods Administration

Ingredient

Ademetionine trisulfate ditosylate dihydrate Adenophora stricta Adenophora tetraphylla Adenophora verticillata Adenosine phosphate

Use A

Restrictions

A, E A, E A, E E E E

(S)-S-Adenosylmethionine is a mandatory component of this ingredient (see separate entry).

Adenosine triphosphate Adhatoda vasica Adipic acid

Adenosine triphosphate disodium Adiantum capillus veneris

Approved for topical use only. Concentration must not exceed 0.1%. Approved as an excipient for topical use only. Approved for topical use only.

A, E A, E E E E

Adipic acid/diethylene glycol/glycerin crosspolymer Adonis vernalis Adzuki bean

Native species if exporting this product please contact the DSEWPC. Approved for topical use only. Concentration must not exceed 5%.

A A, E

Concentration of equivalent dry herbal material must not exceed 10 mg/Kg or 10 mg/L or 0.001%. Only Phaseolus angularis seed (bean) is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Aegopodium podagraria

Substances that may be used in Listed medicines in Australia December 2007

Page 10 of 305

Therapeutic Goods Administration

Ingredient

Aesculus chinensis Aesculus glabra

Use A, E A, E A, E A, E A, E A, E A, E A, E C A, E A, E A, E A, E A, E A, E A, E

Restrictions

Aesculus hippocastanum Aesculus x carnea Agar Aethusa cynapium Agastache rugosa Agave americana Agnuside

Agrimonia eupatoria Agrimonia repens Agrostis tenuis Agropyron repens

Ailanthus altissima Ajuga chamaepitys Ajuga reptans

Substances that may be used in Listed medicines in Australia December 2007

Page 11 of 305

Therapeutic Goods Administration

Ingredient Alanine

Ajuga turkestanica whole plant extract Alantolactone

Use E C A, E A, E A, E A, E E A, E A, E A, E C C

Restrictions

Approved for topical use only. Concentration must not exceed 0.08%.

Alaria esculenta Albizia lebbek Albumen

Albizia julibrissin

Iodine is a mandatory component of this ingredient (see separate entry).

Alchemilla alpina

Alchemilla arvensis Alchemilla vulgaris

Requires pre-clearance from TGAL.

Aldehydes calculated as cinnamaldehyde Aletris farinosa Aletris spicata Alginic acid

Aldehydes calculated as citral

A, E A, E E
Page 12 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Alisma orientale

Use A, E A, E E C C C C C C C

Restrictions

Alisma plantago aquatica Alizarin cyanine green F

Alkaloids calculated as berberine Alkaloids calculated as emetine

Colour permitted only in topical preparations.

Alkaloids calculated as hydrastine Alkaloids calculated as protopine Alkaloids calculated as quinine Alkanna officinalis Allantoin Allicin Alliin

Alkaloids calculated as hyoscyamine

Concentration must not exceed 300 micrograms/Kg or 300 micrograms/L or 0.00003%.

Alkylamides (of Echinacea angustifolia and E. purpurea) Alliaria petiolata

A, E E C C Approved for topical use only.

A, E

Substances that may be used in Listed medicines in Australia December 2007

Page 13 of 305

Therapeutic Goods Administration

Ingredient

Allium ascalonicum Allium cepa Allium fistulosum Allium odorum Allium porrum

Use A, E A, E A, E A, E A, E A, E A, E A, E A, E E E C E

Restrictions

Allium macrostemon

Allium sativum

Allium schoenoprasum Allium ursinum Allura red AC

Allura red AC aluminium lake Allyl isothiocyanate Almond Almond oil

Quantity in the MRDD must not exceed 20 mg.

A, E

Only Prunus dulcis var. dulcis seed (kernel) is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Amygdalin and Hydrocyanic acid are mandatory components of this ingredient (see separate entries). Amygdalin and Hydrocyanic acid are mandatory components of this ingredient (see separate entries).

Substances that may be used in Listed medicines in Australia December 2007

Page 14 of 305

Therapeutic Goods Administration

Ingredient

Alnus glutinosa Alnus rugosa Aloe ferox

Use A, E A, E A, E A, E A, E C C C

Restrictions

Aloe barbadensis

Hydroxyanthracene derivatives calculated as anhydrous barbaloin is a mandatory component of this ingredient in oral preparations. Species listed on CITES if exporting or importing this product please contact the DSEWPC. Hydroxyanthracene derivatives calculated as anhydrous barbaloin is a mandatory component of this ingredient in oral preparations. Species listed on CITES if exporting or importing this product please contact the DSEWPC. Hydroxyanthracene derivatives calculated as anhydrous barbaloin is a mandatory component of this ingredient in oral preparations. Species listed on CITES if exporting or importing this product please contact the DSEWPC.

Aloe peryi

Aloeresin A Aloeresin B Aloeresin C Aloes cape

Aloes barbados

A A C

Hydroxyanthracene derivatives calculated as anhydrous barbaloin is a mandatory component of this ingredient in oral preparations. Species listed on CITES if exporting or importing this product please contact the DSEWPC. Hydroxyanthracene derivatives calculated as anhydrous barbaloin is a mandatory component of this ingredient in oral preparations. Species listed on CITES if exporting or importing this product please contact the DSEWPC.

Substances that may be used in Listed medicines in Australia December 2007

Aloinoside A

Page 15 of 305

Therapeutic Goods Administration

Ingredient

Aloinoside B

Use C C C E E

Restrictions

Alpha acids (humulone, cohumulone, adhumulone) of Humulus lupus Alpha-carotene Alpha-Ionone

Alpha-Phellandrene Alpha tocopherol Alpinia galanga

Alpha tocopherol acetate Alpinia katsumadai Alpinia oxyphylla Alstonia boonei

A, E, C A, E A, E A, E A, E A, E A, E A, E A, E A, E

Approved for topical use only. Approved for topical use only.

When used as an active in oral or sublingual products, the label must include the statement VIT. When used as an active in oral or sublingual products, the label must include the statement VIT.

Alpinia officinarum

Alsidium helminthochorton Alstonia constricta

Iodine is a mandatory component of this ingredient (see separate entry). Native species if exporting this product please contact the DSEWPC.

Substances that may be used in Listed medicines in Australia December 2007

Alternanthera philoxeroides

Page 16 of 305

Therapeutic Goods Administration

Ingredient

Alternaria alternata Althaea officinalis Althaea rosea Alum

Use A, E A, E A, E A, E E E E E E E E E E E E

Restrictions

Aluminium chlorohydrate Aluminium citrate Aluminium distearate

Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only.

Aluminium hydroxide

Approved only in topical preparations for localised effect.

Aluminium hydroxide - dried Aluminium monostearate Aluminium oxide

Aluminium magnesium silicate

Aluminium oxide anhydrous Aluminium silicate Aluminium sodium silicate

Approved for topical use only as an excipient. Approved for topical use only as an excipient.

Substances that may be used in Listed medicines in Australia December 2007

When used in oral or sublingual and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.

Page 17 of 305

Therapeutic Goods Administration

Ingredient

Aluminium starch octenylsuccinate Aluminium stearate Amaranth

Use E E E E

Restrictions

Concentration must not exceed 7%. Approved for topical use only.

Amaranth aluminium lake Amaranthus hybridus Amarogentin Amaranthus retroflexus Ambrosia artemisiifolia Ambrosia psilostachya Aminobenzoic acid Aminobutyric acid Ammi visnaga Ammonia

A, E A, E C A, E A, E A E E

Aminopropyl ascorbyl phosphate

Sunscreen active permitted only in topical products. Concentration must not exceed 15%. PRV may only be used as an excipient in topical preparations. Approved for topical use only. Concentration must not exceed 0.1%.

A E

Substances that may be used in Listed medicines in Australia December 2007

Ammonio methacrylate copolymer

E, C

Concentration of equivalent dry herbal material must not exceed 10 mg/Kg or 10 mg/L or 0.001%. Approved for topical use only as an excipient. Concentration from all ingredients must not exceed 0.5%. Approved for oral use only.

Page 18 of 305

Therapeutic Goods Administration

Ingredient

Ammonium acrylates copolymer Ammonium acryloyldimethyltaurate/VP copolymer Ammonium bicarbonate Ammonium carbonate Ammonium chloride

Use E E E E E E E E E E E

Restrictions

Ammonium acrylates/acrylonitrogens copolymer

Approved for topical use only. Approved for topical use only. Approved for topical use only. Concentration must not exceed 5%.

Ammonium glycyrrhizinate Ammonium hydroxide Ammonium lactate

A, E

This ingredient is only listable as an uncompounded BP substance.

When used as an active, this ingredient is only listable as an uncompounded BP substance. Approved for topical use only as an excipient.

Ammonium laureth sulfate Ammonium lauryl sulfate Ammonium polyacrylate

If for internal use, the concentration must not exceed 0.25%. Ammonia is a mandatory component of this ingredient (see separate entry). Approved for topical use only. Concentration must not exceed 0.1%. Approved for topical use only. Approved for topical use only.

Ammonium phosphate - monobasic

Approved for topical and dental use only as an excipient.

Approved for topical use only. Concentration must not exceed 0.75%.
Page 19 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Ammonium polyacryloyldimethyl taurate Amodimethicone Amomum aromaticum Amomum villosum Amomum xanthioides Ampelopsis japonica Amygdalin Amylase Amyl acetate

Use E E

Restrictions

Approved for topical use only. Concentration must not exceed 3%. PRV may only be used as an excipient in topical preparations.

A, E A, E A, E A, E A, E C E

Amorphophallus rivieri

Amyris balsamifera

Amyris oil west indian Anacyclus pyrethrum

A, C

Listed medicines must not contain any amygdalin. Approved for topical use only.

Anacardium occidentale

A, E A, E A, E A, E E

Permitted only when derived from Aspergillus oryzae.

Substances that may be used in Listed medicines in Australia December 2007

Anacystis nidulans ferment

Approved for topical use only. Concentration must not exceed 0.0025%.

Page 20 of 305

Therapeutic Goods Administration

Ingredient

Anagallis arvensis Ananas sativus

Use A, E A, E A, E A, E A, E A, E C A, E A, E A, E A, E A, E A, E A, E A, E

Restrictions Sponsors must confirm the absence of aristolochic acids or herbal species known to contain these acids. Picrotoxin is a mandatory component of this ingredient (see separate entry).

Anamirta cocculus Anantherum muricatum Anaphalis sinica

Andrographis paniculata

Andrographolide (of Andrographis paniculata) Anemarrhena asphodeloides Anemone altaica Anemone chinensis Anemone hepatica Anethole

Anemone raddeana

Anethum graveolens Angelica acutiloba

When used as an active, permitted only in Medicated Space Sprays or Medicated Throat Lozenges.

Substances that may be used in Listed medicines in Australia December 2007

Page 21 of 305

Therapeutic Goods Administration

Ingredient

Angelica anomala

Use A, E A, E A, E A, E A, E A, E A, E A, E E A, E A, E A, E A, E E

Restrictions

Angelica archangelica Angelica dahurica Angelica polymorpha Angelica pubescens Angelica root dry Angelica root oil Angelica stem Anise oil Angelica seed oil

Aniba rosaeodora Aniseed dry Annatto

Only Angelica archangelica stem young or leaf stalk (petiole) permitted. May only be used as a food excipient refer to introduction for permitted preparations. Permitted without restriction in preparations containing 50% or less. When the concentration is more than 50%, the nominal capacity of the container must be less than 50 mL, a RFI must be fitted on the container and the product label must include the statement CHILD.

Aniseed powder

Substances that may be used in Listed medicines in Australia December 2007

Page 22 of 305

Therapeutic Goods Administration

Ingredient

Anogeissus latifolia Antennaria dioica Anthemis nobilis Anthocyanins

Use A, E A, E A, E E, C C C C C A, E A, E A, E C C C

Restrictions

Anthocyanins calculated as cyanidin chloride (of Sambucus nigra) Anthocyanosides (of Vitis vinifera) Anthocyanosides (of Vaccinium myrtillus) Anthoxanthum odoratum Anthriscus cerefolium Anthyllis vulneraria Apigenin Apiin Anthraquinones calculated as glucofrangulin A

Apigenin-7-glycoside

Substances that may be used in Listed medicines in Australia December 2007

Page 23 of 305

Therapeutic Goods Administration

Ingredient

Apium graveolens Apple

Use A, E A E E E E E A, E A, E A, E A, E E E E

Restrictions Concentration of equivalent dry herbal material must not exceed 10 mg/Kg or 10 mg/L or 0.001%. Only Malus X domestica, M. pumila, M. sylvestris and hybrids fruit permitted. May only be used as a food excipient refer to introduction for permitted preparations. Only Malus X domestica, M. pumila, M. sylvestris and hybrids fruit juice cider vinegar permitted. May only be used as a food excipient refer to introduction for permitted preparations. Only Malus X domestica, M. pumila, M. sylvestris and hybrids fruit fibre permitted. May only be used as a food excipient refer to introduction for permitted preparations. Only Prunus armeniaca fruit flesh permitted. May only be used as a food excipient refer to introduction for permitted preparations. Approved for topical use only. Species listed on CITES if exporting or importing this product please contact the DSEWPC. Species listed on CITES if exporting or importing this product please contact the DSEWPC.

Apocynum cannabinum Apple cider vinegar Apple fibre Apricot

Apricot kernel oil peg-6 esters Aquilaria agallocha Aquilaria sinensis

Aquilegia pubescens Aquilegia vulgaris Arachidonic acid Arachidyl alcohol

Substances that may be used in Listed medicines in Australia December 2007

Arachidyl glucoside

Approved for topical use only.

Approved for topical use only. Concentration must not exceed 1.0%. Approved for topical use only. Concentration must not exceed 0.5%.
Page 24 of 305

Therapeutic Goods Administration

Ingredient

Arachidyl propionate Arachis hypogaea Arachis oil Aralia cordata Aralia hispida

Use E A, E A, E A, E A, E A, E A, E C A, E A, E A, E A, E A, E A C A, E

Restrictions

Approved for topical use only.

Requires the label statement PEANUT. Requires the label statement PEANUT.

Aralia nudicaulis Aralia racemosa Arbutin

Archangelica atropurpurea Arctium lappa Arctium minus

Arctostaphylos uva-ursi Ardisia japonica Areca catechu Arecoline

Arecastrum romanzoffianum

Arecoline is a mandatory component of this ingredient (see separate entry).

Substances that may be used in Listed medicines in Australia December 2007

Concentration from all ingredients must not exceed 10 mg/Kg or 10 mg/L or 0.001%.

Page 25 of 305

Therapeutic Goods Administration

Ingredient Arginine Arginine ferulate

Use A, E E A A A

Restrictions

Arisaema atrorubens Arisaema japonicum Armoracia rusticana Arnebia euchroma Arnica flower dry Arnica mollis

Approved for topical use only. Requires the label statement ARGIN1.

Arisaema consanguineum

Approved for topical use only. Concentration must not exceed 0.0125%. MRDD must contain 1 mg or less of the equivalent dry herbal material. MRDD must contain 1 mg or less of the equivalent dry herbal material. MRDD must contain 1 mg or less of the equivalent dry herbal material.

A, E A, E A A A

Volatile oil components (of Armoracia rusticana) is a mandatory component of this ingredient (see separate entry). If the preparation is for use other than topically on unbroken skin, it is listable only if the MRDD contains 1 mg or less of the equivalent dry herbal material. For topical use on unbroken skin, it is listable without restriction. If the preparation is for use other than topically on unbroken skin, it is listable only if the MRDD contains 1 mg or less of the equivalent dry herbal material. For topical use on unbroken skin, it is listable without restriction. If the preparation is for use other than topically on unbroken skin, it is listable only if the MRDD contains 1 mg or less of the equivalent dry herbal material. For topical use on unbroken skin, it is listable without restriction.

Arnica montana Arrowroot

Arrhenatherum elatius

A, E A, E

Substances that may be used in Listed medicines in Australia December 2007

Page 26 of 305

Therapeutic Goods Administration

Ingredient

Artemia salina extract Artemisia abrotanum Artemisia annua Artemisia argyi Artemisia absinthium

Use E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A A

Restrictions

PRV may only be used as an excipient in topical preparations.

Oil derived from this species is a Customs Prohibited Import requires an import permit/licence. Oil derived from this species is a Customs Prohibited Import requires an import permit/licence. Oil derived from this species is a Customs Prohibited Import requires an import permit/licence. Oil derived from this species is a Customs Prohibited Import requires an import permit/licence. Oil derived from this species is a Customs Prohibited Import requires an import permit/licence. Oil derived from this species is a Customs Prohibited Import requires an import permit/licence. Oil derived from this species is a Customs Prohibited Import requires an import permit/licence. Oil derived from this species is a Customs Prohibited Import requires an import permit/licence. Oil derived from this species is a Customs Prohibited Import requires an import permit/licence. Oil derived from this species is a Customs Prohibited Import requires an import permit/licence. Oil derived from this species is a Customs Prohibited Import requires an import permit/licence.

Artemisia arborescens

Oil derived from this species is a Customs Prohibited Import requires an import permit/licence.

Artemisia dracunculus Artemisia frigida Artemisia herba-alba Artemisia maritima Artemisia pallens

Artemisia tridentata Artemisia vulgaris Arthrospira maxima

Substances that may be used in Listed medicines in Australia December 2007

Arthrospira platensis

Iodine is a mandatory component of this ingredient (see separate entry). May be a native species if exporting this product please contact the DSEWPC. Iodine is a mandatory component of this ingredient (see separate entry). May be a native species if exporting this product please contact the DSEWPC.
Page 27 of 305

Therapeutic Goods Administration

Ingredient

Arum maculatum

Use A C A, E A, E A, E A, E A, E A, E A, E E E

Restrictions

Arundo mauritianica Asafoetida gum

Aryltetralin lignins calculated as podophyllotoxin Asarum europaeum Asarum sieboldii

MRDD must contain 1 mg or less of the equivalent dry herbal material.

Asarum heterotropoides Asclepias tuberosa Ascorbic acid

Sponsors must confirm the absence of aristolochic acids or herbal species known to contain these acids. Sponsors must confirm the absence of aristolochic acids or herbal species known to contain these acids. Sponsors must confirm the absence of aristolochic acids or herbal species known to contain these acids. Iodine is a mandatory component of this ingredient (see separate entry). Approved for topical use only. Concentration must not exceed 2%. Approved for topical use only.

Ascophyllum nodosum Ascorbyl glucoside

Ascorbyl methylsilanol pectinate Ascorbyl palmitate

A, E, C

When used as an active in oral or sublingual products, the label must include the statement VIT.

A, E

When used as an active in oral products, the MRDD must not exceed 100 mg. When used as an active in oral or sublingual products, the label must include the statement VIT.
Page 28 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Ascorbyl tocopheryl maleate Aspalathus linearis Asparagine Asparagus

Use E C

Restrictions

Asiaticoside (of Centella asiatica)

A, E A, E E A, E A, E A E

Approved for topical use only. Concentration must not exceed 0.01%.

Asparagus lucidus

Asparagus officinalis Aspartame

Only Asparagus officinalis shoot permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Asparagus racemosus Aspartic acid

Approved only when the plant part is dried, peeled root, and water extracts or ethanol/water extracts (containing up to 45% ethanol) of the dried, peeled root. Requires the label statement ASPAR. Products for oral ingestion must also include the label statement PKU.

Aspergillus clavatus Aspergillus oryzae Asperula odorata Aster novi-belgii

A, E A, E A, E A, E A, E

Substances that may be used in Listed medicines in Australia December 2007

Page 29 of 305

Therapeutic Goods Administration

Ingredient

Aster tataricus

Use A, E A, E A, E A, E A, E A, E A, E A, E E A, E A, E A, E A C

Restrictions

Astragalus adsurgens Astragalus excarpus

Astragalus complanatus Astragalus gummifer

Astragalus lentiginosus

Astragalus membranaceus Astragalus penduliflorus Atractylodes japonica Atractylodes lancea Atropa belladonna Atropine

Astrocaryum murumuru seed butter

PRV may only be used as an excipient in topical preparations.

Atractylodes macrocephala

Atropine and Alkaloids calculated as hyoscyamine are mandatory components of this ingredient (see separate entries). When used as an active, this ingredient is only listable as an uncompounded BP substance.

Substances that may be used in Listed medicines in Australia December 2007

Attapulgite activated

A, E

Concentration from all ingredients must not exceed 100 micrograms/kg or 100 micrograms/L or 0.00001%.
Page 30 of 305

Therapeutic Goods Administration

Ingredient

Aucubin (of Vitex agnus-castus) Aureobasidium pullulans Avena fatua Avocado Avena sativa Avocado oil

Use C A, E A, E A, E E E E E E A

Restrictions

Gluten is a mandatory component of this ingredient when the plant part is seed and when route of administration is other than topical or mucosal (see separate entry). Only Persea gratissima fruit flesh permitted. May only be used as a food excipient refer to introduction for permitted preparations. Approved for topical use only.

Gluten is a mandatory component of this ingredient when the plant part is seed and when route of administration is other than topical or mucosal (see separate entry). Only Persea gratissima fruit flesh oil fixed permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Avocado oil unsaponifiables Azadirachta indica Azovan blue Azulene

Approved only when it is the oil derived from the seed and is for topical use only. When the concentration of cold pressed Azadirachta indica seed oil exceeds 1% a CRC is required. Requires the label statements PREGNT2, NTAKEN, and CHILD. Colour permitted only in topical preparations. Approved for topical use only.

Backhousia citriodora Bacopa monnieri

A, E A, E

Approved only when it is the oil derived from the leaf and is for topical use only. Concentration must not exceed 10 g/kg or 10 g/L or 1%. Requires the label statements IRRIT, CHILD3, and PREGNT. May be a native species if exporting this product please contact the DSEWPC.
Page 31 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Bacosides calculated as bacoside A (of Bacopa monnieri) Ballota nigra Balm of gilead bud dry Bambusa breviflora Bambusa textilis Banana

Use C

Restrictions

Balm of gilead bud powder

A, E A A

A, E A, E E A, E A, E A, E A, E E E

Baphicacanthus cusia Baptisia confusa Baptisia tinctoria Barium sulfate Barley

Only Musa sterile hybrid cultivars fruit flesh permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Barbarea vulgaris

Approved for topical use only.

Only Hordeum distichon and H. vulgare seed (grain) permitted. May only be used as a food excipient refer to introduction for permitted preparations. Gluten is a mandatory component of this ingredient when the route of administration is other than topical and mucosal (see separate entry).
Page 32 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Barley bran Barley germ Barley leaf

Use E E E E A, E E E E

Restrictions

Only Hordeum distichon and H. vulgare seed (grain) husk or seed coat (bran) permitted. May only be used as a food excipient refer to introduction for permitted preparations. Gluten is a mandatory component of this ingredient when the route of administration is other than topical and mucosal (see separate entry). Only Hordeum distichon and H. vulgare seed (grain) embryo (germ) permitted. May only be used as a food excipient refer to introduction for permitted preparations. Gluten is a mandatory component of this ingredient when the route of administration is other than topical and mucosal (see separate entry). Only Hordeum distichon and H. vulgare herb or leaf permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Barley sprout Barosma betulina Basic fuchsin

Basic butylated methacrylate copolymer Basic violet 2

Only Hordeum distichon and H. vulgare seed (grain) sprout permitted. May only be used as a food excipient refer to introduction for permitted preparations. Gluten is a mandatory component of this ingredient when the route of administration is other than topical and mucosal (see separate entry). Pulegone is a mandatory component of this ingredient (see separate entry). Colour permitted only in topical preparations.

Basil oil comoros

A, E

PRV may only be used as an excipient in topical preparations.

Permitted without restriction in preparations containing 5% or less of methyl chavicol. When the concentration is greater than 5% of methyl chavicol, the nominal capacity of the container must be 25 mL or less, a RFI must be fitted on the container and the product label must include the statement CHILD.
Page 33 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Basil oil european Batyl alcohol Bay leaf Bay oil

Use A, E E E A, E

Restrictions

Permitted without restriction in preparations containing 5% or less of methyl chavicol. When the concentration is greater than 5% of methyl chavicol, the nominal capacity of the container must be 25 mL or less, a RFI must be fitted on the container and the product label must include the statement CHILD. Approved for topical use only. Only Laurus nobilis leaf permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Beeswax - synthetic Beeswax - white Beet red Beeswax - yellow Beetroot

E E E E E E A, E

Permitted without restriction in preparations containing 25% or less. When the concentration is greater than 25% and the nominal capacity of the container is 15 mL or less, a RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. When the concentration is greater than 25% and the nominal capacity of the container is greater than 15 mL but less than or equal to 25 mL, a CRC and RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. Approved for topical use only.

Begonia fimbristipula Beheneth-10

Only Beta vulgaris leaf blade or leaf permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Substances that may be used in Listed medicines in Australia December 2007

Approved for topical use only. Concentration must not exceed 1.5%. Residual levels of ethylene oxide are to be kept below the levels of detection.

Page 34 of 305

Therapeutic Goods Administration

Ingredient

Beheneth-20 Behenic acid Behenoxy dimethicone Behenoyl stearic acid Behenyl alcohol

Use E, C E E E

Restrictions

PRV may only be used as an excipient in topical preparations. Approved for topical use only.

Approved for topical use only as an excipient. MRDD must contain 383.5 mg or less in products for oral ingestion. Approved for topical use only. Concentration must not exceed 2.4%. Approved only in topical preparations for localised effect.

Belamcanda chinensis Belladonna herb dry Belladonna herb powder Bellis perennis Bemotrizinol Bentonite

A, E A A A A E E A, E A, E

Atropine and Alkaloids calculated as hyoscyamine are mandatory components of this ingredient (see separate entries). Atropine and Alkaloids calculated as hyoscyamine are mandatory components of this ingredient (see separate entries). Atropine and Alkaloids calculated as hyoscyamine are mandatory components of this ingredient (see separate entries). Sunscreen active permitted only in topical products. Concentration must not exceed 10%. May be a native species if exporting this product please contact the DSEWPC.

Belladonna herb prepared

Benincasia cerifera Benzaldehyde

Substances that may be used in Listed medicines in Australia December 2007

Page 35 of 305

Therapeutic Goods Administration

Ingredient

Benzalkonium chloride

Use E E E

Restrictions

Benzethonium chloride Benzoic acid

Benzylidene camphor sulfonic acid Benzoin siam

Approved only in products for topical or nasal administration. Concentration must not exceed 5%. Approved only in topical preparations for localised effect. Requires the label statement BNZTHC. Sunscreen active permitted only in topical products. Requires the label statement TBNZO8.

Benzoin sumatra Benzyl alcohol Benzyl benzoate Berberine

A, E A, E E E E C

Benzyl cinnamate

Topical products require the label statement BNZALC. Approved for topical use only.

Berberis aquifolium Berberis vulgaris

Bergamot oil coldpressed Bertholletia excelsa

A, E A, E A, E A, E

Approved for topical use only. Concentration must not exceed 0.15%.

Permitted when: a) steam distilled or rectified; b) in preparations for internal use; c) in preparations containing 0.4% or less of bergamot oil; d) in soaps or bath and shower gels that are washed off the skin; or e) packed in containers labelled with the statement SENS. Oxedrine is a mandatory component of this ingredient when used for internal use (see separate entry).

Substances that may be used in Listed medicines in Australia December 2007

Page 36 of 305

Therapeutic Goods Administration

Ingredient

Beta-1, 2-D-oligofructofuranosides (of Echinacea purpurea) Beta-tocopherol Beta rapa Beta vulgaris Betadex Betaine

Use C

Restrictions

Beta-hydroxy-beta-methylbutyric acid

E, C

Betacarotene Betaglucan

A, E A, E E E E

A, E, C

Betaine hydrochloride Betonica officinalis Betula lenta Betula nigra

E, C

Approved for topical use only. Concentration must not exceed 0.01%. Approved for topical use only.

A, E A, E A, E A, E A, E

Betula papyrifera Betula pendula

Methyl salicylate is a mandatory component of this ingredient (see separate entry).

Substances that may be used in Listed medicines in Australia December 2007

Methyl salicylate is a mandatory component of this ingredient (see separate entry).

Page 37 of 305

Therapeutic Goods Administration

Ingredient

Betula pubescens

Use A, E A A A A A A A A E E C C A, E

Restrictions

Bifidobacterium adolescentis Bifidobacterium animalis

Bifidobacterium animalis ssp animalis Bifidobacterium animalis ssp lactis Bifidobacterium bifidum Bifidobacterium breve Bifidobacterium lactis Bifidobacterium infantis

Bifidobacterium longum Bilberry

Bifidobacterium longum lysate Bilobalide

PRV may only be used as an excipient in topical preparations.

Biochanin A

Only Vaccinium myrtillus fruit permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Substances that may be used in Listed medicines in Australia December 2007

Biosaccharide gum-1

Approved for topical use only. Concentration must not exceed 5%.

Page 38 of 305

Therapeutic Goods Administration

Ingredient Biotin

Biota orientalis Birch leaf dry

Use A, E A, E A, E A, E E E E E

Restrictions When used as an active in oral or sublingual products, the label must include the statement VIT. Requires pre-clearance from TGAL.

Birch tar oil rectified

Bis-diglyceryl polyacyladipate-2 Bisabolol

Bis-peg-12 dimethicone beeswax

Bishydroxyethyl biscetyl malonamide Bitter gourd Bixa orellana

E, C

Approved for topical use only. Approved for topical use only.

Approved for topical use only. Concentration must not exceed 0.2%. PRV may only be used as an excipient in topical preparations.

Black cohosh dry Black currant

Black cohosh powder Black currant fresh

A, E A A E

Only Momordica charantia fruit flesh permitted. May only be used as a food excipient refer to introduction for permitted preparations. Requires the label statement BLKCOH. Requires the label statement BLKCOH.

A, E

Only Ribes nigrum fruit permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Substances that may be used in Listed medicines in Australia December 2007

Page 39 of 305

Therapeutic Goods Administration

Ingredient Blackberry

Black pepper oil Bladderwrack dry

Use A, E E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E

Restrictions Only Rubus fruticosus fruit permitted. May only be used as a food excipient refer to introduction for permitted preparations. Iodine is a mandatory component of this ingredient (see separate entry). Iodine is a mandatory component of this ingredient (see separate entry).

Bladderwrack powder Bletia hyacinthina Blue flag rhizome dry Blumea lacera

Blue flag rhizome powder Boehmeria nivea

Species listed on CITES if exporting or importing this product please contact the DSEWPC.

Boerhavia diffusa Bogbean leaf dry Bois de rose oil

May be a native species if exporting this product please contact the DSEWPC. May be a native species if exporting this product please contact the DSEWPC.

Boerhavia repens

Bogbean leaf powder

Substances that may be used in Listed medicines in Australia December 2007

Bombax malabaricum

Page 40 of 305

Therapeutic Goods Administration

Ingredient Borax

Borago officinalis

Use A, E A, E A, E A C

Restrictions

Borax pentahydrate Boric acid Boron

Permitted only if the preparation is fixed oil derived from the seed.

Boron is a mandatory component of this ingredient (see separate entry).

Boron is a mandatory component of this ingredient (see separate entry). Boron is a mandatory component of this ingredient (see separate entry).

Boron nitride

Boswellia carterii Boswellia serrata Boswellic acid

Boswellia thurifera Botrytis cinerea Brandy

A, E A, E A, E C A, E A, E E

When the dosage form is not dusting powder and the product is for paediatric dermal use, the concentration from all ingredients must not exceed 3500 mg/kg or 3500 mg/L or 0.35%. When the dosage form is dusting powder and the product is for paediatric dermal use, the concentration from all ingredients must not exceed 10 mg/kg or 10 mg/L or 0.001%. If the product is for internal use the concentration must not exceed 3 mg per RDD. If the product is for vaginal use the concentration must not exceed 10 mg/kg or 10 mg/L or 0.001%. Approved for topical use only. Concentration must not exceed 0.5%.

Bovista gigantea

Substances that may be used in Listed medicines in Australia December 2007

Page 41 of 305

Therapeutic Goods Administration

Ingredient

Brassica chinensis Brassica juncea Brassica napus Brassica nigra

Use A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E

Restrictions

Allyl isothiocyanate is a mandatory component of this ingredient when the plant part is seed (see separate entry). Allyl isothiocyanate is a mandatory component of this ingredient when the plant part is seed (see separate entry). Allyl isothiocyanate is a mandatory component of this ingredient when the plant part is seed (see separate entry). Allyl isothiocyanate is a mandatory component of this ingredient when the plant part is seed (see separate entry). Allyl isothiocyanate is a mandatory component of this ingredient when the plant part is seed (see separate entry). Allyl isothiocyanate is a mandatory component of this ingredient when the plant part is seed (see separate entry).

Allyl isothiocyanate is a mandatory component of this ingredient when the plant part is seed (see separate entry). Allyl isothiocyanate is a mandatory component of this ingredient when the plant part is seed (see separate entry). Allyl isothiocyanate is a mandatory component of this ingredient when the plant part is seed (see separate entry).

Brassica oleracea var. botrytis

Brassica oleracea var. capitata Brassica oleracea var. Italica Brassica pekinensis Brassica rapa

Brassica oleracea var. gemmifera Brassica oleracea var. viridis

Allyl isothiocyanate is a mandatory component of this ingredient when the plant part is seed (see separate entry). Allyl isothiocyanate is a mandatory component of this ingredient when the plant part is seed (see separate entry).

Substances that may be used in Listed medicines in Australia December 2007

Page 42 of 305

Therapeutic Goods Administration

Ingredient Brazil nut

Use E E E E E E E E E A

Restrictions

Brilliant black BN Brilliant blue FCF

Only Bertholletia excelsa seed permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Brilliant blue FCF aluminium lake Brilliant blue FCF barium lake Brilliant scarlet 4R Briza media Broad bean pod Broccoli

A, E

Broad bean seed Bromelains

Only Vicia faba fruit (bean pod) cooked permitted. May only be used as a food excipient refer to introduction for permitted preparations. Only Vicia faba seed (bean) cooked permitted. May only be used as a food excipient refer to introduction for permitted preparations. Only Brassica oleracea convar. Botrytis var. symosa immature flower head dark green permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Bromus asper

Substances that may be used in Listed medicines in Australia December 2007

Bromus catharticus

A, E A, E

May be derived from either the stem or fruit of the pineapple (Ananas comosus). Sponsors should hold information to identify whether the bromelain in their product is derived from the fruit or stem.

Page 43 of 305

Therapeutic Goods Administration

Ingredient Bronopol

Bromus inermis

Use A, E E E A, E A, E A E

Restrictions Approved only in topical preparations for localised effect. Requires the label statement BRONOP. Colour permitted only in topical preparations.

Broussonetia papyrifera Brown FK Brucea amarissima Brunfelsia uniflora Brussel sprout Bryonia alba Bryonia dioica Buchu leaf dry Buckwheat

May be a native species if exporting this product please contact the DSEWPC. MRDD must contain 1 mg or less of the equivalent dry herbal material.

A, E A, E A, E A, E E A, E A, E

Only Brassica oleracea convar. Botrytis var. gemmifera axillary bud (swollen tight clusters of young leaves) permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Buchu leaf powder Buddleia officinalis Bulnesia sarmienti

Only Fagopyrum esculentum seed permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Substances that may be used in Listed medicines in Australia December 2007

Page 44 of 305

Therapeutic Goods Administration

Ingredient

Bunias orientalis Burdock leaf dry

Use A, E A, E A, E A, E A, E A, E E E E E E E E E A

Restrictions

Bupleurum falcatum

Burdock leaf powder Burdock root dry Butan-1-ol Butane Butter

Burdock root powder

Residual solvent limit is 50 mg per MDD. Concentration must not exceed 0.5%.

Buttermilk - dried Butyl acetate

Butyl ester of pvm/ma copolymer Butyl hydroxybenzoate Butyl stearate Butyl methoxydibenzoylmethane

Residual solvent limit is 50 mg per MDD. Concentration must not exceed 0.5%. Topical products require the label statement TOTBNZ. Approved for topical use only.

Approved only in topical preparations for localised effect. Concentration must not exceed 15%. Requires the label statements EYE and EYE2. Sunscreen active permitted only in topical products. Concentration must not exceed 5%.

Substances that may be used in Listed medicines in Australia December 2007

Page 45 of 305

Therapeutic Goods Administration

Ingredient

Butylated hydroxyanisole

Use E E E E E E E E E E E A, E

Restrictions

Butylated hydroxytoluene

Butylene glycol dicaprylate/dicaprate

Topical products require the label statement BHANIS.

Butylene/ethylene/styrene copolymer - hydrogenated Butyloctyl salicylate Butyrospermum parkii

Approved for topical use only. Concentration must not exceed 10%. Must not be derived from animals. Approved only in topical preparations for localised effect. The combined concentration of butylene/ethylene/stryene copolymer - hydrogenated and ethylene/propylene/styrene copolymer - hydrogenated must not exceed 9%. Approved for topical use only. Concentration must not exceed 5%. PRV may only be used as an excipient in topical preparations.

C1-8 alkyl tetrahydroxycyclohexanoate C12-13 Pareth-23 C12-13 Pareth-3

C10-30 cholesterol/lanosterol esters

Approved only in topical preparations for localised effect. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL.

Approved for topical use only. Concentration must not exceed 0.125%. Residual levels of 1, 4dioxane and ethylene oxide (and related substances) are to be kept below the levels of detection. Approved for topical use only. Concentration must not exceed 0.125%. Residual levels of 1, 4dioxane and ethylene oxide (and related substances) are to be kept below the levels of detection. Approved for topical use only. Concentration must not exceed 20%. Approved for topical use only. Concentration must not exceed 1.2%.

C12-15 alkyl benzoate C12-15 alkyl lactate

Substances that may be used in Listed medicines in Australia December 2007

Page 46 of 305

Therapeutic Goods Administration

Ingredient

C12-15 alkyl octanoate C12-16 alcohols

Use E E E E E E E E E E E E E E E

Restrictions

C12-20 acid PEG-8 ester C13-14 isoparaffin C15-19 alkane

Approved for topical use only.

PRV may only be used as an excipient in topical preparations. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only.

Approved for topical use only. Concentration must not exceed 0.2%. Approved for topical use only. Concentration must not exceed 7%.

C18-36 acid glycol ester C20-40 alcohols

C18-36 acid triglyceride C20-40 alkyl stearate C20-40 pareth-3 C20-40 pareth-24

Approved for topical use only. Concentration must not exceed 2%. Approved for topical use only. Concentration must not exceed 2%. PRV may only be used as an excipient in topical preparations. Approved for topical use only.

C30-45 alkyl methicone C9-11 isoparaffin C9-11 pareth-3

C6-14 olefin polymers - hydrogenated

Approved for topical use only. Concentration must not exceed 0.25%. Residual levels of ethylene oxide are to be kept below the levels of detection. Approved for topical use only. Concentration must not exceed 7%. Approved only in topical preparations for localised effect.

Substances that may be used in Listed medicines in Australia December 2007

Page 47 of 305

Therapeutic Goods Administration

Ingredient Cabbage Cade oil

C9-15 alkyl phosphate

Use E E

Restrictions

Approved for topical use only. Concentration must not exceed 0.12%.

Caesalpinia sappan Caffeine

Caesalpinia sepiaria Caffeoylquinic acids calculated as cynarin of cynara scolymus Cajuput oil

A, E A, E A, E E, C C

Only Brassica chinensis, B. oleracea and B. pekinensis leaf green permitted. May only be used as a food excipient refer to introduction for permitted preparations.

May only be used as an excipient in topical products. When present as a component of Paullinia cupana in products for oral ingestion, the product requires the label statement CAFF. Permitted without restriction in preparations containing 25% or less. When the concentration is greater than 25% and the nominal capacity of the container is 15 mL or less, a RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. When the concentration is greater than 25% and the nominal capacity of the container is greater than 15 mL but less than or equal to 25 mL, a CRC and RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. Cineole is a mandatory component of Cajuput oil (see separate entry).

A, E, C

Calamba root dry Calamine

Calamba root powder

A A

A, E

Substances that may be used in Listed medicines in Australia December 2007

When used as an active, this ingredient is only listable as an uncompounded BP substance for topical use only.

Page 48 of 305

Therapeutic Goods Administration

Ingredient Calcium

Calamintha officinalis

Use A, E C E

Restrictions

Calcium aluminium borosilicate Calcium amino acid chelate Calcium ascorbate Calcium behenate

A, E A, E A, E E A A E E

PRV may only be used as an excipient in topical preparations.

Calcium ascorbate dihydrate Calcium beta-hydroxy-betamethylbutyrate Calcium carbonate Calcium caseinate Calcium chloride Calcium citrate

If used as an active AND intended as a mineral supplementation, the equivalent quantity of calcium is required on the product label. The declared quantity of calcium must not exceed 25% of the calcium amino acid chelate in the formulation. When used as an active in oral or sublingual products, the label must include the statement VIT. When used as an active in oral or sublingual products, the label must include the statement VIT. Behenic acid is a mandatory component of this ingredient (see separate entry).

Calcium beta-hydroxy-betamethylbutyrate monohydrate

A, E

If used as an active AND intended as a mineral supplementation, the equivalent quantity of calcium is required on the product label.

A, E

Substances that may be used in Listed medicines in Australia December 2007

If used as an active AND intended as a mineral supplementation, the equivalent quantity of calcium is required on the product label.

Page 49 of 305

Therapeutic Goods Administration

Ingredient

Calcium citrate hydrate Calcium diglutamate Calcium folinate Calcium gluconate

Use A, E A, E A, E A, E A, E A, E A, E A, E A, E A, C A, E A, E

Restrictions

If used as an active AND intended as a mineral supplementation, the equivalent quantity of calcium is required on the product label. MDD must not provide more than 500 micrograms of folinic acid. When used as an active in oral or sublingual products, the label must include the statement VIT.

Calcium glycerophosphate

If used as an active AND intended as a mineral supplementation, the equivalent quantity of calcium is required on the product label. If used as an active AND intended as a mineral supplementation, the equivalent quantity of calcium is required on the product label. If used as an active AND intended as a mineral supplementation, the equivalent quantity of calcium is required on the product label. If used as an active AND intended as a mineral supplementation, the equivalent quantity of calcium is required on the product label. When used as an active, this ingredient is only listable as an uncompounded BP substance. If used as an active AND intended as a mineral supplementation, the equivalent quantity of calcium is required on the product label.

Calcium hydrogen phosphate Calcium hydrogen phosphate anhydrous Calcium hydrogen phosphate monohydrate Calcium hydroxide Calcium hydroxycitrate

Calcium lactate anhydrous Calcium lactate gluconate

If used as an active AND intended as a mineral supplementation, the equivalent quantity of calcium is required on the product label. If used as an active AND intended as a mineral supplementation, the equivalent quantity of calcium is required on the product label.
Page 50 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Calcium lactate pentahydrate Calcium lactate trihydrate Calcium orotate Calcium oxide

Use A, E A, E A, E E A, E A, E A, E E E

Restrictions

If used as an active AND intended as a mineral supplementation, the equivalent quantity of calcium is required on the product label. If used as an active AND intended as a mineral supplementation, the equivalent quantity of calcium is required on the product label. If used as an active AND intended as a mineral supplementation, the equivalent quantity of calcium is required on the product label. Approved for topical use only. When used as an active in oral or sublingual products, the label must include the statement VIT.

Calcium pantothenate Calcium phosphate Calcium phosphate - monobasic Calcium saccharate Calcium silicate

If used as an active AND intended as a mineral supplementation, the equivalent quantity of calcium is required on the product label. If used as an active AND intended as a mineral supplementation, the equivalent quantity of calcium is required on the product label.

Calcium sodium caseinate Calcium sodium lactate Calcium stearate

A, E E

Requires the label statement COWMK.

If used as an active AND intended as a mineral supplementation, the equivalent quantity of calcium is required on the product label. When used as an excipient, the route of administration is either oral or sublingual, and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.
Page 51 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Calcium succinate Calcium sulfate Calcium sulfate - dried Calendula flower dry Calendula officinalis Callistemon citrinus

Use A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E

Restrictions

If used as an active AND intended as a mineral supplementation, the equivalent quantity of calcium is required on the product label. If used as an active AND intended as a mineral supplementation, the equivalent quantity of calcium is required on the product label. If used as an active AND intended as a mineral supplementation, the equivalent quantity of calcium is required on the product label. If used as an active AND intended as a mineral supplementation, the equivalent quantity of calcium is required on the product label.

Calcium sulfate anhydrous Calendula flower powder Callicarpa pedunculata Callistephus chinensis Callitris rhomboidea Calluna vulgaris Caltha palustris Calochortus tolmiei

May be a native species if exporting this product please contact the DSEWPC.

Native species if exporting this product please contact the DSEWPC.

Substances that may be used in Listed medicines in Australia December 2007

Page 52 of 305

Therapeutic Goods Administration

Ingredient

Calycanthus floridus Camellia japonica Camellia oleifera Camphor Camellia sinensis

Use A, E A, E A, E A, E A, E E, C

Restrictions

Calycanthus praecox

Camellia oleifera (seed oil) when used as a solvent is restricted to topical/suncreen preparations only. In solid and semi solid preparations, the concentration must not exceed 12.5%. In liquid preparations other than essential oils, the concentration must not exceed 2.5%. In essential oil preparations, when the concentration is greater than 2.5% but less than or equal to 10% and the nominal capacity of the container is 25 mL or less, a RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. In essential oil preparations, when the concentration is greater than 10% and the nominal capacity of the container is 15 mL or less, a RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. In essential oil preparations, when the concentration is greater than 10% and the nominal capacity of the container is greater than 15 mL but less than or equal to 25 mL, a CRC and RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. Camphor, Cineole and Safrole are mandatory components of this ingredient (see separate entries). Camphor and Safrole are mandatory components of this ingredient (see separate entries).

Camphor oil brown Camphor oil white Canada balsam

Campsis grandiflora Cananga odorata

A, E A, E A, E A, E

Substances that may be used in Listed medicines in Australia December 2007

May be a native species if exporting this product please contact the DSEWPC.

Page 53 of 305

Therapeutic Goods Administration

Ingredient

Cananga oil

Use A, E A A, E A, E A, E A, E E E E E E E E

Restrictions

Canarium indicum L. var. indicum Canarium luzonicum Candelilla wax Candida utilis Canola oil

May be a native species if exporting this product please contact the DSEWPC.

Permitted only when the plant part is seed and the plant preparation is an oil. Requires the label statement DERIVED. Species listed on CITES if exporting or importing this product please contact the DSEWPC. Allyl isothiocyanate is a mandatory component of this ingredient (see separate entry).

Canthaxanthin

Cape gooseberry

Capparis masaikai

Caprylic/capric triglyceride

Caprylic/capric/isostearic/adipic triglyceride Caprylic/capric/myristic/stearic triglyceride Capryloyl glycine Caprylic/capric/stearic triglyceride

A, E

Only Physalis pubescens fruit permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Approved for topical use only. Concentration must not exceed 3%. Approved for topical use only. Approved for topical use only. Concentration must not exceed 2%.

Substances that may be used in Listed medicines in Australia December 2007

Page 54 of 305

Therapeutic Goods Administration

Ingredient

Capryloyl salicylic acid Caprylyl glycol Capsaicin Caprylyl methicone

Use E E E C

Restrictions

PRV may only be used as an excipient in topical preparations.

Approved for topical use only. Concentration must not exceed 1.25%. Approved for topical use only. Concentration must not exceed 10%.

Capsella bursa-pastoris Capsicum Capsicum annuum Capsicum dry

A, E E A, E A, E A, E A, E A, E E A, E A, E A, E

Only Capsicum annuum and C. frutescens fruit non-spicy permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Capsicum fruit oleoresin Capsicum frutescens Capsicum powder Caramel Caraway dry Caraway oil

As per USP-NF monograph.

Substances that may be used in Listed medicines in Australia December 2007

Caraway powder

Page 55 of 305

Therapeutic Goods Administration

Ingredient

Carbomer - sodium Carbomer 1342 Carbomer 2001 Carbomer 910 Carbomer 934 Carbomer 940 Carbomer 941 Carbomer 954 Carbomer 956 Carbomer 980 Carbomer 981 Carbon

Use E E E E E E E E E E E E E E E

Restrictions

Approved for topical use only. Approved for topical use only.

Approved for topical use only. Concentration must not exceed 1.0% in formulations at pH 7 (approximately neutral) and 0.1% in formulations at a different pH. Approved only in topical preparations for localised effect. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only.

Carbomer 934p

Approved only in topical preparations for localised effect.

Carbomer U-10 Carbon black

Approved for topical use only. Concentration must not exceed 5%.

Substances that may be used in Listed medicines in Australia December 2007

Page 56 of 305

Therapeutic Goods Administration

Ingredient

Carbon dioxide

Use E C

Restrictions

Carbonyl compounds calculated as citral Cardamom fruit dry Cardamom oil Cardamom fruit powder

A, E A, E A, E C A, E A, E A, E E E E E E

Cardenolic glycosides calculated as digitoxin Cardiospermum halicacabum Carica papaya Carmellose Carlina acaulis

Carmellose calcium Carmellose sodium Carmoisine

Carmosine Aluminium lake

When used in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.

Substances that may be used in Listed medicines in Australia December 2007

Page 57 of 305

Therapeutic Goods Administration

Ingredient Carob gum Carob pod Carotenes

Carnauba wax

Use A, E E E E C A, E A, E A, E E E

Restrictions Only Ceratonia siliqua seed endosperm (starch) powder or extract dry without diluent permitted. May only be used as a food excipient refer to introduction for permitted preparations. Only Ceratonia siliqua fruit pericarp (pod without seeds) permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Carotenoids calculated as betacarotene (of Dunaliella salina) Carpesium abrotanoides Carpinus betulus Carrageenan Carrot Carpinus cordata

Carrot seed oil Carum carvi

Carthamus tinctorius Carya illinoinensis

A, E A, E A, E A, E

Only Daucus carota ssp. sativus root permitted. May only be used as a food excipient refer to introduction for permitted preparations.

When Carthamus tinctorius is used as a solvent the resulting preparation is for topical use only.

Substances that may be used in Listed medicines in Australia December 2007

Page 58 of 305

Therapeutic Goods Administration

Ingredient

Carya ovata Cascara dry Cascara powder Cascarilla oil Cascaroside A Cascaroside B Casein

Use A, E A A C C C

Restrictions Hydroxyanthracene derivatives calculated as cascaroside A is a mandatory component of this ingredient in oral products (see separate entry). MRDD must contain 1 mg or less of the equivalent dry herbal material.

A, E

Hydroxyanthracene derivatives calculated as cascaroside A is a mandatory component of this ingredient in oral products (see separate entry).

Cascarosides calculated as cascaroside A Cashew nut

E E A

If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. Only Anacardium occidentale seed (kernel) is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Hydroxyanthracene glycosides calculated as sennoside B is a mandatory component of this ingredient in oral products (see separate entry).

Cassia angustifolia

Cassia cinnamon bark dry

Cassia cinnamon bark powder

A, E A, E

Substances that may be used in Listed medicines in Australia December 2007

Page 59 of 305

Therapeutic Goods Administration

Ingredient

Cassia fistula Cassia oil

Use A

Restrictions

Cassia occidentalis Cassia senna Cassia tora Castanea mollissima Castanea sativa Castor oil

A, E A, E A A

Hydroxyanthracene glycosides calculated as sennoside B is a mandatory component of this ingredient in oral products (see separate entry).

Hydroxyanthracene glycosides calculated as sennoside B is a mandatory component of this ingredient in oral products (see separate entry). Hydroxyanthracene glycosides calculated as sennoside B is a mandatory component of this ingredient in oral products (see separate entry). Hydroxyanthracene glycosides calculated as sennoside B is a mandatory component of this ingredient in oral products (see separate entry).

When the preparation is for dermal use as a rubefacient the concentration must not exceed 5%. In other products the concentration must not exceed 2%.

Casticin (of Vitex agnus-castus)

A, E A, E C A, E E E A, E A, E

Castor oil - ethoxylated hydrogenated Castor oil - hydrogenated Castor oil - sulfated Casuarina equisitifolia

When used as an active, this ingredient is only listable as an uncompounded BP substance. Approved for topical use only. May be a native species if exporting this product please contact the DSEWPC.

Substances that may be used in Listed medicines in Australia December 2007

Page 60 of 305

Therapeutic Goods Administration

Ingredient

Catalpa bignonioides Catalpa ovata

Use A, E A, E C C

Restrictions

Catechin (of Uncaria gambir) Catechu

Catechins (of Camellia sinensis) Catharanthus roseus Cauliflower

A, E A E

Vinblastine, Vincamine, Vincristine, Vindesine, Vinorelbine and Yohimbine are mandatory components of this ingredient (see separate entries).

Caulophyllum thalictroides Ceanothus americanus Cedar leaf oil Cedrela sinensis Cedrus atlantica Cedrus deodara Cedrus libani

A, E A, E A, E A, E A, E A, E A, E

Only Brassica oleracea convar. Botrytis var. botrytis immature flower head white is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Substances that may be used in Listed medicines in Australia December 2007

Page 61 of 305

Therapeutic Goods Administration

Ingredient Celeriac

Use E E

Restrictions

Celery leaf

Only Apium graveolens var. dulce root is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Only Apium graveolens var. dulce leaf stalk (petiole) or leaf is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Celery seed dry Celery seed oil Cellacephate Cellulase

Celery seed powder

A, E A, E A, E E E E E A, C

Cellulose - dispersible Cellulose - powdered Celosia argentia Celosia cristata

Cellulose - microcrystalline

Permitted only when derived from Trichoderma longibrachiatum,

Centaurea cyanus Centella asiatica

A, E A, E A, E A, E A, E

Centaurium erythraea

Substances that may be used in Listed medicines in Australia December 2007

May be a native species if exporting this product please contact the DSEWPC.

Page 62 of 305

Therapeutic Goods Administration

Ingredient

Centipeda cunninghamii Centipeda minima Cephaelis acuminata

Use A, E A, E A A E E E E E

Restrictions

May be a native species if exporting this product please contact the DSEWPC. May be a native species if exporting this product please contact the DSEWPC. Emetine is a mandatory component of this ingredient (see separate entry). Emetine is a mandatory component of this ingredient (see separate entry). PRV may only be used as an excipient in topical preparations. Approved only in topical preparations for localised effect.

Cephaelis ipecacuanha Cephalins

Cephalanopsis segetum Ceramide 1 Ceramide 2 Ceramide 3

A, E

Ceramide 6 II

Approved for topical use only. Concentration must not exceed 0.05%. Approved only in topical preparations for localised effect. PRV may only be used as an excipient in topical preparations.

Ceratonia siliqua Ceresin

Ceratostigma willmottianum Cereus grandiflorus Ceteareth-12 Ceteareth-15

A, E A, E E E E A, E

Approved for topical use only. Approved for topical use only.

Species listed on CITES if exporting or importing this product please contact the DSEWPC. PRV may only be used as an excipient in topical preparations.

Substances that may be used in Listed medicines in Australia December 2007

Page 63 of 305

Therapeutic Goods Administration

Ingredient

Ceteareth-2

Use E E E E E E E E E E E E E E

Restrictions

Ceteareth-20 Ceteareth-25 Ceteareth-30 Ceteareth-33 Cetearyl glucoside

Approved for topical use only. Approved for topical use only. Approved for topical use only.

Approved for topical use only.

Cetearyl isononanoate Cetearyl octanoate Ceteth-10 Ceteth-2 Ceteth-5 Ceteth-24

Approved for topical use only. Concentration must not exceed 0.2%. Residual levels of 1,4-dioxane and ethylene oxide (and related substances) are to be kept below the level of detection. Approved only in topical preparations for localised effect. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only.

Cetomacrogol 1000 Cetostearyl alcohol Cetraria islandica

Substances that may be used in Listed medicines in Australia December 2007

A, E

May be a native species if exporting this product please contact the DSEWPC.

Page 64 of 305

Therapeutic Goods Administration

Ingredient

Cetrimonium bromide Cetrimonium chloride Cetyl acetate Cetyl alcohol

Use E E E E E E E E E E E E E E

Restrictions

Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only.

Cetyl dimethicone Cetyl esters wax Cetyl lactate Cetyl myristate Cetyl palmitate

Cetyl dimethicone copolyol

Cetyl octanoate

PRV may only be used as an excipient in topical preparations.

Cetyl phosphate

Cetyl ricinoleate

Cetylpyridinium chloride Chaenomeles lagenaria Chaenomeles sinensis

A, E A, E

PRV may only be used as an excipient in topical preparations.

Approved only in topical preparations for localised effect. Requires the label statement CPYCHL.

Substances that may be used in Listed medicines in Australia December 2007

Page 65 of 305

Therapeutic Goods Administration

Ingredient

Chaenomeles speciosa Chaetomium indicum Chalk

Use A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E C A, E A, E A, E

Restrictions

Chaetomium globosum

Chamaecyparis lawsoniana Chamaelirium luteum Chamomile flower dry Chamomile oil english

When used as an active, this ingredient is only listable as an uncompounded BP substance.

Chamomile oil german Charcoal - activated Cheiranthus cheiri Chelidonine

Changium smyrnioides

Requires the label statement ACCOAL.

Chelidonium majus Chelone glabra

Substances that may be used in Listed medicines in Australia December 2007

Chenopodium album

Oral products require the label statement CELAND.

Page 66 of 305

Therapeutic Goods Administration

Ingredient

Chenopodium ambrosioides Chenopodium vulvaria Cherry Chestnut sweet Chicken Chilli Chicken powder - black boned Chimaphila umbellata Chitin

Use A, E A, E E E E E A A, E A, E E E E A

Restrictions

Volatile oil components (of Chenopodium ambrosioides) is a mandatory component of this ingredient (see separate entry).

Only Prunus avium, P. cerasus and hybrids fruit flesh permitted. May only be used as a food excipient refer to introduction for permitted preparations. Requires pre-clearance from TGAL. Requires pre-clearance from TGAL.

Only Castanea sativa seed (nut kernel) permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Chionanthus virginica Chitosan

Only Capsicum annuum and C. frutescens fruit spicy-hot is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Chlamydomonas reinhardti cytoplasm extract ICID 2004 Chlorbutol

PRV may only be used as an excipient in topical preparations. Requires the label statements CHITO and SFOOD. PRV may only be used as an excipient in topical preparations.

Approved for topical use only. Concentration must not exceed 0.5%. Requires the label statement CHLORB.
Page 67 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient Chlorella

Use E

Restrictions

Chlorella vulgaris (Chlorella pyrenoidosa is invalid) Chlorhexidine acetate Chloride Chlorine Chlorhexidine gluconate

A, E E E C C

Only Chlorella vulgaris (Chlorella pyrenoidosa is invalid) cells permitted. May be used as a food excipient refer to introduction for permitted preparations. Iodine is a mandatory component of this ingredient (see separate entry). Native species - if exporting this product please contact the DSEWPC. Iodine is a mandatory component of this ingredient (see separate entry). Native species - if exporting this product please contact the DSEWPC. Approved for topical use only. Approved for topical use only.

Chloroacetamide Chlorocresol Chloroform Chlorophyll

E E E E E E A, E

Concentration from all ingredients must not exceed 4%. Approved for topical use only.

Approved for topical use only. Concentration must not exceed 3%. Topical products require the label statement CHLCRS. Concentration must not exceed 0.006%. Residual solvent limit is 0.6 mg per MDD.

Chlorophyll-copper complexes Chlorophyllin-copper complex Chloroxylenol

Approved for topical use only.


Page 68 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Chlorphenesin

Use E E E E E E E E C

Restrictions

Chocolate brown HT Cholecalciferol Cholesterol

A, E, C

Approved for topical use only.

Cholesteryl hydroxystearate Cholesteryl macadamiate Cholesteryl/behenyl/octyldodecyl lauroyl glutamate Cholesteryl/octyldodecyl lauroyl glutamate Choleth-24 Choline

If the product is for internal use it is listable only if the MRDD contains 25 micrograms or less of vitamin D. When used as an active in oral or sublingual products, the label must include the statement VIT. Approved for topical use only as an excipient. Requires pre-clearance from TGAL. Approved for topical use only. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL.

Approved only in topical preparations for localised effect. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL.

Approved for topical use only. Concentration must not exceed 0.5%. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL Approved for topical use only.

PRV may only be used as an excipient in topical preparations. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL

Choline bitartrate

Chondrodendron tomentosum

A, E A

Requires pre-clearance from TGAL.

Concentration of equivalent dry herbal material must not exceed 10 mg/Kg or 10 mg/L or 0.001%.
Page 69 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Chondroitin sulfate

Use C

Restrictions

Chondroitin sulfate - bovine

Chondroitin sulfate - bovine calcium Chondroitin sulfate - bovine sodium Chondroitin sulfate - shark Chondroitin sulfate - shark calcium Chondroitin sulfate - shark sodium Chondrus crispus Chondrus dry Chondrus extract Chromic chloride

A, C A A A A A A A

Can only be used as a component and it is not listable in its own right. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL.

Chondroitin sulfate - bovine potassium

Chondroitin sulfate - shark potassium

A, E A, E A, E A, E

Iodine is a mandatory component of this ingredient (see separate entry). Iodine is a mandatory component of this ingredient (see separate entry).

Iodine is a mandatory component of this ingredient (see separate entry).

Substances that may be used in Listed medicines in Australia December 2007

If used as an active AND intended as a mineral supplementation, the equivalent quantity of chromium is required on the product label.

Page 70 of 305

Therapeutic Goods Administration

Ingredient Chromium

Use C

Restrictions

Chromium nicotinate Chromium picolinate

Chromium oxide greens

A, E E A, E A, E A, E A, E A, E A, E C A, E A, E C A, E A

MRDD may only provide 50 micrograms or less of chromium from organic sources (ie chromium picolinate and chromium nicotinate). Chromium sourced from inorganic materials is listable without restrictions. Chromium is a mandatory component of this ingredient (see separate entry). PRV may only be used as an excipient in topical preparations.

Chrysanthemum balsamita Chrysanthemum indicum

Chromium is a mandatory component of this ingredient (see separate entry).

Chrysanthemum leucanthemum Chrysanthemum marshallii Chrysanthemum sinense Chrysophanol

Chrysosporium pruinosum Cibotium barometz Cichoric acid Cichorium intybus Cicuta virosa

Species listed on CITES if exporting or importing this product please contact the DSEWPC.

Substances that may be used in Listed medicines in Australia December 2007

MRDD must contain 1 mg or less of the equivalent dry herbal material.

Page 71 of 305

Therapeutic Goods Administration

Ingredient

Cimicifuga foetida

Use A, E A, E A, E A, E A A A A

Restrictions

Cimicifuga heracleifolia Cimicifuga racemosa Cimicifuga simplex Cinchona bark dry

Requires the label statement BLKCOH.

Cinchona bark powder Cinchona officinalis Cineole Cinchona pubescens

Quinidine and Quinine are mandatory components of this ingredient (see separate entries). Quinidine and Quinine are mandatory components of this ingredient (see separate entries). Quinidine and Quinine are mandatory components of this ingredient (see separate entries). Quinidine and Quinine are mandatory components of this ingredient (see separate entries).

A, E, C

Cinnamomum camphora Cinnamomum cassia

A, E A, E

When used as an active, permitted only in Medicated Space Sprays or Medicated Throat Lozenges. When the concentration is greater than 25% and the nominal capacity of the container is 15 mL or less, a a RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. When the concentration is greater than 25% and the nominal capacity of the container is greater than 15 mL but less than or equal to 25 mL, a CRC and RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. If the plant preparation is an oil, the concentration of this oil must not exceed 10 mg/Kg or 10 mg/L or 0.001%. Cassia oil is a mandatory component of this ingredient (see separate entry).

Camphor, Cineole and Safrole are mandatory components of this ingredient (see separate entries).

Substances that may be used in Listed medicines in Australia December 2007

Page 72 of 305

Therapeutic Goods Administration

Ingredient

Cinnamomum zeylanicum

Use A, E

Restrictions

Cinnamon bark oil Cinnamon dry Cinnamon leaf oil

A, E A, E A, E

If the plant part is bark and the plant preparation is an oil, the concentration of this oil must not exceed 2%. When the plant part is leaf, the plant preparation is an oil, the concentration of this oil is greater than 25%, and the nominal capacity of the container is 15 mL or less, a RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. When the plant part is leaf, the plant preparation is an oil the concentration of this oil is greater than 25%, and the nominal capacity of the container is greater than 15 mL but less than or equal to 25 mL, a CRC and RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. Concentration must not exceed 2%.

Cinnamon powder Cinoxate Cis-betacarotenes Cistanche salsa

A, E A C

Permitted without restriction in preparations containing 25% or less. When the concentration is greater than 25% and the nominal capacity of the container is 15 mL or less, a RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. When the concentration is greater than 25% and the nominal capacity of the container is greater than 15 mL but less than or equal to 25 mL, a CRC and RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. Sunscreen active permitted only in topical products. Concentration must not exceed 6%.

Cistanche deserticola Cistus ladaniferus

A, E A, E A, E

Species listed on CITES if exporting or importing this product please contact the DSEWPC.

Substances that may be used in Listed medicines in Australia December 2007

Page 73 of 305

Therapeutic Goods Administration

Ingredient Citral Citrate

Use E C

Restrictions

Citric acid - anhydrous Citric acid-dihydrate Citron Citric acid monohydrate Citronella oil Citronellol

A, E, C A, E A, E E E A, E A, E A, E A, E A, E A, E

Sponsors should consider the impact of excipients on the sensitivity of the skin to sunlight and should ensure the finished product is safe for its intended purpose. Sponsors should consider the impact of excipients on the sensitivity of the skin to sunlight and should ensure the finished product is safe for its intended purpose. Sponsors should consider the impact of excipients on the sensitivity of the skin to sunlight and should ensure the finished product is safe for its intended purpose. Topical products require the label statement CITRON. Approved for topical use only.

Only Citrus medica fruit flesh or fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Citrullus colocynthis Citrullus vulgaris Citrus aurantium Citrus aurantifolia

Citrus bioflavonoids extract

Oxedrine is a mandatory component of this ingredient when used for internal use (see separate entry).

Substances that may be used in Listed medicines in Australia December 2007

Page 74 of 305

Therapeutic Goods Administration

Ingredient Citrus fibre

Citrus chachiensis Citrus junos seed extract 1:10 in 90% E:W ICID 2006 Citrus limetta Citrus limon

Use A, E E E

Restrictions Only Citrus (species) fruit fibre is permitted. May only be used as a food excipient refer to introduction for permitted preparations. PRV may only be used as an excipient in topical preparations.

A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E

Citrus maxima Citrus medica

Oxedrine is a mandatory component of this ingredient when used for internal use (see separate entry).

Citrus reticulata Citrus sinensis Citrus unshiu

Oxedrine is a mandatory component of this ingredient when used for internal use (see separate entry) Oxedrine is a mandatory component of this ingredient when used for internal use (see separate entry). Oxedrine is a mandatory component of this ingredient when used for internal use (see separate entry).

Citrus x paradisi Citrus x wilsonii Clary oil

Substances that may be used in Listed medicines in Australia December 2007

Page 75 of 305

Therapeutic Goods Administration

Ingredient

Claviceps purpurea Clematis armandii Clematis recta Clematis sinensis Clematis vitalba Clerodendron trichotomum Clinopodion polycephalum Cliver herb dry Clove bud oil Cliver herb powder

Use A A, E A, E A, E A, E A, E A, E A, E A, E A, E

Restrictions

Concentration of equivalent dry herbal material must not exceed 10 mg/Kg or 10 mg/L or 0.001%. Sponsors must confirm the absence of aristolochic acids or herbal species known to contain these acids. Sponsors must confirm the absence of aristolochic acids or herbal species known to contain these acids. Sponsors must confirm the absence of aristolochic acids or herbal species known to contain these acids. Sponsors must confirm the absence of aristolochic acids or herbal species known to contain these acids.

Clove dry

A, E

Permitted without restriction in preparations containing 25% or less. When the concentration is greater than 25% and the nominal capacity of the container is 15 mL or less, a RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. When the concentration is greater than 25% and the nominal capacity of the container is greater than 15 mL but less than or equal to 25 mL, a CRC and RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN.

Substances that may be used in Listed medicines in Australia December 2007

Page 76 of 305

Therapeutic Goods Administration

Ingredient

Clove leaf oil

Use A, E

Restrictions

Clove powder

Clove stem oil

A, E A, E

Permitted without restriction in preparations containing 25% or less. When the concentration is greater than 25% and the nominal capacity of the container is 15 mL or less, a RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. When the concentration is greater than 25% and the nominal capacity of the container is greater than 15 mL but less than or equal to 25 mL, a CRC and RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. Permitted without restriction in preparations containing 25% or less. When the concentration is greater than 25% and the nominal capacity of the container is 15 mL or less, a RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. When the concentration is greater than 25% and the nominal capacity of the container is greater than 15 mL but less than or equal to 25 mL, a CRC and RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN.

Cnicus benedictus Cnicus japonicus Cnicus marianus

A, E A, E A, E A, E A, E E E

Cnidium monnieri Cocamide dea

Cnidium officinale Cocamide mea

Approved for topical use only. Approved for topical use only.

Substances that may be used in Listed medicines in Australia December 2007

Page 77 of 305

Therapeutic Goods Administration

Ingredient

Cocamidopropyl betaine Coccolobia uvifera Cochineal

Use E

Restrictions

Cocculus sarmentosus Cochlearia officinalis Cocillana dry

A, E A, E E A, E A, E A A E E E E

Approved for topical use only. Concentration must not exceed 0.8% (buccal mucosa), 1% (dermal application) and 6% (wash-on/wash off products). Levels of impurities 3dimethylaminopropylamine (DMAPA) and amidoamine (dimethylaminopropyl cocoamide; AA) should be controlled to below the level of detection.

Sponsors must confirm the absence of aristolochic acids or herbal species known to contain these acids.

Cochliobolus heterostrophus Cocillana powder Coco-betaine

Coco-caprylate/caprate Cocoa powder Coconut Cocoglycerides

A, E

Approved for topical use only.

Approved for topical use only.

Only Cocos nucifera seed (nut) endosperm (flesh) is permitted. May only be used as a food excipient refer to introduction for permitted preparations.
Page 78 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient Coconut oil

Coconut acid

Use E E E A, E

Restrictions

Coconut oil - fractionated Cocos nucifera Cod-liver oil

Approved for topical use only.

Coconut oil - hydrogenated

Codonopsis lanceolata Codonopsis pilosula Coffea arabica Coffee Codonopsis tangshen Coffea canephora Cognac oil green Cola acuminata

A, E A, E A, E A, E A, E A, E A, E E A, E A, E A, E

If vitamin A is claimed as a component then it must conform to the BP monograph for cod-liver oil.

Coix lachryma-jobi

Only Coffea arabica and C. canephora seed (bean) is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Substances that may be used in Listed medicines in Australia December 2007

Page 79 of 305

Therapeutic Goods Administration

Ingredient

Cola cotyledon dry Cola nitida Colchicine

Use A, E A, E A, E C A

Restrictions

Cola cotyledon powder

Colchicum autumnale Colecalciferol Collagen Coleus forskohlii Collagen - hydrolysed Colocasia esculenta Colophony

A, E A, E E E

Concentration must not exceed 10 mg/kg or 10 mg/L or 0.001%.

Concentration of equivalent dry herbal material must not exceed 10 mg/Kg or 10 mg/L or 0.001%. If the product is for internal use it is listable only if the MRDD contains 25 micrograms or less of vitamin D. When used as an active in oral or sublingual products, the label must include the statement VIT.

If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL.

Collinsonia canadensis

A, E A, E A, E A A, E

Colostrum powder - bovine Commiphora abyssinica

Requires pre-clearance from TGAL. Requires the label statement BOVCOL.


Page 80 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Commiphora erythraea Commiphora molmol Commiphora myrrha Condurangin

Use A, E A, E A, E A C A A

Restrictions

Concentrated omega-3 triglyceridesfish Conifer green needle complex Conioselium univittatum Convallaria majalis Copaiba oil Convolvulus arvensis

Approved for oral use only. Permitted in oral and topical products only.

A, E A, E A, E A, E A, E C E

Concentration of equivalent dry herbal material must not exceed 10 mg/Kg or 10 mg/L or 0.001%.

Copaifera langsdorffii Copernicia cerifera Copper

Copper acetyl tyrosinate methylsilanol

Approved for topical use only.


Page 81 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Copper gluconate Coptis chinensis Coptis japonica

Use A, E E A, E A, E E A, E A, E A, E A, E A, E E A, E A, E A, E A, E

Restrictions

Copper tripeptide-1

Concentration of copper compounds in topical products must not exceed 5%. Products for internal use must not contain a MDD more than 5 mg of copper. If used as an active AND intended as a mineral supplementation, the equivalent quantity of copper is required on the product label. Approved for topical use only. Concentration must not exceed 3%.

Corallina officinalis Cordyceps sinensis Coriander dry Coriander oil

Approved for topical use only. Concentration must not exceed 1%.

Must not contain any material of animal origin such as insect larvae.

Coriander powder Corn glycerides Corn silk dry

Coriandrum sativum

Corn silk powder Cornus florida

Substances that may be used in Listed medicines in Australia December 2007

Cornus officinalis

Page 82 of 305

Therapeutic Goods Administration

Ingredient

Corydalis ambigua Corydalis cava

Use A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E E A, E A, E

Restrictions

Corydalis bungeana Corydalis fabacea

Corydalis formosa

Corydalis turtschaninovii Corylus americana Corylus avellana Costus root oil Cotton

Cosmos bipinnatus Costus spicatus Cottonseed oil

Species listed on CITES if exporting or importing this product please contact the DSEWPC.

Cottonseed oil - hydrogenated Couch grass rhizome dry Couch grass rhizome powder

Substances that may be used in Listed medicines in Australia December 2007

Page 83 of 305

Therapeutic Goods Administration

Ingredient Coumarin

Use C

Restrictions

Cowberry

Cranberry

E E A, E A, E A, E A, E A, E A, E A, E A, E E E, C

Permitted only as a component and if its concentration is less than 0.001%. If it is in a proprietary ingredient as a fragrance or similar reason (ie non-therapeutic) then the restriction does not apply. Only Vaccinium vitis-idaea fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Only Vaccinium oxycoccus fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Crataegus cuneata

Crataegus laevigata

Crataegus monogyna Crateva nurvala Creatine

Crataegus pinnatifida

Creatine monohydrate Creatine phosphate Creatinine Cresol

Requires the label statement PROFES. Requires the label statement PROFES. Requires the label statement PROFES.

Approved for topical use only. Concentration must not exceed 0.2%.

Substances that may be used in Listed medicines in Australia December 2007

Approved only in topical preparations for localised effect. Requires the label statement CRESOL. Concentration of phenols including cresols and xylenols and any other homologue of phenol boiling below 220 degrees centigrade must not exceed 3%.

Page 84 of 305

Therapeutic Goods Administration

Ingredient

Crithmum maritimum leaf ext 1:1 in 50% 1,3-butyleneglycol : W ICID2002 Crithmum maritimum whole plant extract 1:9 in 50% propylene glycol : W ICID2004 Crocus sativus Crospovidone Croscarmellose sodium Croton cascarilla Croton eluteria Cubeb oil

Use E E E E

Restrictions

PRV may only be used as an excipient in topical preparations. Concentration must not exceed 1%. Approved for topical use only. Concentration must not exceed 0.00341%.

A, E

Cryptomeria japonica Cucumber

A A

When used in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. MRDD must contain 1 mg or less of the equivalent dry herbal material.

A, E A, E E A, E A, E A, E

MRDD must contain 1 mg or less of the equivalent dry herbal material.

Cucumis melo

Cucumis sativus

Only Cucumis sativus fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Cucurbita maxima

Substances that may be used in Listed medicines in Australia December 2007

Page 85 of 305

Therapeutic Goods Administration

Ingredient

Cucurbita moschata Cucurbita pepo Cucurbitacin B Cucurbitacin E Cumin oil

Use A, E A, E C C

Restrictions

Cuminum cyminum Cunila pulegioides

A, E A, E A, E A, E A, E A, E A, E A, E A, E

Cupressus arizonica Cupressus funebris

Cupressus macrocarpa Cupric citrate

Cupressus sempervirens Cupric citrate hemipentahydrate

Permitted only if the MRDD provides 750 micrograms or less of copper from cupric citrate OR if the MRDD provides 1.86 milligrams or less of cupric citrate. If used as an active AND intended as a mineral supplementation, the equivalent quantity of copper is required on the product label.

Permitted only if the MRDD provides 750 micrograms or less of copper from Cupric citrate hemipentahydrate OR if the MRDD provides 2.13 milligrams or less of cupric citrate hemipentahydrate. If used as an active AND intended as a mineral supplementation, the equivalent quantity of copper is required on the product label.
Page 86 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Cupric nitrate trihydrate Cupric oxide Cupric sulfate anhydrous

Use E A, E

Restrictions

Approved for topical use only. Concentration must not exceed 0.00008%

Cupric sulfate monohydrate Cupric sulfate pentahydrate Curculigo orchioides Curcuma aromatica Curcuma longa

A, E, C A, E A, E A, E A, E A, E A, E A, E C

In products for internal use it is listable without restriction. In other types of products the concentration from all ingredients must not exceed 5%. If used as an active AND intended as a mineral supplementation, the equivalent quantity of copper is required on the product label. In products for internal use it is listable without restriction. In other types of products the concentration from all ingredients must not exceed 5%. If used as an active AND intended as a mineral supplementation, the equivalent quantity of copper is required on the product label. When used topically, Cupric sulfate anhydrous is a mandatory component of this ingredient (see separate entry). If used as an active AND intended as a mineral supplementation, the equivalent quantity of copper is required in the application and also on the product label. When used topically, Cupric sulfate anhydrous is a mandatory component of this ingredient (see separate entry). If used as an active AND intended as a mineral supplementation, the equivalent quantity of copper is required in the application and also on the product label.

Curcuma xanthorrhiza Curcuma zedoaria Curcumin

Substances that may be used in Listed medicines in Australia December 2007

Curcuminoids (of Curcuma longa)

A, E, C
Page 87 of 305

Therapeutic Goods Administration

Ingredient

Cuscuta epithymum Cuscuta europaea

Use A, E A, E A, E A, E A, E A, E C A, E A, E E E C A, E

Restrictions

Cuscuta hygrophilae Cuscuta racemosa Cusparia febrifuga Cyanidin

Cyamopsis tetragonolobus Cyanocobalamin

Cyathula officinalis

Cyclamen aldehyde Cyclomethicone

When used as an active in oral or sublingual products, the label must include the statement VIT. Approved for topical use only. Approved for topical use only.

Cyclamen europaeum

Cyclopentane sesquiterpenes (of Valeriana officinalis) Cydonia oblonga Cymbopogon flexuosus

Species listed on CITES if exporting or importing this product please contact the DSEWPC.

A, E A, E
Page 88 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Cymbopogon martini Cymbopogon nardus Cynanchum atratum Cynara scolymus

Use A, E A, E A, E A, E A, E A, E C A, E A, E A, E A, E A, E A, E A, E A

Restrictions

Cymbopogon schoenanthus Cynanchum stauntonii

Cynarine (of Cyanara scolymus) Cynodon dactylon Cyperus longus Cynomorium songariorum Cyperus rotundus Cysteine Cystine

Cypripedium pubescens Cysteine hydrochloride Cytisus laburnum

A, E, C

Species listed on CITES if exporting or importing this product please contact the DSEWPC.

Substances that may be used in Listed medicines in Australia December 2007

Sparteine is a mandatory component of this ingredient (see separate entry).

Page 89 of 305

Therapeutic Goods Administration

Ingredient

D-Alpha-tocopherol

Use

D-Alpha-tocopheryl acetate D-Pulegone

D-Alpha-tocopheryl acid succinate Dactylis glomerata Dahlia pinnata Daidzein Daidzin

A, E, C A, E, C A, E, C C A, E A, E A, E C C

Restrictions

When used as an active in oral or sublingual products, the label must include the statement VIT. When used as an active in oral or sublingual products, the label must include the statement VIT. When used as an active in oral or sublingual products, the label must include the statement VIT.

Daemonorops draco

Permitted without restriction in preparations containing 4% or less. When the concentration is greater than 4%, the nominal capacity of the container must be 15 mL or less, a CRC and RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN.

Dalbergia odorifera Dandelion leaf dry

Damiana leaf powder

A, E A A, E A, E A, E A, E
Page 90 of 305

Dandelion leaf powder Dandelion root dry

Substances that may be used in Listed medicines in Australia December 2007

Dandelion root powder

Therapeutic Goods Administration

Ingredient

Daphne genkwa Date

Use A, E A E C A A, E E E E E E E E C

Restrictions MRDD must contain 1 mg or less of the equivalent dry herbal material.

Daphne mezereum Datura stramonium Daucosterol Daucus carota

Only Phoenix dactylifera fruit flesh (pitted) is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Approved only for use in oral preparations. Alkaloids calculated as hyoscyamine is a mandatory component of this ingredient (see separate entry).

Dea-cetyl phosphate

DEA-Oleth-3 phosphate Decyl glucoside Decyl oleate

Approved for topical use only.

Decarboxy carnoisine dihydrochloride

Approved only in topical preparations for localised effect. Concentration must not exceed 1.0%. Requires the label statements EYE and EYE2. PRV may only be used as an excipient in topical preparations. Approved for topical use only. Approved for topical use only.

Dehydroacetic acid Delphinidin

Dehydroxanthan gum

Approved only in topical preparations for localised effect. Requires the label statement DACACD. Approved for topical use only. Concentration must not exceed 0.2%.

Substances that may be used in Listed medicines in Australia December 2007

Page 91 of 305

Therapeutic Goods Administration

Ingredient

Delphinium staphisagria Delta-tocopherol

Use A A E E, C

Restrictions

Demineralised fish proteoglycan extract Denatonium benzoate Dendrobium nobile

Concentration of equivalent dry herbal material must not exceed 0.2%.

Desmodium styracifolium Desmodium triquetum Devil's claw tuber dry Dexpanthenol Dextrates Dextrin

A, E A, E A, E A A E E E E E

Species listed on CITES if exporting or importing this product please contact the DSEWPC.

Devil's claw tuber powder

A, E

When used as an active in oral or sublingual products, the label must include the statement VIT.

Dextrin palmitate

Di-C12-13 alkyl malate

Substances that may be used in Listed medicines in Australia December 2007

Di-C12-15 alkyl fumarate

PRV may only be used as an excipient in topical preparations.

Approved for topical use only. Concentration must not exceed 5%. Approved for topical use only. Concentration must not exceed 5%.
Page 92 of 305

Therapeutic Goods Administration

Ingredient

Di-N propyl isocinchomeronate Diallyl disulfide

Use E E C E E C C

Restrictions

Di-PPG-3 myristyl ether adipate

Approved for topical use only. Concentration must not exceed 25%.

Diammonium lauryl sulfosuccinate Dianthus superbus Diazolidinylurea

Approved for topical use only. Concentration must not exceed 15%. Approved for topical use only.

Dibenzocyclooctadiene lignans calculated as g-schisandrins (of Schizandra chinensis fruit) Dibutyl adipate

A, E

Approved for topical use only. Topical products require the label statement DUREA.

Dibenzocyclooctadiene lignans (of Schizandra chinensis seed) Dibutyl phthalate Dibutyl sebacate Dicaprylyl ether

E E E E E E

Approved only in topical preparations for localised effect. Approved for topical use only.

Dicaprylyl carbonate Dicaprylyl maleate

Approved for topical use only. Concentration must not exceed 34%. Approved for topical use only. Approved for topical use only. Concentration must not exceed 10%.

Substances that may be used in Listed medicines in Australia December 2007

Page 93 of 305

Therapeutic Goods Administration

Ingredient

Dichlorobenzyl alcohol Dichloromethane Dictamnus albus Diethanolamine Dichroa febrifuga

Use E E

Restrictions Concentration must not exceed 0.06%. Residual solvent limit is 6 mg per MDD.

Dictamnus desycarpus Diethyl phthalate

A, E A, E A, E E E E E E E E A A A

Diethyl toluamide

Approved for topical use only. Concentration must not exceed 5%.

Diethylaminomethylcoumarin Diethylhexyl-2,6-naphthalate Diethylhexyl sebacate Digitalis leaf dry Digitalis leaf powder Digitalis purpurea

Diethylene glycol monoethyl ether

Approved only in topical preparations for localised effect. Concentration must not exceed 20%. Requires the label statement DEET. PRV may only be used as an excipient in topical preparations. Approved for topical use only.

Approved only in topical preparations for localised effect. Concentration must not exceed 10%. Requires the label statement EYE2. Approved for topical use only. Concentration must not exceed 5%. Concentration must not exceed 10 mg/Kg or 10 mg/L or 0.001%. Concentration must not exceed 10 mg/Kg or 10 mg/L or 0.001%.

Substances that may be used in Listed medicines in Australia December 2007

Concentration of equivalent dry herbal material must not exceed 10 mg/Kg or 10 mg/L or 0.001%.

Page 94 of 305

Therapeutic Goods Administration

Ingredient

Diglycol/chdm/isophthalates/sip copolymer Dihydrocholeth-30 Dihydroxyacetone

Use E E E E E E E E E

Restrictions

Approved for topical use only.

Dihydrogenated tallow phthalic acid amide Diisopropyl adipate

PRV may only be used as an excipient in topical preparations. Approved for topical use only.

Approved for topical use only. Concentration must not exceed 5%. Approved for topical use only. Concentration must not exceed 15%. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Concentration must not exceed 10%.

Diisopropyl dimer dilinoleate Diisopropyl sebacate

Diisostearyl dimer dilinoleate Dilauryl thiodipropionate Dill herb oil Dill seed oil

Dimer distearyltricarbonate Dimethicone 10 Dimethicone 100

A, E A, E E E E E

Approved for topical use only. Concentration must not exceed 4%. Approved for topical use only.

Substances that may be used in Listed medicines in Australia December 2007

Dimethicone 1000

Page 95 of 305

Therapeutic Goods Administration

Ingredient

Dimethicone 10000 Dimethicone 12500 Dimethicone 20 Dimethicone 30 Dimethicone 200 Dimethicone 350 Dimethicone 360 Dimethicone 450 Dimethicone 5 Dimethicone 50 Dimethicone 4000

Use E E E E

Restrictions

PRV may only be used as an excipient in topical preparations. Approved only in topical preparations for localised effect. Approved for topical use only.

A, E A, E E E E E E E E E E

When used as an active, this ingredient is only listable as an uncompounded BP substance. Approved for topical use only as an excipient. Concentration must not exceed 4%. When used as an active, this ingredient is only listable as an uncompounded BP substance. Approved for topical use only as an excipient. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. PRV may only be used as an excipient in topical preparations.

Dimethicone 500

Approved for topical use only. Concentration must not exceed 10%.

Dimethicone copolyol

Dimethicone copolyol phosphate Dimethicone crosspolymer

Approved only in topical preparations for localised effect.

Substances that may be used in Listed medicines in Australia December 2007

Approved for topical use only. Concentration must not exceed 15%.

Page 96 of 305

Therapeutic Goods Administration

Ingredient

Dimethicone/methicone copolymer Dimethicone/vinyl dimethicone crosspolymer Dimethiconol Dimethiconol stearate Dioctyl adipate Dioctyl maleate

Use E E E E E E E

Restrictions

Approved for topical use only. Concentration must not exceed 4%. PRV may only be used as an excipient in topical preparations. Approved for topical use only. Approved for topical use only.

Approved for topical use only. Concentration must not exceed 2%. Approved for topical use only. Approved for topical use only.

Dioctyl succinate

Dioscorea batatas

Dioscorea collettii

Dioscorea hypoglauca Dioscorea japonica Dioscorea opposita Dioscorea villosa

A, E A, E A, E A, E A, E A, E A, E C

Dioscorea septemloba

Substances that may be used in Listed medicines in Australia December 2007

Diosgenin and dioscin calc as diosgenin (of Dioscorea villosa)

Page 97 of 305

Therapeutic Goods Administration

Ingredient

Diosgenin (of Dioscorea villosa) Diospyros kaki Dioxane Dioxybenzone

Use C C A, E A E E E E E E E

Restrictions

Concentration must not exceed 10 mg/kg or 10 mg/L or 0.001%. PRV may only be used as an excipient in topical preparations.

Dipentaerythrityl hexacaprylate/hexacaprate Dipentaerythrityl tetrahydroxystearate/tetraisostearate Diphenyl dimethicone Dipropylene glycol

Sunscreen active permitted only in topical products. Concentration must not exceed 3%.

Dipotassium glycyrrhizate

Approved for topical use only. Concentration must not exceed 5%. Approved for topical use only.

Dipropylene glycol dibenzoate Dipropylene glycol salicylate Dipsacus asper Dipsacus japonicus Dipteryx odorata

Approved for topical use only. Concentration must not exceed 0.1%. Approved for topical use only. Concentration must not exceed 1.3%. Approved for topical use only.

A, E A, E A, E

Substances that may be used in Listed medicines in Australia December 2007

Page 98 of 305

Therapeutic Goods Administration

Ingredient

Disodium ascorbyl sulfate

Use E E E E E E E E E E E E E

Restrictions

Disodium cocoamphodiacetate Disodium edetate Disodium NADH

Disodium dimethicone copolyol sulfosuccinate Disodium lauriminodipropionate tocopheryl phosphates Disodium oleamido PEG-2 sulfosuccinate

Approved only in topical preparations for localised effect. Approved for topical use only.

Approved for topical use only. Concentration must not exceed 14%. Requires the label statement EYE. When used in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. Approved for topical use only. Concentration must not exceed 3%. PRV may only be used as an excipient in topical preparations. Approved for topical use only. Concentration must not exceed 1%. PRV may only be used as an excipient in topical preparations.

Disodium ricinoleamido MEAsulfosuccinate Disodium stearoyl glutamate Distarch phosphate Disteardimonium hectorite

Approved for topical use only. Concentration must not exceed 3%. Approved for topical use only. Concentration must not exceed 4%. Approved for topical use only. Concentration must not exceed 2%. Approved for topical use only.

Disteareth-6 dimonium chloride Distearyldimonium chloride

Approved for topical use only. Concentration must not exceed 0.4%.
Page 99 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Divinyldimethicone/dimethicone copolymer DL-Alpha-tocopherol DL-Alpha-tocopheryl acetate DL-Borneol

Use E

Restrictions

DL-Alpha-tocopheryl acid succinate DL-Limonene

A, E, C A, E, C E E E E

Approved for topical use only. Concentration must not exceed 1.5%.

A, E, C

When used as an active in oral or sublingual products, the label must include the statement VIT.

When used as an active in oral or sublingual products, the label must include the statement VIT. When used as an active in oral or sublingual products, the label must include the statement VIT. Approved for topical use only. Approved for topical use only.

DL-Threonine

DMDM Hydantoin Docusate sodium Dolichos lablab Dolomite

Docosahexaenoic acid

A, E E, C

Dracaena draco Drimia indica

A, E A, E A, E A, E A, E

When used in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.

Drechslera sorokiniana

Substances that may be used in Listed medicines in Australia December 2007

Page 100 of 305

Therapeutic Goods Administration

Ingredient

Drimia maritima

Use A, E A A, E A, E A, E A, E A, E A, E A, E A, E A, E A A, E A, E E

Restrictions Sunscreen active permitted only in topical products. Concentration must not exceed 15%. May be a native species if exporting this product please contact the DSEWPC.

Drometrizole trisiloxane Drosera burmanni Drosera longifolia Drosera intermedia

Drosera ramentacia

Drosera rotundifolia Drynaria fortunei

Drosera rotundifolia mis Dryobalanops aromatica Dryopteris filix-mas Dunaliella salina

Dryopteris crassirhizoma

Dulacia inopiflora (synonym Liriosma ovata)

MRDD must contain 1 mg or less of the equivalent dry herbal material.

Substances that may be used in Listed medicines in Australia December 2007

Durvillaea antartica extract ICID 2000

Approved for topical use only. Concentration must not exceed 0.1%.

Page 101 of 305

Therapeutic Goods Administration

Ingredient Ecamsule Echinacea angustifolia Echinacea pallida Echinacoside Echinacea purpurea Echinops spinosus Eclipta prostrata Ectoin Edetate sodium Edetic acid Eggplant

Use A A, E A, E A, E C A, E A, E E E E E A, E E, C A, E A, E

Restrictions

Sunscreen active permitted only in topical products. Concentration must not exceed 10%.

Native species if exporting this product please contact the DSEWPC. PRV may only be used as an excipient in topical preparations. Concentration must not exceed 0.25%.

Approved for topical and nasal use only. Concentration must not excced 0.2%

Eichhornia crassipes

Eicosapentaenoic acid Elaeis guineensis

Only Solanum melongena fruit flesh or fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Steroidal alkaloids calculated as solanine is a mandatory component of this ingredient (see separate entry).

Elaeagnus angustifolia

Substances that may be used in Listed medicines in Australia December 2007

Page 102 of 305

Therapeutic Goods Administration

Ingredient Elastin

Use E E

Restrictions

Elastin - hydrolysed

Approved for topical use only. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL.

Elder flower black dry

Elder flower black powder Elecampane rhizome dry Eleocharis tuberosa

A, E A, E A, E A, E A, E A, E A A A C

Approved for topical use only. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL.

Elecampane rhizome powder Elettaria cardamomum

Eleutherococcus root dry

May be a native species if exporting this product please contact the DSEWPC.

Eleutherococcus root powder Eleutherococcus senticosus Elscholtzia splendens Emerald Emetine

Ellagic acid (of Punica granatum)

A, E E C

PRV may only be used as an excipient in topical preparations. Concentration from all ingredients must not exceed 0.2%.
Page 103 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient Emu oil Eosine

Use A, E E A A C A, E A, E C A, E A, E A, E A, E A, E A, E A, E

Restrictions

Ephedra distachya Ephedra sinica Ephedrine

Native species if exporting this product please contact the DSEWPC. Colour permitted only in topical preparations.

Ephedrine is a mandatory component of this ingredient (see separate entry). Ephedrine is a mandatory component of this ingredient (see separate entry).

Epicoccum nigrum Epigaea repens

Concentration from all ingredients must not exceed 10 mg/kg or 10 mg/L or 0.001%. Customs Prohibited Import requires an import permit/licence.

Epigallocatechin-3-0-gallate Epilobium palustre Epilobium parviflorum

Epimedium brevicornu Epimedium sagittatum Equisetum arvense Equisetum hiemale

Epimedium grandiflorum

Substances that may be used in Listed medicines in Australia December 2007

Page 104 of 305

Therapeutic Goods Administration

Ingredient

Ergocalciferol

Use A, E E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E E E E

Restrictions

Ergothioneine

Erigeron breviscapus Erigeron canadensis Eriobotrya japonica

If the product is for internal use it is listable only if the MRDD contains 25 micrograms or less of vitamin D. When used as an active in oral or sublingual products, the label must include the statement VIT. PRV may only be used as an excipient in topical preparations.

Eriocaulon buergerianum Eriodictyon crassifolium Eriodictyon glutinosum Erodium cicutarium Eruca sativa Erythritol Erythrina variegata Erythrosine

Eriodendron anfractuosum

May be a native species if exporting this product please contact the DSEWPC. Approved for topical use only. Concentration must not exceed 0.1%.

Substances that may be used in Listed medicines in Australia December 2007

Erythrosine aluminium lake

Page 105 of 305

Therapeutic Goods Administration

Ingredient

Erythrulose Escin

Use E C C

Restrictions

Eschscholtzia californica

Esters calculated as menthyl acetate Ethanol Ethanol - absolute Ethanolamine Ethohexadiol Ethyl acetate Ether - solvent

A, E

Approved only in topical preparations for localised effect. Concentration must not exceed 2%. Requires the label statement EYE.

A, E, C A, E E E E E E E E

When used as an active, this ingredient is only listable as an uncompounded BP substance. If the concentration from all ingredients is more than 3%, the product label must include the statement ETHAN. When used as an active, this ingredient is only listable as an uncompounded BP substance. If the concentration from all ingredients is more than 3%, the product label must include the statement ETHAN. Approved for topical use only. Concentration must not exceed 5%. Concentration of must not exceed 10%.

Ethyl acrylate

Approved only in topical preparations for localised effect. Requires the label statement EHEXAD. Concentration must not exceed 0.5%. Residual solvent limit is 50 mg per MDD.

Ethyl butylacetylaminopropionate Ethyl hydroxybenzoate

Approved only in topical preparations for localised effect. Concentration must not exceed 7.5%. Requires the label statement EYE2. Topical products require the label statement TOTBNZ.
Page 106 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Ethyl linoleate Ethyl maltol

Use E E E E E E E E E E C E E E E

Restrictions

Ethyl linolenate

Approved for topical use only. Approved for topical use only. Approved for topical use only.

Ethyl methacrylate Ethyl vanillin

Ethylbisiminomethyl guaiacol manganese chloride Ethylcellulose Ethylene brassylate Ethylene glycol Ethylene oxide

Approved for topical use only. Concentration must not exceed 0.002%. PRV may only be used as an excipient in topical preparations.

Ethylene glycol monostearate Ethylenediamine

Concentration should not exceed 0.062%. Residual solvent limit is 6.2 mg per MDD. Concentration must not exceed 1 mg/kg or 1 mg/L or 0.0001%. Approved for topical use only.

Ethylene/acrylic acid copolymer Ethylene/propylene/styrene copolymer - hydrogenated Ethylhexyl ethylhexanoate

Approved for topical use only. Concentration must not exceed 0.5%. PRV may only be used as an excipient in topical preparations.

The combined concentration of butylene/ethylene/stryene copolymer - hydrogenated and ethylene/propylene/styrene copolymer - hydrogenated must not exceed 9%.
Page 107 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Ethylhexylglycerin Etidronic acid Eucalyptus citriodora

Use E E

Restrictions

Approved for topical use only. Concentration must not exceed 5%.

A, E

Approved for topical use only. Concentration in topical preparations must not exceed 1%. Other than topical the concentration must not exceed 10 mg/kg or 10 mg/L or 0.001%.

Eucalyptus dives

Eucalyptus ficifolia

Eucalyptus fruticetorum Eucalyptus globulus Eucalyptus oil

A, E A, E A, E A, E A, E A, E A, E A, E A, E

Permitted without restriction in preparations containing 25% or less of eucalyptus oil. When the concentration of eucalyptus oil is greater than 25% and the nominal capacity of the container is 15 mL or less, a RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. When the concentration of eucalyptus oil is greater than 25% and the nominal capacity of the container is greater than 15 mL but less than or equal to 25 mL, a CRC and RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. Cineole is a mandatory component of this ingredient (see separate entry). Native species if exporting this product please contact the DSEWPC. As per Eucalyptus citriodora (see above). As per Eucalyptus citriodora (see above). As per Eucalyptus citriodora (see above). As per Eucalyptus citriodora (see above). As per Eucalyptus citriodora (see above). As per Eucalyptus citriodora (see above). As per Eucalyptus citriodora (see above). As per Eucalyptus citriodora (see above). As per Eucalyptus citriodora (see above).
Page 108 of 305

Eucalyptus macrorhyncha Eucalyptus radiata

Eucalyptus rostrata

Substances that may be used in Listed medicines in Australia December 2007

Eucalyptus tereticortis

Therapeutic Goods Administration

Ingredient

Eucommia ulmoides Eugenia cumini Eugenol

Use A, E A, E E

Restrictions

Euonymus atropurpureus Euonymus europaeus Eupatorium fortunei

A A

Approved for topical use only, Permitted without restriction in preparations containing 25% or less. When the concentration is greater than 25% and the nominal capacity of the container is 15 mL or less, a RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. When the concentration is greater than 25% and the nominal capacity of the container is greater than 15 mL but less than or equal to 25 mL, a CRC and RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. MRDD must contain 1 mg or less of the equivalent dry herbal material.

Eupatorium japonicum

Eupatorium perfoliatum Eupatorium purpureum Euphorbia cyparissias Euphorbia dry

A, E A, E A, E A, E A, E A, E A, E A, E

Euphorbia antisyphilitica

Species listed on CITES if exporting or importing this product please contact the DSEWPC. Species may be listed on CITES if exporting or importing this product please contact the DSEWPC.

Substances that may be used in Listed medicines in Australia December 2007

Euphorbia heterodoxa

Species listed on CITES if exporting or importing this product please contact the DSEWPC.

Page 109 of 305

Therapeutic Goods Administration

Ingredient

Euphorbia hirta

Use A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E

Restrictions

Euphorbia lathyris Euphorbia peplus

Euphorbia pekinensis Euphorbia powder

Euphorbia resinifera Euphrasia officinalis Euryale ferox Evodia lepta

Euphorbia sieboldiana

Species may be listed on CITES if exporting or importing this product please contact the DSEWPC.

Species listed on CITES if exporting or importing this product please contact the DSEWPC.

Evening primrose oil Evodia rutaecarpa Fabiana imbricata Fagus grandifolia

Fagopyrum esculentum

Oxedrine is a mandatory component of this ingredient when used for internal use (see separate entry).

Substances that may be used in Listed medicines in Australia December 2007

Page 110 of 305

Therapeutic Goods Administration

Ingredient Farnesol

Fagus sylvatica Fast green FCF Fatty acids

Use A, E E E E C A, E E A, E A, E A, E A, E

Restrictions PRV may only be used as an excipient in topical preparations. PRV may only be used as an excipient in topical preparations.

Fats and glyceridic oils, Limnanthes alba seed Fennel bitter seed dry Fennel leaf Fennel oil

Fennel sweet seed dry

Only Foeniculum vulgare ssp. vulgare var. dulce leaf stalk (petiole) base is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Ferric ammonium citrate Ferric chloride anhydrous

Iron is a mandatory component of this ingredient (see separate entry). Iron-containing Listed medicines require the label statement IRONDEF. Iron containing multivitamin/mineral products indicated for general nutritional support, and which do not make specific iron-deficiency related claims are exempt from this requirement. Iron is a mandatory component of this ingredient (see separate entry). Iron-containing Listed medicines require the label statement IRONDEF. Iron containing multivitamin/mineral products indicated for general nutritional support, and which do not make specific iron-deficiency related claims are exempt from this requirement.
Page 111 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Ferric chloride hexahydrate Ferric glycerophosphate Ferric oxide

Use A, E A, E E, C

Restrictions

Iron is a mandatory component of this ingredient (see separate entry). Iron-containing Listed medicines require the label statement IRONDEF. Iron containing multivitamin/mineral products indicated for general nutritional support, and which do not make specific iron-deficiency related claims are exempt from this requirement. Iron is a mandatory component of this ingredient (see separate entry). Iron-containing Listed medicines require the label statement IRONDEF. Iron containing multivitamin/mineral products indicated for general nutritional support, and which do not make specific iron-deficiency related claims are exempt from this requirement.

Ferric pyrophosphate Ferrous carbonate Ferrous chloride Ferrous fumarate

A, E A A, E A, E

Iron is a mandatory component of this ingredient (see separate entry). Iron-containing Listed medicines require the label statement IRONDEF. Iron containing multivitamin/mineral products indicated for general nutritional support, and which do not make specific iron-deficiency related claims are exempt from this requirement. Iron is a mandatory component of this ingredient (see separate entry). Iron-containing Listed medicines require the label statement IRONDEF. Iron containing multivitamin/mineral products indicated for general nutritional support, and which do not make specific iron-deficiency related claims are exempt from this requirement. Iron is a mandatory component of this ingredient (see separate entry). Iron-containing Listed medicines require the label statement IRONDEF. Iron containing multivitamin/mineral products indicated for general nutritional support, and which do not make specific iron-deficiency related claims are exempt from this requirement. Iron is a mandatory component of this ingredient (see separate entry). Iron-containing Listed medicines require the label statement IRONDEF. Iron containing multivitamin/mineral products indicated for general nutritional support, and which do not make specific iron-deficiency related claims are exempt from this requirement.
Page 112 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Ferrous gluconate Ferrous gluconate dihydrate Ferrous lactate Ferrous phosphate Ferrous succinate Ferrous sulfate

Use A, E A, E A, E A, E A, E A, E

Restrictions

Iron is a mandatory component of this ingredient (see separate entry). Iron-containing Listed medicines require the label statement IRONDEF. Iron containing multivitamin/mineral products indicated for general nutritional support, and which do not make specific iron-deficiency related claims are exempt from this requirement.

Iron is a mandatory component of this ingredient (see separate entry). Iron-containing Listed medicines require the label statement IRONDEF. Iron containing multivitamin/mineral products indicated for general nutritional support, and which do not make specific iron-deficiency related claims are exempt from this requirement. Iron is a mandatory component of this ingredient (see separate entry). Iron-containing Listed medicines require the label statement IRONDEF. Iron containing multivitamin/mineral products indicated for general nutritional support, and which do not make specific iron-deficiency related claims are exempt from this requirement. Iron is a mandatory component of this ingredient (see separate entry). Iron-containing Listed medicines require the label statement IRONDEF. Iron containing multivitamin/mineral products indicated for general nutritional support, and which do not make specific iron-deficiency related claims are exempt from this requirement.

Iron is a mandatory component of this ingredient (see separate entry). Iron-containing Listed medicines require the label statement IRONDEF. Iron containing multivitamin/mineral products indicated for general nutritional support, and which do not make specific iron-deficiency related claims are exempt from this requirement. Iron is a mandatory component of this ingredient (see separate entry). Iron-containing Listed medicines require the label statement IRONDEF. Iron containing multivitamin/mineral products indicated for general nutritional support, and which do not make specific iron-deficiency related claims are exempt from this requirement.

Substances that may be used in Listed medicines in Australia December 2007

Page 113 of 305

Therapeutic Goods Administration

Ingredient

Ferrous sulfate - dried Ferula assa-foetida Ferula foetida Ferula galbaniflua Ferula rubricaulis Ferula sumbul Ferulic acid

Use A, E A, E A, E A, E A, E A, E E, C C

Restrictions

Iron is a mandatory component of this ingredient (see separate entry). Iron-containing Listed medicines require the label statement IRONDEF. Iron containing multivitamin/mineral products indicated for general nutritional support, and which do not make specific iron-deficiency related claims are exempt from this requirement.

Ferulic and isoferulic acids Festuca elatior Feverfew herb dry Ficus carica Fig

Feverfew herb powder Ficus pumila

A, E A A

Approved for topical use only.

A, E A, E E

Substances that may be used in Listed medicines in Australia December 2007

Only Ficus carica fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Page 114 of 305

Therapeutic Goods Administration

Ingredient Fig dry Filipendula ulmaria

Use A, E A, E A, E A, E A, E A, E C C C C E

Restrictions

Fir needle oil canadian Fir needle oil siberian Fish oil - natural

Fish oil, rich in in Omega-3 acids

If therapeutic indications are made against Vitamin A or Cholecalciferol (Vitamin D) then these are mandatory components of this ingredient (see separate entries). May be a native species if exporting this product please contact the DSEWPC. If therapeutic indications are made against Vitamin A or Cholecalciferol (Vitamin D) then these are mandatory components of this ingredient (see separate entries). May be a native species if exporting this product please contact the DSEWPC.

Flavanolignins calculated as silybin

Flavonoid glycosides (of Hypericum perforatum) Fluorescein sodium Fluoride

Flavonoids calculated as baicalin (of Scutellaria baicalensis)

When used in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.

Substances that may be used in Listed medicines in Australia December 2007

Foeniculum vulgare

A, E

In dental products, the concentration from all ingredients must not exceed 15 mg/kg or 15 mg/L or 0.0015%. In other products, the concentration from all ingredients must not exceed 1000 mg/kg or 1000 mg/L or 0.1%.
Page 115 of 305

Therapeutic Goods Administration

Ingredient Folic acid

Use A, E E E E E C C

Restrictions

Food orange 6 Food orange 7 Food red 13

MRDD must not provide more than 500 micrograms. When used as an active in oral or sublingual products, the label must include the statement VIT. Additional conditions related to dissolution testing and permitted indications apply.

Formaldehyde/melamine/tosylamide copolymer Formononetin Forskolin (of Coleus forskohlii) Forsythia suspensa Fragaria chiloensis Fragaria vesca

Colour permitted only in topical preparations.

PRV may only be used as an excipient in topical preparations.

Fragaria virginiana Frangula bark dry

A, E A, E A, E A, E A

Fragaria x ananassa

Glucofrangulins calculated as glucofrangulin A is a mandatory component of this ingredient (see separate entry).
Page 116 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Frangula bark powder Fraxinus americana Fraxinus excelsior Fraxinus nigra Fraxinus ornus

Use A

Restrictions

A, E A, E A, E A, E A, E C A, E A, E A, E A, E A, E A, E E A

Glucofrangulins calculated as glucofrangulin A is a mandatory component of this ingredient (see separate entry).

Fraxinus rhynchophylla Fritillaria cirrhosa

Free alcohols calculated as menthol Fritillaria thundbergii Fritillaria verticillata Fructose Fucus vesiculosus Fumaric acid

Fumaria officinalis Fumitory herb dry

Iodine is a mandatory component of this ingredient (see separate entry).

Substances that may be used in Listed medicines in Australia December 2007

Page 117 of 305

Therapeutic Goods Administration

Ingredient

Fumitory herb powder Fusarium oxysporum Galega officinalis Galium aparine Galium verum

Use A C

Restrictions

Furostanol saponins calc as protodioscin (of Tribulus terrestris) Fusarium vasinfectum Galeopsis ochroleuca Galium palustre

A, E A, E A, E A, E A, E A, E A, E A, E E E

Galphimia glauca

Gamma-decalactone

Gamma-linoleic acid Gamma-tocopherol

Gamma-linolenic acid Ganoderma lucidum

E, C E, C

Approved for topical use only. Approved for topical use only.

Substances that may be used in Listed medicines in Australia December 2007

A, E

Page 118 of 305

Therapeutic Goods Administration

Ingredient

Garcinia quaesita Garden bean Gardenia florida Garlic bulb dry

Use A, E E A, E A, E A, E A, E A, E A, E C A, E A, E A, E E A, E

Restrictions Only Phaseolus coccineus and P. vulgaris fruit (bean pod) is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Garlic bulb fresh

Garlic bulb powder Garlic oil

Garlic clove powder

Gallic acid (of Punica granatum) Gastrodia elata Gelatin Gaultheria procumbens Gelatin - hydrolysed Gelidium amansii

Species listed on CITES if exporting or importing this product please contact the DSEWPC. Methyl salicylate is a mandatory component of this ingredient (see separate entry).

If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. Iodine is a mandatory component of this ingredient (see separate entry).

Substances that may be used in Listed medicines in Australia December 2007

Page 119 of 305

Therapeutic Goods Administration

Ingredient Gellan gum Gelsemium dry

Use E A A A C C

Restrictions Concentration must not exceed 1 mg/Kg or 1 mg/L or 0.0001%. Concentration must not exceed 1 mg/Kg or 1 mg/L or 0.0001%.

Gelsemium powder Genista tinctoria Genistein Genistin

Gelsemium sempervirens

A, E

Concentration of equivalent dry herbal material must not exceed 1 mg/Kg or 1 mg/L or 0.0001%.

Gentian dry

Gentian powder Gentiana lutea

A, E A, E A, E A, E A, E A, E A, E C C

Gentiana macrophylla Gentiana rhodantha Gentiana scabra Gentianose

Gentianella amarella Gentiopicroside

Substances that may be used in Listed medicines in Australia December 2007

Page 120 of 305

Therapeutic Goods Administration

Ingredient Geraniol Geranium maculatum Geranium oil

Use E A, E A, E A, E A, E E A, E A, E A, E A, E A, E A, E A, E C C

Restrictions

Approved for topical use only.

Geranium robertianum Geranium sibiricum Geranyl acetate Geum rivale Ghatti gum Ginger dry Ginger oil

Geum urbanum

Approved for topical use only.

Gigartina mamillosa

May be a native species if exporting this product please contact the DSEWPC.

Iodine is a mandatory component of this ingredient (see separate entry). May be a native species if exporting this product please contact the DSEWPC.

ginger powder Gingerol-[6]

Substances that may be used in Listed medicines in Australia December 2007

Gingerols calculated as gingerol-[6]

Page 121 of 305

Therapeutic Goods Administration

Ingredient

Ginkgo biloba Ginkgolides

Use A, E C C C C C C C A, E A, E A, E A, E A, E A

Restrictions

Ginkgo flavonglycosides

Ginkgolides and bilobalide Ginsenoside Rg1

Ginsenosides calculated as ginsenoside Rg1 Ginsenosides calculated as Rg1 and Rb1 Ginsenosides Rg1, Re, Rf, Rg2, Rb1, Rb2, Rc, Rd (Panax ginseng) Glechoma hederacea Glechoma longituba Gleditsia australis Glehnia littoralis Gleditsia officinalis Gloriosa superba

Colchicine is a mandatory component of this ingredient (see separate entry).


Page 122 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Glucofrangulin A

Use C C

Restrictions If the MRDD contains 10 mg or less of hydroxyanthracene derivatives and the product is NOT promoted or marketed as laxative, it is listable without restrictions. In products intended for oral use, if the MRDD contains 10 mg or less of hydroxyanthracene derivatives and the product is promoted or marketed as laxative, the product label must include the statements: CHILD3, LAX1, LAX2, and S. In products intended for oral use, if the MRDD contains more than 10 mg of hydroxyanthracene derivatives and the product is promoted or marketed as a laxative, the product label must include the statements CHILD3, LAX1, LAX2, LAX3, and S. In products intended for oral use, if the MRDD contains more than 10 mg of hydroxyanthracene derivatives and the product is NOT promoted or marketed as a laxative, the product label must include the statements: CHILD3, LAX2, LAX3, LAX4, LAX5, and S. Not listable if the dosage form of the preparation is a tablet. Customs Prohibited Import when in tablet form requires an import permit/licence.

Glucofrangulins calculated as glucofrangulin A

Glucomannan Glucosamine

Gluconolactone

E E C

Glucosamine hydrochloride Glucosamine sulfate

Glucosamine sulfate-potassium chloride complex

A, E A A

A, E, C

If sourced from seafood, the product label must include the statement SFOOD. If sourced from seafood, the product label must include the statement SFOOD. If sourced from seafood, the product label must include the statement SFOOD. If sourced from seafood, the product label must include the statement SFOOD.

Glucosamine sulfate-sodium chloride complex

Substances that may be used in Listed medicines in Australia December 2007

Page 123 of 305

Therapeutic Goods Administration

Ingredient Glucose

Use

Glucose - anhydrous Glucose - liquid

A, E, C A, E E E E A, E A, E A, E E C E E

Restrictions

When used as an excipient in oral products and the total amount of all sugars (glucose, invert sugar, lactose, maltose, and sucrose) exceeds 100 mg in the MDD of the product, the label requires the statement SUGARS. If one of the sugars is lactose the label also requires the statement LACT.

When used as an excipient in oral products and the total amount of all sugars (glucose, invert sugar, lactose, maltose, and sucrose) exceeds 100 mg in the MDD of the product, the label requires the statement SUGARS. If one of the sugars is lactose the label also requires the statement LACT. When used as an excipient in oral products and the total amount of all sugars (glucose, invert sugar, lactose, maltose, and sucrose) exceeds 100 mg in the MDD of the product, the label requires the statement SUGARS. If one of the sugars is lactose the label also requires the statement LACT. Approved for topical use only. Glucose is a mandatory component of this ingredient (see separate entry). Approved for topical use only. Concentration must not exceed 0.1%. Approved for topical use only.

Glucose glutamate Glucosylrutin Glutamic acid Glutamine Gluten

Glutamic acid hydrochloride Glutathione

Glycereth-26

Approved for topical use only.

Substances that may be used in Listed medicines in Australia December 2007

Glycerin/oxybutylene copolymer stearyl ether

Medicines containing more than 0.3% gluten require the label statement GLUTEN. Approved for topical use only. Concentration must not exceed 7%. PRV may only be used as an excipient in topical preparations.

Page 124 of 305

Therapeutic Goods Administration

Ingredient Glycerol

Use A, E E E E E E E E E E E E E E E

Restrictions

Glycerol triacetate Glyceryl behenate Glyceryl dilaurate Glyceryl dioleate

If used as a BP Uncompounded preparation no restrictions, if used as an active as part of a formulation, restricted to topical only. If used as an excipent there are no restrictions. Behenic acid is a mandatory component of this ingredient (see separate entry). Approved only in topical preparations for localised effect. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only.

Glyceryl diisostearate

Glyceryl distearate Glyceryl laurate

Glyceryl isostearate Glyceryl linoleate

Approved only in topical preparations for localised effect.

Approved for topical use only. Concentration must not exceed 3%.

Glyceryl linolenate

Glyceryl mono-oleate

Glyceryl monostearate Glyceryl myristate

Glyceryl monostearate - selfemulsifying

Substances that may be used in Listed medicines in Australia December 2007

Approved for topical use only.

Page 125 of 305

Therapeutic Goods Administration

Ingredient

Glyceryl oleate citrate Glyceryl polyacrylate Glyceryl ricinoleate Glyceryl rosinate

Use E E E E E E E E E E

Restrictions

Glyceryl palmito-stearate

Approved for topical use only. Concentration must not exceed 4%.

Glyceryl polymethacrylate

Approved for topical use only. Concentration must not exceed 0.15%. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only.

Glyceryl sorbitan oleostearate Glyceryl stearate citrate

Glyceryl triacetyl hydroxystearate Glyceryl triacetyl ricinoleate Glycine Glycine max Glycitein Glycitin

Approved for topical use only. Concentration must not exceed 5%. Approved for topical use only.

A, E A, E C C

Approved for topical use only. Concentration must not exceed 6%.

Glycogen

Substances that may be used in Listed medicines in Australia December 2007

Glycol distearate

E E

Approved only in topical preparations for localised effect. Approved for topical use only.
Page 126 of 305

Therapeutic Goods Administration

Ingredient

Glycol stearate Glycollic acid

Use E E

Restrictions

Approved for topical use only.

Glycoproteins

Glycosaminoglycans - hydrolysed Glycyrrhetinic acid Glycyrrhiza glabra

E E

E, C

Approved only in topical preparations for localised effect. Concentration must not exceed 20%. When present as an excipient in sunscreens, the concentration must not exceed 5%. If the concentration of glycollic acid is greater than 5% but less than 20% and it is a sunscreen it is listable only if pH is 3.5 or greater. Sponsors should consider the impact of excipients on the sensitivity of the skin to sunlight and should ensure the finished product is safe for its intended purpose. PRV may only be used as an excipient in topical preparations. Approved for topical use only. Approved for topical use only.

Glycyrrhiza uralensis Glycyrrhizinic acid

A, E A, E E, C A, E A, E A, E E A, E

Gnaphalium multiceps

Gnaphalium polycephalum Gnaphalium uliginosum Gold Golden rod herb dry

Substances that may be used in Listed medicines in Australia December 2007

Page 127 of 305

Therapeutic Goods Administration

Ingredient

Golden seal root dry Golden syrup Gooseberry Grape

Use A A E E E E E E E A, E A, E

Restrictions

Golden seal root powder Gomphrena globosa Gossypium herbaceum Grape seed oil

Species listed on CITES if exporting or importing this product please contact the DSEWPC.

Sucrose is a mandatory component of this ingredient in oral or sublingual preparations (see separate entry). Only Ribes grossularia fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Only Vitis vinifera fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Only Vitis vinifera seed oil fixed is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Only Vitis vinifera fruit juice fermented red is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Ethanol is a mandatory component of this ingredient (see separate entry).

Grape wine red

Grape wine sherry Grape wine white

Only Vitis vinifera fruit juice fermented sherry is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Ethanol is a mandatory component of this ingredient (see separate entry). Only Vitis vinifera fruit juice fermented white is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Ethanol is a mandatory component of this ingredient (see separate entry).

Substances that may be used in Listed medicines in Australia December 2007

Page 128 of 305

Therapeutic Goods Administration

Ingredient Grapefruit Grass pea

Use E E

Restrictions

Grapefruit oil coldpressed Gratiola linifolia

A, E A, E A, E A, E A, E A, E A A E

Only Citrus X paradisi fruit or fruit flesh is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Only Lathyrus sativus seed (grain) cooked is permitted. May only be used as a food excipient refer to introduction for permitted preparations. MRDD must contain 1 mg or less of the equivalent dry seed (grain) and must not contain any lathyrogenic amino acids.

Greater nettle herb dry Greater nettle root dry

Greater nettle herb powder Greater nettle root powder Green lipped mussel dried Green lipped mussel oil Green S Grindelia camporum Grindelia robusta Ground ivy herb dry

A, E A, E A, E
Page 129 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient Guaiacol

Ground ivy herb powder Guaiacum officinale Guaiacum resin Guanine Guaiacum sanctum Guanosine Guar gum

Use A, E A A, E A, E A, E E E E E C

Restrictions

Species listed on CITES if exporting or importing this product please contact the DSEWPC. Species listed on CITES if exporting or importing this product please contact the DSEWPC. Species listed on CITES if exporting or importing this product please contact the DSEWPC. Approved for topical use only. Approved for topical use only. Concentration must not exceed 0.01%. Approved for topical use only.

Guar hydroxypropyltrimonium chloride Guarea rusbyi Guava

A, E A, E A, E A, E

Gymnema sylvestre

Gymnemic acids (of Gymnema sylvestre) Gymnocladus dioica

Only Psidium guajava fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Substances that may be used in Listed medicines in Australia December 2007

Page 130 of 305

Therapeutic Goods Administration

Ingredient

Gynura pinnatifida Halibut-liver oil

Use A, E A, E A, E A, E A, E A, E E E C

Restrictions

Hamamelis leaf dry

Hamamelis leaf powder Hamamelis virginiana Hamamelis water Hard fat Haricot bean Harpagoside Hazel nut

Harpagophytum procumbens Harungana madagascariensis Hazel nut oil

A, E A, E E E E

Only Phaseolus vulgaris seed (bean) haricot or navy is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Only Corylus avellana seed (nut kernel) is permitted. May only be used as a food excipient refer to introduction for permitted preparations. PRV may only be used as an excipient in topical preparations.

Substances that may be used in Listed medicines in Australia December 2007

HDI/Trimethylol hexyllactone crosspolymer

Only Corylus avellana seed (nut kernel) oil fixed is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Page 131 of 305

Therapeutic Goods Administration

Ingredient Hectorite HEDTA Hedera helix

Use E E A

Restrictions

Approved for topical use only. Approved for topical use only.

Hedyotis diffusa

Helianthemum nummularium Helianthus annuus Helianthus tuberosus

A, E A, E A, E A, E A, E A, E A A A A E

Emetine is a mandatory component of this ingredient (see separate entry).

Helichrysum angustifolium Helichrysum arenarium Helleborus niger Helleborus viridis

Helonias rhizome dry Hemidesmus indicus Heptane

MRDD must contain 1 mg or less of the equivalent dry herbal material. MRDD must contain 1 mg or less of the equivalent dry herbal material.

Helonias rhizome powder

Substances that may be used in Listed medicines in Australia December 2007

Heracleum hemsleyanum

A, E A, E

Concentration must not exceed 0.5%. Residual solvent limit is 50 mg per MDD.
Page 132 of 305

Therapeutic Goods Administration

Ingredient Hesperidin Hexane

Herniaria glabra

Use A, E A, E E E E E E E A, E, C

Restrictions

Hevea brasiliensis Hexyl laurate

Hexyl nicotinate Hexyldecanol

Concentration must not exceed 0.029%. Approved for topical use only.

Hexyldecyl stearate Hexylene glycol

Approved for topical use only. Concentration must not exceed 3%. PRV may only be used as an excipient in topical preparations. Approved for topical use only.

Hibiscus abelmoschus Hibiscus esculentus Hibiscus mutabilis Hibiscus sabdariffa

A, E A, E A, E A, E A, E E

May be a native species if exporting this product please contact the DSEWPC.

Hieracium pilosella

Substances that may be used in Listed medicines in Australia December 2007

Himanthalia elongata whole plant extract ICID 2000

PRV may only be used as an excipient in topical preparations.


Page 133 of 305

Therapeutic Goods Administration

Ingredient

Hippomane mancinella Hirschfeldia incana Histidine

Use A A A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E E

Restrictions

Hippophae rhamnoides

Physostigmine is a mandatory component of this ingredient (see separate entry).

Histidine hydrochloride Holcus lanatus Holy thistle herb dry

Allyl isothiocyanate is a mandatory component of this ingredient when the plant part is seed (see separate entry).

Holy thistle herb powder Homalomena occulta Homosalate Honey

Sunscreen ingredient permitted only in topical products. Concentration must not exceed 15%.

Honey - purified Honey extract

Oral products must include the label statement BABY2. If the product is for oral ingestion and the total amount of all sugars (glucose, invert sugar, lactose, maltose, and sucrose) exceeds 100 mg in the MDD, then the label must include the statement SUGARS. Oral products must include the label statement BABY2. If the product is for oral ingestion and the total amount of all sugars (glucose, invert sugar, lactose, maltose, and sucrose) exceeds 100 mg in the MDD, then the label must include the statement SUGARS. Approved for topical use only. Concentration must not exceed 1%.

Substances that may be used in Listed medicines in Australia December 2007

Page 134 of 305

Therapeutic Goods Administration

Ingredient

Honokiol (of Magnolia officinalis) Hop strobile dry Hops oil Hop strobile powder Hordeum distichon Hordeum vulgare Horse radish

Use C A, E A, E A, E A, E A, E E

Restrictions

Gluten is a mandatory component of this ingredient when the plant part is seed and the route of administration is other than topical and mucosal (see separate entry). Gluten is a mandatory component of this ingredient when the plant part is seed and the route of administration is other than topical and mucosal (see separate entry). Only Armoracia rusticana root is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Volatile oil components (of Armoracia rusticana) is a mandatory component of this ingredient (see separate entry).

Hottonia palustris Hovenia dulcis Humulone

Houttuynia cordata

A, E A, E A, E C A, E E

Humulus lupulus Hyaluronic acid

Approved for topical use only. Requires pre-clearance from TGAL.


Page 135 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Hydnocarpus anthelmintica Hydrangea arborescens Hydrangea paniculata Hydrastine Hydrastis canadensis Hydrochloric acid Hydrocyanic acid

Use A

Restrictions

A, E A, E C A, E E C A, E A, E E E E E

If the plant part is seed and it is for use other than topical, the MRDD must contain 1 mg or less of the equivalent dry seed. The seed used topically and plant parts other than seed are listable without restriction.

Hydrocotyle umbellata Hydrogen peroxide

Species listed on CITES if exporting or importing this product please contact the DSEWPC. Only the root included on CITES powders, pills, extracts, tonics etc are excluded. Review required when the quantity is greater than 0.5%.

Hydrogenated coco-glycerides Hydrogenated dimer dilinoleyl/dimethylcarbonate copolymer Hydrogenated polydecene Hydrolysed algin

The concentration from all ingredients must not exceed 1 microgram/kg or 1 microgram/L or 0.0000001%. May only be used as an active in topical products. Concentration must not exceed 3%. Approved for topical use only. Concentration must not exceed 3%. Approved for topical use only. Concentration must not exceed 4%. Approved for topical use only.

Substances that may be used in Listed medicines in Australia December 2007

Approved for topical use only. Concentration must not exceed 0.02%.

Page 136 of 305

Therapeutic Goods Administration

Ingredient

Hydrolysed extensin

Use E E E C C C

Restrictions

Hydrolysed soy flour Hydrolyzed oat flour Hydroquinone

PRV may only be used as an excipient in topical preparations. PRV may only be used as an excipient in topical preparations. PRV may only be used as an excipient in topical preparations.

Hydroquinone derivatives calculated as anhydrous arbutin Hydroxocobalamin Hydroxyanthracene derivatives

Concentration from all ingredients must be less than 10 mg/kg or 10 mg/L or 0.001%. When used as an active in oral or sublingual products, the label must include the statement VIT.

A, E

Hydroxyanthracene derivatives calculated as anhydrous barbaloin Hydroxyanthracene derivatives calculated as cascaroside A Hydroxyanthracene derivatives calculated as rhein

C C C

If the MRDD contains 10 mg or less of hydroxyanthracene derivatives and the product is NOT promoted or marketed as laxative, it is listable without restrictions. In products intended for oral use, if the MRDD contains 10 mg or less of hydroxyanthracene derivatives and the product is promoted or marketed as laxative, the product label must include the statements CHILD3, LAX1, LAX2, and S. In products intended for oral use, if the MRDD contains more than 10 mg of hydroxyanthracene derivatives and the product is promoted or marketed as a laxative, the product label must included the statements CHILD3, LAX1, LAX2, LAX3, and S. In products intended for oral use, if the MRDD contains more than 10 mg of hydroxyanthracene derivatives and the product is NOT promoted or marketed as a laxative, the product label must include the statements: CHILD3, LAX2, LAX3, LAX4, LAX5, and S. Restrictions as per Hydroxyanthracene derivatives (see separate entry) Restrictions as per Hydroxyanthracene derivatives (see separate entry) Restrictions as per Hydroxyanthracene derivatives (see separate entry)
Page 137 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Hydroxyanthracene glycosides calculated as cascaroside A Hydroxyanthracene glycosides calculated as sennoside B Hydroxyapatite Hydroxycaprylic acid Hydroxycitric acid

Use C C

Restrictions

Restrictions as per Hydroxyanthracene derivatives (see separate entry)

A, E E A E E E E E E

Restrictions as per Hydroxyanthracene derivatives (see separate entry) PRV may only be used as an excipient in topical preparations.

Hydroxycitrate complex Hydroxyethyl cetearamidopropyldimonium chloride Hydroxyethyl urea Hydroxyethylcellulose

If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. Approved only when it contains one or more of the three salts (calcium, sodium or potassium hydroxycitrate) of hydroxycitric acid. Approved for topical use only. Concentration must not exceed 0.1%. Approved for topical use only. Concentration must not exceed 1%.

A, C

Hydroxyethylmethylcellulose Hydroxylated milk glycerides Hydroxylysine Hydroxymethylcellulose

A, E

Approved for topical use only. Concentration must not exceed 0.1%.

Substances that may be used in Listed medicines in Australia December 2007

Page 138 of 305

Therapeutic Goods Administration

Ingredient

Hydroxyoctacosanyl hydroxystearate Hydroxyproline Hydroxypropyl beta cyclodextrin Hydroxypropyl starch Hydroxystearic acid Hylocereus undatus Hyoscamus leaf dry Hyoscine

Use E E E E E E C A, E

Restrictions

Approved only in topical preparations for localised effect. Approved for topical use only

Hydroxypropyl distarch phosphate Hydroxypropylcellulose

Approved for topical use only. Concentration must not exceed 2%. Synonym: Hydroxypropyl starch phosphate

Hydroxytyrosol (of Olea europaea)

A, E A A C C

Approved for topical use only. Concentration must not exceed 9%.

Species listed on CITES if exporting or importing this product please contact the DSEWPC.

Hyoscamus leaf powder Hyoscyamine

Alkaloids calculated as hyoscyamine and Hyoscine are mandatory components of this ingredient (see separate entries). Alkaloids calculated as hyoscyamine and Hyoscine are mandatory components of this ingredient (see separate entries). Concentration from all ingredients must be less than 300 micrograms/kg or 300 micrograms/L or 0.00003%. Concentration from all ingredients must be less than 300 micrograms/kg or 300 micrograms/L or 0.00003%.

Substances that may be used in Listed medicines in Australia December 2007

Page 139 of 305

Therapeutic Goods Administration

Ingredient

Hyoscyamus niger Hypericin

Use A C C C A, E A, E A, E C E E

Restrictions

Hyperforin (of Hypericum perforatum)

Alkaloids calculated as hyoscyamine and Hyoscine are mandatory components of this ingredient (see separate entries).

Hypericin deriv calc as hypericin (of H. perforatum) Hypericum ascyron Hypericum japonicum

Hypericum perforatum Hyperoside (of Betula) Hypromellose

Preparations for oral ingestion containing this ingredient as a herbal ingredient or a mother tincture require the label statement STJOHN.

Hypromellose phthalate Hyptis suaveolens Iberis amara Hyssopus officinalis

A, E A, E A, E C
Page 140 of 305

Substances that may be used in Listed medicines in Australia December 2007

Icariin (of Epimedium brevicornu)

Therapeutic Goods Administration

Ingredient

Ilex aquifolium Ilex chinensis Ilex rotunda

Use A, E A, E A, E A, E A, E A, E E C A, E A, E A, E E E

Restrictions

Ilex paraguariensis Ilex verticillata Illicium verum Imidurea

Permitted without restriction in preparations containing 50% or less. When the plant preparation is an oil and the concentration of this oil is more than 50%, the nominal capacity of the container must be 50 mL or less, a RFI must be fitted on the container and the product is label must include the statement CHILD. Approved only in topical preparations for localised effect. Topical products require the label statement IMIDUR.

Immunoglobulin G - bovine Impatiens balsamina Imperata cylindrica Indigo carmine Impatiens glandulifera

Indigo carmine aluminium lake Indigofera tinctoria

May be a native species if exporting this product please contact the DSEWPC.

Substances that may be used in Listed medicines in Australia December 2007

A, E

Page 141 of 305

Therapeutic Goods Administration

Ingredient Inositol Inula britannica Inula helenium Inulin Inula racemosa Invert syrup Iodine

Use A, E A, E A, E A, E A, E E C

Restrictions

Glucose is a mandatory component of this ingredient in oral and sublingual products (see separate entry). In preparations for external use, the concentration of available iodine (excluding salts, derivatives or iodophors) must not exceed 2.5%. In preparations for internal use the RDD must contain less than 300 micrograms of iodine. Approved only in topical preparations for localised effect. Concentration in aqueous preparations must not exceed 10%. Approved for topical use only. Emetine is a mandatory component of this ingredient (see separate entry). Emetine is a mandatory component of this ingredient (see separate entry). Emetine is a mandatory component of this ingredient (see separate entry). Emetine is a mandatory component of this ingredient (see separate entry).
Page 142 of 305

Iodopropynyl butylcarbamate Ionone Ipecacuanha dry

E E A A A A

Ipecacuanha powder

Ipecacuanha prepared Ipomoea batatas

Ipecacuanha root liquid extract

Substances that may be used in Listed medicines in Australia December 2007

A, E

Therapeutic Goods Administration

Ingredient

Ipomoea jalapa Ipomoea purga Iris florentina Iris pallida Iris tenax Iron

Use A, E A, E A, E A, E A, E A, E A, E A, E C

Restrictions

Iridophycus flaccidum Iris germanica

Iodine is a mandatory component of this ingredient (see separate entry).

Iris versicolor

Iron amino acid chelate

A, E

MRDD must contain 24 mg or less of iron. Undivided preparations with a MRDD of 24 mg of iron or less must be supplied in a pack containing less than 750 mg or less of iron (excluding iron oxides when present as an excipient [up to 1% in undivided preparations]). Solid dosage forms containing more than 5 mg of elemental iron in each dosage unit and liquid preparations containing more than 250 mg of elemental iron in the total contents of the container are required to have a CRC. Divided preparations for internal use are listable without pack size restrictions when the quantity of iron from all ingredients in the product (excluding up to 10 mg of iron oxide when used as an excipient) is 5 mg or less per dosage unit and the MRDD contains less than 24 mg of iron. If the divided dosage form contains more than 5 mg of iron per dosage unit but the MRDD contains less than 24 mg of iron then the product is listable when supplied in a pack containing 750 mg or less of iron (excluding up to 10 mg of iron oxide when used as an excipient). When used internally, iron is a mandatory component of this ingredient (see separate entry). Ironcontaining Listed medicines are required to include the label statement IRONDEF. Iron containing multivitamin/mineral products indicated for general nutritional support, and which do not make specific iron-deficiency related claims are exempt from this label requirement.

Substances that may be used in Listed medicines in Australia December 2007

Page 143 of 305

Therapeutic Goods Administration

Ingredient

Iron oxide black Iron oxide red

Use E E E

Restrictions

In divided preparations for internal use the concentration must not exceed 10 mg per dosage unit. In undivided preparations for internal use, when the concentration exceeds 1%, it is considered part of the total iron content. In divided preparations for internal use the concentration must not exceed 10 mg per dosage unit. In undivided preparations for internal use, when the concentration exceeds 1%, it is considered part of the total iron content. In divided preparations for internal use the concentration must not exceed 10 mg per dosage unit. In undivided preparations for internal use, when the concentration exceeds 1%, it is considered part of the total iron content. When used internally, iron is a mandatory component of this ingredient (see separate entry). Ironcontaining Listed medicines are required to include the label statement IRONDEF. Iron containing multivitamin/mineral products indicated for general nutritional support, and which do not make specific iron-deficiency related claims are exempt from this label requirement. Approved for topical use only.

Iron oxide yellow Iron phosphate Irone

A, E E

Isatis tinctoria

Isoamyl methoxycinnamate Isoascorbic acid Isobutane Isobutyl alcohol

A, E A E E E E E

Sunscreen active permitted only in topical products. Concentration must not exceed 10%. Approved for topical use only.

Isobutyl hydroxybenzoate Isobutyl salicylate

Concentration must not exceed 0.5%. Residual solvent limit is 50 mg per MDD. Approved for topical use only.

Approved only in topical preparations for localised effect. Requires the label statement TOTBNZ.
Page 144 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Isocetyl alcohol

Use E E E E E E E E E E C C C

Restrictions

Isocetyl linoleoyl stearate Isocetyl stearate Isodeceth-6

Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only.

Isodecyl isononanoate Isodecyl oleate Isododecane Isoeicosane

Isodecyl neopentanoate

Approved for topical use only. Concentration must not exceed 1%.

Isodon japonicus leaf and stem extract Isoferulic acid

PRV may only be used as an excipient in topical preparations.

Isoflavone glycosides calc as genistin and daidzin (of Glycine max) Isoflavones calc daidzin/ein, genistin/ein, glycitin/ein (Glycine max)

Approved for topical use only. Concentration must not exceed 2%.

Substances that may be used in Listed medicines in Australia December 2007

Page 145 of 305

Therapeutic Goods Administration

Ingredient

Isoflavones calculated as daidzin, daidsein and puerarin (of Pueraria lobata) Isohexadecane Isoleucine Isomalt

Use C C

Restrictions

Isoflavones (of Trifolium pratense)

E E E E E E E E E E E

A, E

Approved for topical use only.

Isononyl isononanoate Isopropyl acetate Isopropyl adipate Isopropyl alcohol

When the quantity of sugar alcohols per RDD exceeds 2 g, the quantity of the sugar alcohols must be declared on the label in addition to the label statement SUGOLS. Approved for topical use only. Concentration must not exceed 15%. Approved for topical use only. Approved for topical use only.

Isopropyl hydroxybenzoate Isopropyl isostearate Isopropyl lanolate

Approved only in topical preparations for localised effect. Requires the label statement TOTBNZ. Approved for topical use only. Approved for topical use only.

Isopropyl lauroyl sacrosinate Isopropyl myristate

Approved for topical use only. Concentration must not exceed 3.0%.

Substances that may be used in Listed medicines in Australia December 2007

Page 146 of 305

Therapeutic Goods Administration

Ingredient

Isopropyl palmitate Isopropyl stearate Isoquercitrin

Use E E E C E E E E E E C

Restrictions

Isopropyl titanium triisostearate Isostearic acid

Approved for topical use only. Approved for topical use only.

Approved for topical use only. Concentration must not exceed 0.3%. Approved for topical use only. Approved for topical use only. Approved for topical use only.

Isostearyl alcohol

Isostearyl isostearate Isostearyl palmitate Isovitexin

Isostearyl neopentanoate Isotridecyl isononanoate Ispaghula husk dry Iva axillaris

PRV may only be used as an excipient in topical preparations.

Approved for topical use only. Concentration must not exceed 2%. PRV may only be used as an excipient in topical preparations.

Ispaghula husk powder

A, E A, E A, E A A

If a dose for children is stated, it must be followed by the label statement PSYLL. If a dose for children is stated, it must be followed by the label statement PSYLL.

Jamaica dogwood bark dry

Substances that may be used in Listed medicines in Australia December 2007

Jamaica dogwood bark powder

Page 147 of 305

Therapeutic Goods Administration

Ingredient

Jasmine lactone

Use E A, E A, E A, E A, E E E

Restrictions

Jasminum officinale

Jateorrhiza columba Jateorrhiza palmata Jatropha curcas Jojoba esters

Approved for topical use only.

Jerusalem artichoke Juglans cinerea Juglans nigra Juglans regia

A, E A, E A, E A, E A, E A, E A, E A, E

Only Helianthus tuberosus tuber is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Approved for topical use only. Concentration must not exceed 25%.

Juncus effusus

Juniper berry oil

Juniperus californica Juniperus communis Juniperus oxycedrus

Substances that may be used in Listed medicines in Australia December 2007

Page 148 of 305

Therapeutic Goods Administration

Ingredient

Juniperus virginiana Kadsura coccinea Kaempferol Kaolin Kaempferia galanga Kalmia latifolia Kaolin - heavy Kaolin - light

Use A, E A, E A, E C A, E E E E C C

Restrictions

Kavalactones (of Piper methysticum) Kelp dry Keratin

Kawapyrones (of Piper methysticum) Kelp powder

A, E A, E E E E

If the dosage form is tablet or capsule then the quantity must not exceed 125 mg per tablet or capsule. MDD in oral products must not exceed 250 mg. Oral products containing more than 25 mg per dose require the label statement PIPER. Iodine is a mandatory component of this ingredient (see separate entry). Iodine is a mandatory component of this ingredient (see separate entry). Approved for topical use only. Concentration must not exceed 5%. Approved for topical use only. Concentration must not exceed 5%. PRV may only be used as an excipient in topical preparations.

Keratin - hydrolysed Keratin amino acids

Substances that may be used in Listed medicines in Australia December 2007

Page 149 of 305

Therapeutic Goods Administration

Ingredient Kerosene

Use E C E E A, E A A

Restrictions

Ketones calculated as menthone Kidney bean Kiwi fruit

In liquid preparations, the concentration must not exceed 25%. In solid and semi-solid preparations, it is listable without restrictions.

Only Phaseolus vulgaris seed (bean) kidney is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Only Actinidia chinensis fruit (berry) is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Kochia scoparia

Korean ginseng root dry Krameria ixiena

Korean ginseng root powder Krameria triandra Kunzea ambigua Labdanum oil

Species listed on CITES if exporting or importing this product please contact the DSEWPC. Only if root and from the Russian Federation. Species listed on CITES if exporting or importing this product please contact the DSEWPC. Only if root and from the Russian Federation.

Kukui (Aleurites moluccana) nut oil

A, E A, E E A

Approved only in topical preparations for localised effect.

A, E

Permitted only if it is an essential oil, supplied in a container with a RFI, for topical use only and labelled with the statements CHILD, EXTERN and UNDILU.

Substances that may be used in Listed medicines in Australia December 2007

Page 150 of 305

Therapeutic Goods Administration

Ingredient

Lablab bean

Use E E E

Restrictions

Lachnanthes tinctoria Lactalbumin Lactic acid Lactamide MEA Lactobacillus acidophilus Lactobacillus brevis Lactobacillus casei

A, E

Only Dolichos lablab seed (bean) is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

A, E A A A A A A A A

If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. PRV may only be used as an excipient in topical preparations. When used as an active, this ingredient is only listable as an uncompounded BP substance. Sponsors should consider the impact of excipients on the sensitivity of the skin to sunlight and should ensure the finished product is safe for its intended purpose.

Lactobacillus amylovorus

Lactobacillus crispatus

Lactobacillus delbrueckii ssp bulgaricus Lactobacillus fermentum

Lactobacillus delbrueckii ssp lactis

Substances that may be used in Listed medicines in Australia December 2007

Page 151 of 305

Therapeutic Goods Administration

Ingredient

Lactobacillus gallinarum Lactobacillus gasseri Lactobacillus kefir Lactobacillus johnsonii

Use A A A A A A A A E A A A A E A

Restrictions

Lactobacillus kefiranofaciens Lactobacillus kefirgranum Lactobacillus parakefir Lactobacillus plantarum Lactobacillus reuteri

Lactobacillus plantarum ferment lysate Lactobacillus rhamnosus

PRV may only be used as an excipient in topical preparations.

Lactobacillus salivarius ssp salicinius Lactobionic acid

Lactobacillus salivarius ssp salivarius Lactoferrin - bovine

Approved for topical use only.

Substances that may be used in Listed medicines in Australia December 2007

Requires the label statement COWMK. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL.

Page 152 of 305

Therapeutic Goods Administration

Ingredient Lactose

Use E, C E

Restrictions

Lactose anhydrous Lactuca sativa Lactulose Lactuca virosa

When used as an excipient in oral products and the total amount of all sugars (glucose, invert sugar, lactose, maltose, and sucrose) exceeds 100 mg in the MDD of the product, the label requires the statement SUGARS. If one of the sugars is lactose the label also requires the statement LACT.

A, E A, E E A, E A, E A, E A, E A, E A, E E E

When used as an excipient in oral products and the total amount of all sugars (glucose, invert sugar, lactose, maltose, and sucrose) exceeds 100 mg in the MDD of the product, the label requires the statement SUGARS. If one of the sugars is lactose the label also requires the statement LACT.

Lactulose solution

Lagenaria vulgaris Laminaria digitata Lamium album Laneth-20 Laneth-5

Laminaria cloustoni Laminaria japonica

When used as an active, this ingredient is only listable as an uncompounded BP substance. Iodine is a mandatory component of this ingredient (see separate entry). Iodine is a mandatory component of this ingredient (see separate entry). Approved for topical use only. Approved for topical use only.
Page 153 of 305

Iodine is a mandatory component of this ingredient (see separate entry).

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Lanolin - hydrogenated Lanolin - hydroxylated Lanolin alcohol Lanolin oil Lanolin wax Lanosterol Lantana camara Larix decidua

Use E E E E E E A

Restrictions

Approved for topical use only. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. Approved for topical use only. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. Approved for topical use only. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. Approved for topical use only. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. Approved for topical use only. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. PRV may only be used as an excipient in topical preparations. MRDD must contain 1 mg or less of the equivalent dry herbal material. Requires the label statement CHAP.

Larrea tridentata Lathyrus sativus Laurel leaf oil

Lashiosphera nipponica Lauramine oxide

A, E A, E A, E A, E E A, E

MRDD must contain 1 mg or less of the equivalent dry herbal material and must contain no lathyrogenic amino acids. Approved for topical use only.

Substances that may be used in Listed medicines in Australia December 2007

Page 154 of 305

Therapeutic Goods Administration

Ingredient Laureth-10 Laureth-12 Laureth-2 Laureth-3 Laureth-4 Laureth-7 Laureth-8 Laureth-9 Laureth-23

Use E E E E E E E E E E E E E

Restrictions Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only.

Approved for topical use only. Concentration must not exceed 4.0%. Residual levels of ethylene oxide are to be kept below the levels of detection.

Lauric acid

Lauroyl lysine

Approved for topical use only.

Laurus nobilis

Lauryl betaine

Lauryl glucoside

A, E

Approved for topical use only. Concentration must not exceed 0.75%. Approved for topical use only.

Approved for topical use only. Concentration must not exceed 12%.
Page 155 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Lauryl lactate Lauryl PCA Lauryl PEG/PPG-18/18 Methicone Lauryl polyglucose Lauryl pyrrolidone

Use E E E E E E E E A, E A, E A, E A, E A, E

Restrictions

Approved for topical use only. Concentration must not exceed 3%. Sponsors should consider the impact of excipients on the sensitivity of the skin to sunlight and should ensure the finished product is safe for its intended purpose. Approved for topical use only. Concentration must not exceed 1.0%. Approved for topical use only. Concentration must not exceed 2%. Approved for topical use only.

Lauryldimonium hydroxypropyl hydrolysed collagen Lauryldimonium hydroxypropyl hydrolysed soy protein Laurylmethicone copolyol Lavandin oil abrial Lavandula angustifolia Lavandula intermedia Lavandula spica Lavender oil

Approved for topical use only. Concentration must not exceed 1% in 'leave-on' products and 3% in 'wash-on/wash-off' products. Approved for topical use only. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. Approved for topical use only. Concentration must not exceed 0.007%. Approved for topical use only.

Camphor is a mandatory component of this ingredient (see separate entry).

Camphor is a mandatory component of this ingredient (see separate entry). Camphor is a mandatory component of this ingredient (see separate entry).

Substances that may be used in Listed medicines in Australia December 2007

Page 156 of 305

Therapeutic Goods Administration

Ingredient Lead

Lawsonia inermis Lecithin

Use A, E C A, E A, E E A A

Restrictions Concentration must not exceed 0.001%. Requires pre-clearance from TGAL.

Lecithin - egg

Lecithin - hydrogenated

If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. Approved for topical use only. Concentration must not exceed 5%.

Lecithin liquid - soy phosphatidylserine-enriched soy Lecithin powder - soy phosphatidylserine-enriched soy Ledebouriella divaricata Ledum groenlandicum Ledum palustre Lemna minor Lemon Ledebouriella seseloides

Soy phosphatidylserine is a mandatory component of this ingredient (see separate entry).

A, E A, E A, E A, E A, E E A, E

Soy phosphatidylserine is a mandatory component of this ingredient (see separate entry).

May be a native species if exporting this product please contact the DSEWPC.

Substances that may be used in Listed medicines in Australia December 2007

Lemon balm leaf dry

Only Citrus limon fruit flesh or fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations.
Page 157 of 305

Therapeutic Goods Administration

Ingredient Lemon oil

Lemon balm leaf powder Lemon oil distilled Lemon peel dried Lemongrass oil Lens culinaris Lentil

Use A, E A, E A, E A, E A, E A, E A, E E A, E A, E A, E A, E E A, E

Restrictions Permitted only when: a) steam distilled or rectified; b) in preparations for internal use; c) in preparations containing 0.05% or less of lemon oil; d) in soaps or bath and shower gels that are washed off the skin; or e) packed in containers labelled with the statement SENS.

Lemon oil terpeneless

May be a native species if exporting this product please contact the DSEWPC.

Lentinula edodes

Leonurus cardiaca

Only Lens culinaris seed is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Leonurus sibiricus

Lepidium apetalum Lespedeza capitata

Leptospermum petersonii

Approved for topical use only. Concentration must not exceed 5%.

Substances that may be used in Listed medicines in Australia December 2007

Page 158 of 305

Therapeutic Goods Administration

Ingredient Lettuce

Use E

Restrictions

Leucine

Leuzea uniflorum Levocarnitine

Levisticum officinale

A, E A, E A, E A, C A A A A C C

Only Lactuca sativa leaf or herb is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Levocarnitine fumarate

Levocarnitine hydrochloride Levocarnitine tartrate Levomenol Liatris odoratissima Ligusticum lucidum Ligusticum sinense

Levocarnitine magnesium citrate

Lignans calc secoisolariciresinol diglucoside (Linum usitatissimum seed)

A, E A, E A, E
Page 159 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient Ligustilide

Ligusticum wallichii Ligustrum lucidum Ligustrum vulgare Lilium brownii Lilium candidum

Use A, E C A, E A, E A, E A, E A, E A, E A, E E E

Restrictions

Lilium lancifolium Lilium tigrinum Lime Lime fruit

Lilium longiflorum

Lime oil coldpressed Lime oil distilled Lime tree flower dry

A, E A, E A, E

Only Citrus aurantifolia fruit flesh or fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Permitted only when: a) in preparations for internal use; b) in preparations containing 0.5% or less of lime oil; c) in soaps or bath and shower gels that are washed off the skin; or d) packed in containers labelled with the statement SENS.

Substances that may be used in Listed medicines in Australia December 2007

Page 160 of 305

Therapeutic Goods Administration

Ingredient Limonene Linalool

Lime tree flower powder

Use A, E E E E E

Restrictions Maxium daily dose in oral preparations is 10 mg. Approved for topical use only. Approved for topical use only.

Linalyl acetate

Lindera strychnifolia Linoleic acid Linseed acid Linseed dry Linseed oil

Linoleamidopropyl PG-dimonium chloride phosphate Linolenic acid

A, E E, C E, C E

Approved for topical use only. Concentration must not exceed 0.5%. Approved for topical use only.

Linseed powder Lipase

A, E A, E A, E A, E A, C A, E

PRV may only be used as an excipient in topical preparations.

Linum usitatissimum Lippia citriodora

Lipase is only listable when derived from Rhizopus oryzae.


Page 161 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Lippia dulcis

Use A, E A, E A, E A, E A, E A, E A, E A, E A, E C A

Restrictions

Liquidambar formosana Liquidambar orientalis Liquidambar styraciflua Liquorice dry

Liquidambar taiwaniana Liquorice liquid extract Liquorice powder Litchi chinensis Lithium

Lithospermum officinale Litsea cubeba Lobelia dry Lobaria pulmonaria Lobelia inflata

A, E A, E A A

Concentration from all ingredients must not exceed 0.01%.

MRDD must contain 1 mg or less of the equivalent dry herbal material.

May be a native species if exporting this product please contact the DSEWPC.

Concentration must not exceed 0.001% or 10 mg/kg or 10ml/L or 10 ppm unless the product is administered by smoking or burning. Concentration must not exceed 0.001% or 10 mg/kg or 10ml/L or 10 ppm unless the product is administered by smoking or burning.
Page 162 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Lobelia powder Lobeline Lolium multiflorum Lolium perenne

Use A C

Restrictions

Lolium temulentum Lonicera japonica

A, E A, E A, E A, E A, E A, E A, E E A, E A, E A, E A, E A, E

Concentration must not exceed 0.001% or 10 mg/kg or 10ml/L or 10 ppm unless the product is administered by smoking or burning.

Lonicera caprifolium

Lonicera periclymenum Lophatherum gracile Loquat

May be a native species if exporting this product please contact the DSEWPC.

Loranthus parasiticus Lotus corniculatus Lovage oil Lovage root dry

Loropetalum chinensis

Only Eriobotrya japonica fruit flesh or fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Substances that may be used in Listed medicines in Australia December 2007

Page 163 of 305

Therapeutic Goods Administration

Ingredient

Lovage root powder Ludwigia prostrata Luffa cylindrica Luffa purgans Lutein

Use A, E A, E A, E A, E A, C C C

Restrictions

May be a native species if exporting this product please contact the DSEWPC.

Lutein esters calculated as lutein (of Targetes erecta) Luteolin-7-O-glucoside (of Cyanara scolymus) Lychee Lycium barbarum Lycium chinense Lycopene

A, E A, E A, C A, E A, E A, E

Only Litchi chinensis fruit flesh is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Lycopersicon esculentum Lycopodium annotinum Lycopodium clavatum

Steroidal alkaloids calculated as solanine is a mandatory component of this ingredient (see separate entry). May be a native species if exporting this product please contact the DSEWPC.

Substances that may be used in Listed medicines in Australia December 2007

Page 164 of 305

Therapeutic Goods Administration

Ingredient

Lycopodium complanatum Lycopus europaeus Lycopus lucidus Lycopus virginicus

Use A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E E E

Restrictions

Lygodium japonicum Lysimachia vulgaris Lysine

Lysimachia christinae

Pulegone is a mandatory component of this ingredient (see separate entry).

Lysine hydrochloride Lythrum salicaria Macadamia nut

Lythrum hyssopifolium Lythrum verticillatum Macadamia nut oil

A, E, C

May be a native species if exporting this product please contact the DSEWPC.

May be a native species if exporting this product please contact the DSEWPC.

Only Macadamia ternifolia seed (nut kernel) is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Only Macadamia ternifolia seed (nut kernel) oil fixed is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Substances that may be used in Listed medicines in Australia December 2007

Macadamia ternifolia

A, E

Page 165 of 305

Therapeutic Goods Administration

Ingredient Mace

Use E

Restrictions

Mace oil Macrocystis pyrifera Macrogol 1000 Macrogol 1450 Macrogol 1500 Macrogol 200 Macrogol 300

A, E A, E E E E E E E E E E

Only Myristica fragrans seed aril is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Safrole is a mandatory component of this ingredient (see separate entry).

Permitted without restriction in preparations containing 50% or less. When the concentration is greater than 50%, the nominal capacity of the container must be 25 mL or less, a RFI must be fitted on the container and the product label must include the statement CHILD. Safrole is a mandatory component of this ingredient (see separate entry). Iodine is a mandatory component of this ingredient (see separate entry). Approved for topical use only.

Macrogol 20000 Macrogol 3000 Macrogol 3350 Macrogol 40 Macrogol 400

Approved for topical use only.

A, E

When used as an active, this ingredient is only listable as an uncompounded BP substance. Approved for topical use only.

Substances that may be used in Listed medicines in Australia December 2007

Page 166 of 305

Therapeutic Goods Administration

Ingredient

Macrogol 4000 Macrogol 600

Use E E E E E E E E C

Restrictions Approved for topical use only.

Macrogol 45000 Macrogol 6000 Macrogol 800 Macrogol 900 Magnesium

Macrogol 600000 Macrogol 8000

Magnesium amino acid chelate Magnesium ascorbate Magnesium ascorbate monohydrate Magnesium ascorbyl phosphate Magnesium aspartate

A, E A, E A, E E A, E

Approved for topical use only. Concentration must not exceed 0.95%.

Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label.

When used as an active in oral or sublingual products, the label must include the statement VIT. Approved for topical use only.

When used as an active in oral or sublingual products, the label must include the statement VIT. Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label.

Substances that may be used in Listed medicines in Australia December 2007

Page 167 of 305

Therapeutic Goods Administration

Ingredient

Magnesium aspartate anhydrous Magnesium aspartate dihydrate Magnesium carbonate Magnesium carbonate - heavy Magnesium carbonate - light Magnesium chloride Magnesium citrate

Use A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E E

Restrictions

Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label.

Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label. Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label. Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label. Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label. Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label. Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label.

Magnesium diglutamate Magnesium gluconate Magnesium glycerophosphate Magnesium hydroxide Magnesium nitrate

Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label. When used as an active, this ingredient is only listable as an uncompounded BP substance. Approved for topical use only.

Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label.

Substances that may be used in Listed medicines in Australia December 2007

Page 168 of 305

Therapeutic Goods Administration

Ingredient

Magnesium orotate Magnesium oxide

Use A, E A, E A, E A, E A, E A, E A, E A, E E A, E A, E

Restrictions

Magnesium orotate dihydrate Magnesium oxide - heavy Magnesium oxide - light Magnesium phosphate

Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label. Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label. Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label. Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label. Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label. Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label. Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label. Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label.

Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label.

Magnesium phosphate - dibasic trihydrate Magnesium stearate Magnesium sulfate

Magnesium phosphate - tribasic anhydrous

Magnesium sulfate - dried

Substances that may be used in Listed medicines in Australia December 2007

Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label.

Page 169 of 305

Therapeutic Goods Administration

Ingredient

Magnesium sulfate dihydrate

Use A, E A, E A, E E A, E A, E A, E A, E A, E C E E

Restrictions

Magnesium sulfate monohydrate Magnesium sulfate trihydrate Magnesium trisilicate Magnolia glauca Magnolia liliflora

Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label. Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label. Magnesium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of magnesium is required on the label.

Magnolia obovata

Magnolia officinalis Magnolia salicifolia Maize

Magnolol (of Magnolia officinalis) Maize bran Maize oil

Only Zea mays seed (kernel) is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

A, E

Only Zea mays seed (kernel) husk or seed coat (bran) is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Substances that may be used in Listed medicines in Australia December 2007

Page 170 of 305

Therapeutic Goods Administration

Ingredient

Malachite green Male fern dry Malic acid Male fern powder Malpighia glabra Malt extract Maltitol

Use E A A E A, E A, E E E E E E E

Restrictions

Colour permitted only in topical preparations.

MRDD must contain 1 mg or less of equivalent dry herbal material. May be a native species if exporting this product please contact the DSEWPC. MRDD must contain 1 mg or less of equivalent dry herbal material. May be a native species if exporting this product please contact the DSEWPC. Sponsors should consider the impact of excipients on the sensitivity of the skin to sunlight and should ensure the finished product is safe for its intended purpose.

Malpighia punicifolia

Maltitol solution Maltodextrin Maltol Maltose

When the quantity of sugar alcohols per RDD exceeds 2 g, the quantity of the sugar alcohols must be declared on the label in addition to the label statement SUGOLS. When the quantity of sugar alcohols per RDD exceeds 2 g, the quantity of the sugar alcohols must be declared on the label in addition to the label statement SUGOLS.

When used as an excipient in oral products and the total amount of all sugars (glucose, invert sugar, lactose, maltose, and sucrose) exceeds 100 mg in the MDD of the product, the label requires the statement SUGARS. If one of the sugars is lactose the label also requires the statement LACT.
Page 171 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Malus pumila

Use A, E A, E A, E A, E A, E A, E C E

Restrictions

Malus sylvestris

Malus X domestica Malva moschata Malva sylvestris Malvidin

Malva verticillata Mandarin

Mandarin oil coldpressed Mandragora officinarum Manganese

A, E A C

Only Citrus reticulata and hybrids formed with C. sinensis and/or C. X paradisi fruit flesh or fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Concentration must not exceed 10 mg/kg or 10 mg/L or 0.001%. Atropine, Hyoscine and Hyoscyamine are mandatory components of this ingredient (see separate entries).

Manganese amino acid chelate Manganese aspartate

A, E A, E

If used as an active AND intended as a mineral supplementation, the equivalent quantity of manganese is required on the label.

Manganese is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of manganese is required on the label.
Page 172 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Manganese chloride

Use A, E A, E A, E A, E A, E A, E A, E E E A, E A, E

Restrictions

Manganese gluconate Manganese oxide

Manganese is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of manganese is required on the label. Manganese is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of manganese is required on the label. Manganese is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of manganese is required on the label. Manganese is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of manganese is required on the label. Manganese is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of manganese is required on the label. Manganese is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of manganese is required on the label.

Manganese glycerophosphate Manganese sulfate Mangifera indica Mango

Manganese sulfate monohydrate

Manihot utilissima Mannitol Maranta arundinacea

Only Mangifera indica fruit flesh or fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations. When the quantity of sugar alcohols per RDD exceeds 2 g, the quantity of the sugar alcohols must be declared on the label in addition to the label statement SUGOLS.

Substances that may be used in Listed medicines in Australia December 2007

Page 173 of 305

Therapeutic Goods Administration

Ingredient

Marjoram oil spanish Marjoram oil sweet Marrubiin

Use A, E A, E C A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E

Restrictions

Permitted without restriction in preparations containing 50% or less. When the concentration is greater than 50%, the nominal capacity of the container must be 50mL or less, a RFI must be fitted on the container and the product label must include the statement CHILD. Permitted without restriction in preparations containing 50% or less. When the concentration is greater than 50%, the nominal capacity of the container must be 50mL or less, a RFI must be fitted on the container and the product label must include the statement CHILD.

Marrubium vulgare

Marsdenia reichenbaachi Marshmallow root dry Martynia parviflora Mastic

Marshmallow root powder

Matricaria flower dry Matricaria recutita

Meadowsweet herb dry

Meadowsweet herb powder

Substances that may be used in Listed medicines in Australia December 2007

Page 174 of 305

Therapeutic Goods Administration

Ingredient

Medicago sativa Medium chain triglycerides Melaleuca alternifolia

Use A, E E

Restrictions

A, E

When the ingredient is a fresh leaf extract and the extraction ratio is between 34:1 and 46:1 then the quantity of l-canavanine in the extract must not be more than that in the fresh leaf. When the ingredient is a herbal extract, the quantity of l-canavanine in the extract must not be more than that in the dry herbal material.

Melaleuca cajuputi

A, E

Permitted without restriction in preparations containing 25% or less of melaleuca oil. When the concentration of melaleuca oil is greater than 25% and the nominal capacity of the container is 15 mL or less, a RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. When the concentration of melaleuca oil is greater than 25% and the nominal capacity of the container is greater than 15 mL but less than or equal to 25 mL, a CRC and RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. Melaleuca oil, Cajuput oil and Cineole are mandatory components of this ingredient (see separate entries). Native species if exporting this product (excluding oil) please contact the DSEWPC.

Melaleuca dissitiflora

A, E

Permitted without restriction in preparations containing 25% or less of melaleuca oil. When the concentration of melaleuca oil is greater than 25% and the nominal capacity of the container is 15 mL or less, a RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. When the concentration of melaleuca oil is greater than 25% and the nominal capacity of the container is greater than 15 mL but less than or equal to 25 mL, a CRC and RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. Cajuput oil and Cineole are mandatory components of this ingredient (see separate entries). Native species if exporting this product (excluding oil) please contact the DSEWPC. Permitted without restriction in preparations containing 25% or less of melaleuca oil. When the concentration of melaleuca oil is greater than 25% and the nominal capacity of the container is 15 mL or less, a RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. When the concentration of melaleuca oil is greater than 25% and the nominal capacity of the container is greater than 15 mL but less than or equal to 25 mL, a CRC and RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. Cineole is a mandatory component of this ingredient (see separate entry). Native species if exporting this product (excluding oil) please contact the DSEWPC.

Substances that may be used in Listed medicines in Australia December 2007

Page 175 of 305

Therapeutic Goods Administration

Ingredient

Melaleuca ericifolia Melaleuca oil Melanin

Use A, E A, E A, E E A, E A, E E E

Restrictions

Melaleuca linariifolia

Melaleuca quinquenervia Melilotus officinalis Melissa officinalis Melon

A, E, C

As per Melaleuca dissitiflora (see above). As per Melaleuca dissitiflora (see above). As per Melaleuca dissitiflora (see above).

As per Melaleuca dissitiflora (see above).

PRV may only be used as an excipient in topical preparations. If derived from skin, hair, feathers or human urine this ingredient requires pre-clearance from TGAL. Coumarin is a mandatory component of this ingredient (see separate entry).

Menadione sodium bisulfite Menispermum canadense Mentha aquatica Mentha arvensis

Only Cucumis melo fruit flesh or fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. MRDD must contain 1 mg or less of the equivalent dry herbal material. Sponsors must confirm the absence of aristolochic acids or herbal species known to contain these acids.

Mentha haplocalyx

A, E A, E A, E

Substances that may be used in Listed medicines in Australia December 2007

Page 176 of 305

Therapeutic Goods Administration

Ingredient

Mentha pulegium Mentha spicata Mentha X cardiaca Mentha X piperita Menthol

Use A, E A, E A, E A, E A, E A, E C C C

Restrictions

D-Pulegone and Volatile oil components (of Mentha pulegium) are mandatory components of this ingredient (see separate entries).

Mentha X piperita nothosubsp. citrata Menthol (of Mentha arvensis) Menthol (of Peppermint oil) Menthoxypropanediol Menthyl anthranilate Menthyl lactate Menthyl PCA

Menthol (of Mentha X piperita)

When used as an active, permitted only in Medicated Space Sprays or Medicated Throat Lozenges.

E E E

Permitted only as an excipient in oral products. Concentration must not exceed 0.04%. Approved only in topical preparations for localised effect.

Sunscreen active permitted only in topical products. Concentration must not exceed 5%. PRV may only be used as an excipient in topical preparations.

Menyanthes trifoliata Meretrix meretrix

A, E A, E

Substances that may be used in Listed medicines in Australia December 2007

Page 177 of 305

Therapeutic Goods Administration

Ingredient

Mespilus germanica Meta-Cresol Methanol

Use A, E E E E E E E C E E E E E

Restrictions Approved for topical use only.

Methacrylic acid copolymer Methicone

Methionine

E, C

Methyl acetate

Methyl acetyl ricinoleate Methyl benzoate Methyl chavicol Methyl ether

A, E

Concentration must not exceed 0.3%. Residual solvent limit is 30 mg per MDD. Approved for topical use only. Concentration must not exceed 1%.

Concentration must not exceed 0.5%. Residual solvent limit is 50 mg per MDD. Approved for topical use only. Approved for topical use only. Approved for topical use only.

Methyl ethyl ketone Methyl gluceth-10 Methyl gluceth-20

Concentration must not exceed 0.5%. Residual solvent limit is 50 mg per MDD. Product must contain 25% or less of designated solvents as defined in Part 1 of the SUSMP. PRV may only be used as an excipient in topical preparations. Approved for topical use only. Approved for topical use only.

Substances that may be used in Listed medicines in Australia December 2007

Methyl gluceth-20 sesquihydrate

Page 178 of 305

Therapeutic Goods Administration

Ingredient

Methyl glucose dioleate

Use E E E E E E E E E E E E E, C

Restrictions

Methyl glucose sesquioleate

Methyl glucose sesquistearate Methyl hydrojasmonate Methyl isobutyl ketone Methyl methacrylate Methyl salicylate Methyl stearate

Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only.

Methyl hydrogenated rosinate Methyl hydroxybenzoate

Topical products require the label statement TOTBNZ.

Concentration must not exceed 0.5%. Residual solvent limit is 50 mg per MDD. Product must contain 25% or less of designated solvents as defined in Part 1 of the SUSMP.

Methylated spirit - industrial Methylcellulose Methylchloroisothiazolinone

Approved for topical use only. In liquid preparations, the concentration must be less than 25%.

Methyldibromo glutaronitrile Methylene bis-benzotriazolyl tetramethylbutylphenol

A, E

Substances that may be used in Listed medicines in Australia December 2007

Approved for topical use only. Approved for topical use only.

Sunscreen active permitted only in topical products. Concentration must not exceed 10%.

Page 179 of 305

Therapeutic Goods Administration

Ingredient

Methylisothiazolinone Methylpropanediol

Use E E E E E E

Restrictions

Methylsilanol mannuronate Mica

Approved for topical use only.

Methylstyrene/vinyltoluene copolymer Micrococcus luteus lysate Microcos paniculata Milk - goat Microsporum gypseum Milk - nonfat dry Milk - whole dry

Approved for topical use only. Concentration in the product must not exceed 10%. PRV may only be used as an excipient in topical preparations. Approved for topical use only. Approved for topical use only.

A, E A E E E E A, E A, E

PRV may only be used as an excipient in topical preparations.

Requires pre-clearance from TGAL.

If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL.

Milk protein - hydrolysed Milk thistle fruit dry Milk thistle fruit powder

If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL.

Substances that may be used in Listed medicines in Australia December 2007

Page 180 of 305

Therapeutic Goods Administration

Ingredient Millet

Use E

Restrictions

Millettia dielsiana

Millettia reticulata Mimulus guttatus Mitchella repens

Mimosa ternuiflora bark 4:1 aqueous extract ICID 2004 Mint oil dementholised Moghania macrophylla Molasses - blackstrap Molybdenum

A, E A, E E A, E A, E A, E A, E E C

Only Panicum milliaceum seed (grain) is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

PRV may only be used as an excipient in topical preparations.

Molybdenum trioxide Momordica charantia

Momordica balsamina

Sucrose is a mandatory component of this ingredient in oral and sublingual products (see separate entry). Molybdenum is a mandatory component of this ingredient. MDD of molybdenum from molybdenum trioxide must not exceed 125 micrograms. Review required. May be a native species if exporting this product please contact the DSEWPC. May be a native species if exporting this product please contact the DSEWPC.

Substances that may be used in Listed medicines in Australia December 2007

Momordica cochinchinensis

A, E A, E A, E

Page 181 of 305

Therapeutic Goods Administration

Ingredient

Monarda didyma

Use A, E E A, E A, E E A, E A, E A, E E E

Restrictions

Mono- and di- glycerides

Monoammonium glutamate Monopotassium glutamate Monosodium glutamate Monotospora brevis Monstera deliciosa Montan wax Mordant red 11

Monosodium dihydrogen citrate

When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.

If the plant part is leaf, the MRDD must contain 1 mg or less of the equivalent dry leaf. If any other plant part, it is listable without restriction. Colour permitted only in topical preparations. Concentration must not exceed 0.05%.

Morinda citrifolia

Morinda officinalis Morus alba

Moringa pterygosperma

A, E A, E A, E

Only the fruit juice or fruit powder are permitted. Fruit powder must be produced by freezedrying the whole fruit, excluding the seeds.

Substances that may be used in Listed medicines in Australia December 2007

Page 182 of 305

Therapeutic Goods Administration

Ingredient

Morus bombycis Morus nigra

Use A, E A, E A A E

Restrictions

Motherwort herb dry Mucopolysaccharide Mucor racemosus Mucuna pruriens Mulberry Mung bean

Motherwort herb powder

A, E A, E E E

PRV may only be used as an excipient in topical preparations.

Only Morus alba and M. nigra fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Only Vigna radiata seed (bean) is permitted. May only be used as a food excipient refer to introduction for permitted preparations. May be a native species if exporting this product please contact the DSEWPC.

Murraya exotica

Murraya koenigii Musa sapientum Musk ketone Musk xylol

A, E A, E A, E E E

Substances that may be used in Listed medicines in Australia December 2007

Mussel - green lipped

Approved for topical use only. Approved for topical use only.

Page 183 of 305

Therapeutic Goods Administration

Ingredient Mustard

Use E E E C

Restrictions

Mustard oil volatile Mustard seed oil Myreth-4 Myosotis arvensis Myrica cerifera Myricetin Myristic acid

A, E A, E A, E E

Only Brassica juncea, B. nigra and Sinapis alba seed is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Allyl isothiocyanate is a mandatory component of this ingredient (see separate entry). Allyl isothiocyanate is a mandatory component of this ingredient (see separate entry). Only Brassica juncea, B. nigra and Sinapis alba seed oil fixed is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Allyl isothiocyanate is a mandatory component of this ingredient (see separate entry). PRV may only be used as an excipient in topical preparations.

Myristica fragrans Myristyl alcohol Myristyl lactate

A, E E E E

Permitted without restriction in preparations containing 50% or less. When the concentration is greater than 50%, the nominal capacity of the container must be 25 mL or less, a RFI must be fitted on the container and the product label must include the statement CHILD. Safrole is a mandatory component of this ingredient (see separate entry). Approved for topical use only. Approved for topical use only. Approved for topical use only.
Page 184 of 305

Myristyl myristate

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Myroxylon balsamum Myroxylon pereirae Myrrh Myrrh oil

Use A, E A, E A, E A, E A, E A, E A, E C A, E A, E A, E A, E E E E

Restrictions

Myrrhis odorata

Myrsine africana

Myrtus communis

Naphthaquinones calc as lapachol (of Tabebuia avellanedae heartwood) Nardostachys chinensis Nasturtium officinale Nauclea officinalis

Nelumbium speciosum Neopentyl glycol dicaprylate/dicaprate Neopentyl glycol diheptanoate Neopentyl glycol diisostearate

May be a native species if exporting this product please contact the DSEWPC. Approved for topical use only. PRV may only be used as an excipient in topical preparations.

Substances that may be used in Listed medicines in Australia December 2007

Approved for topical use only. Concentration must not exceed 5%.

Page 185 of 305

Therapeutic Goods Administration

Ingredient

Neopentyl glycol dioctanoate Nepeta cataria Nephelium longana Nerium oleander Nicotinamide Neurospora crassa

Use E A, E A A

Restrictions

Approved for topical use only. Concentration must not exceed 5%.

Pulegone is a mandatory component of this ingredient (see separate entry).

Nicotinamide ascorbate Nicotinic acid Nigella sativa Nigella damascena

A, E A, E A, E A, E A, E A, E E E E

A, E, C A, E, C

Concentration of equivalent dry herbal material must not exceed 1 mg/Kg or 1 mg/L or 0.0001%. When used as an active in oral or sublingual products, the label must include the statement VIT. When used as an active in oral or sublingual products, the label must include the statement VIT.

Product must contain 100 mg or less of nicotinic acid per dosage unit. When used as an active in oral or sublingual products, the label must include the statement VIT.

Nigritella angustifolia Nigrospora sphaerica Nitric acid Nonoxinol 10 Nonoxinol 9

Species listed on CITES if exporting or importing this product please contact the DSEWPC. Approved for topical use only as an excipient. Concentration must not exceed 0.5%. Approved for topical use only.

Substances that may be used in Listed medicines in Australia December 2007

Approved only in topical preparations for localised effect. Concentration must not exceed 25%.

Page 186 of 305

Therapeutic Goods Administration

Ingredient

Nordihydroguaiaretic acid Notopterygium forbesii Nuphar japonicum Nuphar luteum Nutmeg dry Nutmeg oil Notopterygium incisium

Use E A, E A, E A, E A, E A, E A, E A, E A A

Restrictions

Approved for topical use only. Concentration must not exceed 0.3%.

Safrole is a mandatory component of this ingredient (see separate entry)

Nutmeg powder Nux vomica dry

Permitted without restriction in preparations containing 50% or less. When the concentration is greater than 50%, the nominal capacity of the container must be 25 mL or less, a RFI must be fitted on the container and the product label must include the statement CHILD. Safrole is a mandatory component of this ingredient (see separate entry). Safrole is a mandatory component of this ingredient (see separate entry) Concentration must not exceed 10 mg/Kg or 10 mg/L or 0.001%. Concentration must not exceed 10 mg/Kg or 10 mg/L or 0.001%.

Nux vomica powder Nycteria capensis Nylon Nylon-12

Nyctanthes arbor-tristis

A, E A, E E E

Approved for topical use only.

Approved only in topical preparations for localised effect.


Page 187 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Nymphaea alba Oat

Use A, E A, E E E A, E A, E A, E A, E A, E A, E E, C E E

Restrictions

Nymphaea odorata Oat bran Oatmeal colloidal

Only Avena sativa seed (grain) is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Gluten is a mandatory component of this ingredient when the route of administration is other than topical and mucosal (see separate entry). Only Avena sativa seed (grain) husk or seed coat (bran) is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Gluten is a mandatory component of this ingredient when the route of administration is other than topical and mucosal (see separate entry).

Ocimum basilicum

Ocimum kilimandscharicum Ocimum minimum Ocotea pretiosa Octacosanol Octhilinone Ocimum tenuiflorum

Gluten is a mandatory component of this ingredient when the route of administration is other than topical and mucosal (see separate entry). Camphor is a mandatory component of this ingredient (see separate entry).

Octadecene/MA copolymer

Safrole is a mandatory component of this ingredient (see separate entry). Approved for topical use only. Approved for topical use only.

Substances that may be used in Listed medicines in Australia December 2007

Page 188 of 305

Therapeutic Goods Administration

Ingredient

Octocrylene

Use A E E E E E E E E E E E

Restrictions

Octoxinol 10

Octyl hydroxystearate Octyl isononanoate Octyl palmitate Octyl salicylate Octyl stearate Octyl triazone

Sunscreen active permitted only in topical products. Concentration must not exceed 10%. Approved for topical use only. Approved for topical use only.

Octyl methoxycinnamate

A A A

Approved only in topical preparations for localised effect. Approved for topical use only. Approved for topical use only.

Sunscreen active permitted only in topical products. Concentration must not exceed 10%. Sunscreen active permitted only in topical products. Concentration must not exceed 5%.

Octylbicycloheptenedicarboximide Octyldodecanol Octyldodeceth-25

Sunscreen active permitted only in topical products. Concentration must not exceed 5%. Approved for topical use only.

Approved only in topical preparations for localised effect. Requires the label statement OBCARB.

Octyldodecyl myristate Octyldodecyl stearate

Octyldodecyl neopentanoate

Approved for topical use only. Concentration must not exceed 5%. Residual levels of 1, 4-dioxane and ethylene oxide (and related substances) are to be kept below the levels of detection. PRV may only be used as an excipient in topical preparations. Approved for topical use only.

Substances that may be used in Listed medicines in Australia December 2007

Approved for topical use only. Concentration must not exceed 2.0%.

Page 189 of 305

Therapeutic Goods Administration

Ingredient

Oenanthe crocata

Use A A

Restrictions

Oenanthe phellandrium Oenothera biennis Oenothera stricta

Oil (of Syzygium aromaticum) Oil (of Tanacetum vulgare) Okoubaka aubrevillei Olea europaea Oleanolic acid Oleic acid Oleth-10 Oleth-2 Oleth-3 Oleth-20

A, E A, E C C

MRDD must contain 1 mg or less of the equivalent dry herbal material.

MRDD must contain 1 mg or less of the equivalent dry herbal material.

A, E A, E C E, C E E E E E

May only be used as a component and it is not listable in its own right. Concentration from all ingredients must not exceed 0.8%.

Approved for topical use only. Approved for topical use only. Approved for topical use only.

Approved for topical use only. Dioxane and Ethylene oxide are mandatory components of this ingredient (see separate entries).

Substances that may be used in Listed medicines in Australia December 2007

Oleth-3 phosphate

Approved for topical use only. Concentration must not exceed 0.1%.

Page 190 of 305

Therapeutic Goods Administration

Ingredient Oleth-5 Oleuropein

Use E C E

Restrictions

Oleyl alcohol Olibanum oil Olive

Approved for topical use only. Approved for topical use only.

Oligofructose Olive oil

A, E A, E E C A, E A, E E A, E A, E A, E A, E A, E

Omega-3 marine triglycerides Omphalia lapidescens Onion Onion oil

Only Olea europaea fruit flesh (pitted) is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Ononis spinosa

Only the Allium cepa bulb is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Onopordon acanthium Ophiopogon japonicus

Onosmodium virginianum

Substances that may be used in Listed medicines in Australia December 2007

Page 191 of 305

Therapeutic Goods Administration

Ingredient

Opopanax chironium Opuntia ficus-indica Orange Orange flower oil Orange oil

Use A, E A, E E A, E A, E A, E A, E A, E A, E E E

Restrictions Species listed on CITES if exporting or importing this product please contact the DSEWPC.

Only Citrus sinensis fruit flesh or fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Orange oil bitter coldpressed Orange oil distilled Orange oil terpeneless Orange roughy oil Orchis latifolia

Permitted only when: a) in preparations for internal use; b) in preparations containing 1.4% or less of orange oil bitter; c) in soaps or bath and shower gels that are washed off the skin; or d) packed in containers labelled with the statement SENS.

Orange peel dried bitter Orbignya speciosa

Oreodaphne californica Origanum majorana

A, E A, E A, E

Approved for topical use only.

Approved for topical use only.

Species listed on CITES if exporting or importing this product please contact the DSEWPC.

Substances that may be used in Listed medicines in Australia December 2007

Page 192 of 305

Therapeutic Goods Administration

Ingredient

Origanum oil spanish Origanum vulgare Ornithine

Use A, E A, E A, E A, E A, E A, E A, E A, E E E

Restrictions

Ornithine aspartate

Ornithine monohydrochloride Ornithogalum umbellatum Orostachys fimbriatus Oroxylon indicum Orris root oil

A, E, C

Ortho-Cymen-5-ol

Ortho-Phenylphenol Oryza sativa Oryzanol

Orthosiphon stamineus

A, E A, E E, C A, E A, E

Approved for topical use only. Concentration must not exceed 0.1%. PRV may only be used as an excipient in topical preparations.

May be a native species if exporting this product please contact the DSEWPC.

Osbeckia chinensis Ottelia alismoides

Substances that may be used in Listed medicines in Australia December 2007

May be a native species if exporting this product please contact the DSEWPC.

Page 193 of 305

Therapeutic Goods Administration

Ingredient

Oxacyclohexadecan-2-one Oxalis acetosella Oxedrine

Use E C C A, E

Restrictions

Approved for topical use only.

Oxindole alkaloids calc as mitraphylline (of Uncaria tomentosa bark) Oxybenzone Oyster Oyster shell Padimate O

Concentration in RDD must not exceed 30 mg. Sunscreen active permitted only in topical products. Concentration must not exceed 10%.

A E E

p-Anisic acid

A, E A

Paecilomyces variotii Paeonia lactiflora Paeonia obovata Paeonia veitchii

A, E A, E A, E A, E A, E A, E

PRV may only be used as an excipient in topical preparations.

Sunscreen active permitted only in topical products. Concentration must not exceed 8%.

Paeonia suffruticosa

Substances that may be used in Listed medicines in Australia December 2007

Paliurus spina-christi

Page 194 of 305

Therapeutic Goods Administration

Ingredient

Palm fruit oil

Use A, E E A, E A, E E E E E E E E

Restrictions Approved for topical use only. Concentration must not exceed 1%.

Palm glycerides - hydrogenated Palm kernel oil Palm kernel oil - fractionated Palm oil - hydrogenated Palmarosa oil Palmitic acid

Palm kernel oil - hydrogenated

When used as an active, this ingredient is only listable as an uncompounded BP substance. Approved for topical use only. Concentration must not exceed 1.2%.

Palmitoyl hydroxypropyltrimonium amylopectin/glycerin crosspolymer Palmitoyl oligopeptide Palmitoyl pentapeptide-3 Palmitoyl tetrapeptide-3 Panax ginseng Panax japonicus

A, E

Approved for topical use only. Concentration must not exceed 2%. Concentration of polycyclic aromatic hydrocarbons should be kept below the level of detection.

Approved for topical use only. Concentration must not exceed 0.01%.

Approved for topical use only. Concentration must not exceed 0.002%. Approved for topical use only. Concentration must not exceed 0.001%.

A, E A

Approved for topical use only. Concentration must not exceed 0.0005%.

Species listed on CITES if exporting or importing this product please contact the DSEWPC. Only if root and from the Russian Federation.

Substances that may be used in Listed medicines in Australia December 2007

Page 195 of 305

Therapeutic Goods Administration

Ingredient

Panax notoginseng

Use A A A E E E E C C A, E A, E

Restrictions Species listed on CITES if exporting or importing the root of this plant please contact the DSEWPC. Species listed on CITES if exporting or importing the root of this plant please contact the DSEWPC. Approved for topical use only. Approved for topical use only.

Panax pseudoginseng Panax quinquefolium Panicum milliaceum Pantethine Panthenol

Panthenyl ethyl ether Pantolactone Pantothenic acid

When used as an active in oral or sublingual products, the label must include the statement VIT.

Pantothenic acid polypeptide Papain Paper

Pantothenic acid (of Saccharomyces cerevisiae) Papain (of Carica papaya)

A, E, C

When used as an active in oral or sublingual products, the label must include the statement VIT. Approved for topical use only. Concentration must not exceed 0.1%.

A, E E

Approved for topical use only.


Page 196 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Para-Hydroxybenzoic acid Paraffin - hard Paraffin - light liquid Paraffin - liquid Paraffin - soft white

Use E E

Restrictions

A, E A, E A, E A, E A, E A, E A, E A, E E A, E A, E A, E A, E

When used as an active, this ingredient is only listable as an uncompounded BP substance. When used as an active, this ingredient is only listable as an uncompounded BP substance. When used as an active, this ingredient is only listable as an uncompounded BP substance. Approved for topical use only. When used as an active, this ingredient is only listable as an uncompounded BP substance.

Paraffin - soft yellow Parameria laevigata Parietaria diffusa Paris polyphylla Parsley Paris quadrifolia Parsley herb dry Parsley herb oil Parsley seed oil

Only Petroselinum crispum leaf and herb is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Parsley herb powder

Substances that may be used in Listed medicines in Australia December 2007

Page 197 of 305

Therapeutic Goods Administration

Ingredient

Parthenocissus tricuspidata Parthenolide Paspalum notatum

Use A, E C A, E A, E A E E A, E

Restrictions

Passiflora caerulea

Passiflora herb dry Patent blue V

Passiflora incarnata

Patent blue V aluminium lake Patrinia scabiosaefolia Patrinia villosa Paullinia cupana Pawpaw Pea

A, E A, E A, E A, E E E

Paullinia pinnata

Caffeine is a mandatory component of this ingredient when intended for oral ingestion (see separate entry).

Only Carica papaya fruit flesh or fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Only Pisum sativum seed (pea) green or other colours permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Substances that may be used in Listed medicines in Australia December 2007

Page 198 of 305

Therapeutic Goods Administration

Ingredient Peach Pear

Use E E E E E E E E E E E E E A, E

Restrictions

Peanut Pecan

Only Prunus persica fruit flesh is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Only Arachis hypogaea seed is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Requires the label statement PEANUT. Only Pyrus communis fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Pectin

PEG-10 dimethicone PEG-10 soya sterol PEG-100 stearate PEG-12 dilaurate

Only Carya illinoinensis seed (nut kernel) is permitted. May only be used as a food excipient refer to introduction for permitted preparations. PRV may only be used as an excipient in topical preparations. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only.

PEG-120 methyl glucose dioleate PEG-120 stearate PEG-15 cocamine PEG-150 stearate

PEG-150 distearate

Substances that may be used in Listed medicines in Australia December 2007

Approved only in topical preparations for localised effect.

Page 199 of 305

Therapeutic Goods Administration

Ingredient

PEG-2 oleate

Use E E E E E E

Restrictions

PEG-20 almond glycerides

PEG-20 methyl glucose distearate PEG-20 sorbitan isostearate PEG-20 stearate PEG-25 PABA

Approved for topical use only. Approved for topical use only.

PEG-20 methyl glucose sesquistearate

Approved for topical use only. Concentration must not exceed 0.5%. Approved only in topical preparations for localised effect. Approved only in topical preparations for localised effect. Approved for topical use only. Sunscreen active permitted only in topical products. Approved for topical use only. Approved for topical use only. Approved for topical use only.

PEG-30 dipolyhydroxystearate PEG-30 stearate PEG-4 dilaurate PEG-4 laurate PEG-4 stearate PEG-35 castor oil

A E E E E E E E

E,

Approved only in topical preparations for localised effect.

PEG-40 castor oil

Approved only in topical preparations for localised effect. Dioxane and Ethylene oxide are mandatory components of this ingredient (see separate entries).

Substances that may be used in Listed medicines in Australia December 2007

PEG-40 hydrogenated castor oil

Page 200 of 305

Therapeutic Goods Administration

Ingredient

PEG-40 sorbitan diisostearate PEG-40 stearate PEG-5 castor oil PEG-45/dodecyl glycol copolymer PEG-5 glyceryl stearate PEG-5 rapeseed sterol PEG-50 stearate

Use E E E E E E E E E E E E E E

Restrictions

Approved only in topical preparations for localised effect. Dioxane and Ethylene oxide are mandatory components of this ingredient (see separate entries). Approved for topical use only. Approved for topical use only. Approved for topical use only.

Approved for topical use only. Approved for topical use only.

PEG-55 propylene glycol oleate PEG-6 lauramide PEG-6 Methyl ether

PRV may only be used as an excipient in topical preparations.

Approved for topical use only. Concentration in the product must not exceed 0.6%. Approved only in topical preparations for localised effect. PRV may only be used as an excipient in topical preparations.

PEG-60 almond glycerides

PEG-60 glyceryl isostearate PEG-7 cocamide

PEG-60 hydrogenated castor oil

Approved only in topical preparations for localised effect. Concentration for products applied directly to the skin must not exceed 10%. Concentration when used in bath oil products is not to exceed 30% prior to addition to the bath. Approved for topical use only. Concentration must not exceed 2%. Approved for topical use only. Approved for topical use only.

Substances that may be used in Listed medicines in Australia December 2007

Page 201 of 305

Therapeutic Goods Administration

Ingredient

PEG-7 glyceryl cocoate PEG-75 lanolin

Use E E E E E E E E E E E

Restrictions

PEG-7 hydrogenated castor oil PEG-75 stearate

Approved for topical use only. Approved for topical use only.

Approved for topical use only.

PEG-8 cetyl dimethicone PEG-8 distearate PEG-8 stearate

Approved for topical use only. Concentration must not exceed 1.5%. Approved for topical use only. Approved for topical use only.

PEG-8 propylene glycol cocoate PEG/PPG-14/7 dimethyl ether PEG/PPG-18/18 dimethicone PEG/PPG-20/15 dimethicone Pelargonium graveolens Peltigera canina

Approved for topical use only. Concentration must not exceed 0.0005%.

PRV may only be used as an excipient in topical preparations

Penicillium chrysogenum Penicillium digitatum Penicillium expansum

A, E A, E A, E A, E A, E

Approved for topical use only. Concentration must not exceed 3%. PRV may only be used as an excipient in topical preparations.

Substances that may be used in Listed medicines in Australia December 2007

Page 202 of 305

Therapeutic Goods Administration

Ingredient

Penicillium glaucum Pennyroyal oil

Use A, E A, E A, E C

Restrictions

Penicillium notatum Pentacyclic oxindole alkaloids (of Uncaria tomentosa) Pentadoxynol-200 Pentaerythrityl tetra-di-t-butyl hydrocinnamate Pentaerythrityl tetralaurate

When used topically, the MRDD must only provide 150 mg or less. For any other route of administration, the MRDD must provide 50 mg or less. D-Pulegone is a mandatory component of this ingredient (see separate entry). PRV may only be used as an excipient in topical preparations. PRV may only be used as an excipient in topical preparations. Approved for topical use only. Approved for topical use only. Concentration must not exceed 61%. Approved for topical use only.

E E E E E E E C E

Pentaerythrityl tetraisostearate Pentaerythrityl tetraoctanoate Pentasodium ethylenediamine tetramethylene phosphonate Pentylene glycol Peonidin Pepper black

Approved for topical use only. Concentration must not exceed 0.1%. Approved for topical use only. Concentration must not exceed 5%.

Substances that may be used in Listed medicines in Australia December 2007

Only Piper nigrum fruit unripe (whole peppercorn) is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Page 203 of 305

Therapeutic Goods Administration

Ingredient

Pepper white

Use E

Restrictions

Peppermint leaf dry Peppermint oil

Peppermint leaf powder

A, E A, E A, E E A, E A, E E A, E A, E E A, E A, E A, E

Only Piper nigrum fruit endocarp and seed ripe (peppercorn without soft outer layer) is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Perfluoropolymethylisopropyl ether Perilla frutescens Periploca sepium Permethrin Persic oil

Approved for topical use only.

Persea gratissima Persimmon

Approved for topical use only as an excipient. Concentration must not exceed 2%.

Amygdalin and Hydrocyanic acid are mandatory components of this ingredient (see separate entries).

Peru balsam

Peru balsam oil

Only Diospyros kaki fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Petitgrain oil paraguay

Substances that may be used in Listed medicines in Australia December 2007

Oxedrine is a mandatory component of this ingredient when used for internal use (see separate entry).

Page 204 of 305

Therapeutic Goods Administration

Ingredient Petunidin

Petroselinum crispum

Use A, E C A, E A, E A A, E A, E A, E A, E A, E A, E A, E A, E E E

Restrictions

Peucedanum decursivum Peumus boldus

Peucedanum praeruptorum Phalaris arundinacea Phalaris canariensis Phaseolus angularis

Volatile oil components (of Peumus boldus) is a mandatory component of this ingredient (see separate entry).

Phaseolus calcaratus Phaseolus coccineus Phaseolus vulgaris Phellinus robiniae Phenacetin

Phellodendron amurense Phenethyl alcohol

Approved for topical use only.

Substances that may be used in Listed medicines in Australia December 2007

Approved for topical use only. Products for topical use require the label statement PHEALC.

Page 205 of 305

Therapeutic Goods Administration

Ingredient

Phenethyl benzoate Phenol

Use E E E E E E E

Restrictions

Phenethyl dimethicone Phenoxyethanol

Approved for topical use only. Concentration must not exceed 6%.

Approved for topical use only. Concentration must not exceed 0.2%. Products for topical use require the label statement PHOETH. Approved for topical use only. Approved for topical use only. Approved for topical use only.

Phenoxyethylparaben Phenyl dimethicone Phenylalanine Phenyl trimethicone

Approved only in topical preparations for localised effect. Concentration of phenols including cresols and xylenols and any other homologue of phenol boiling below 220 degrees centigrade should not exceed 3%. Requires the label statement PHENOL.

Phenylbenzimidazole sulfonic acid Phleum pratense Phloxine B

A, E A C A, E E

Products for oral ingestion require the label statement PKU. Products that contain more than 500 mg per daily dose require the label statement PREGNT2. Sunscreen active permitted only in topical products. Concentration must not exceed 4%.

Phloroglucinol derivatives calculated as humulone Phoenix dactylifera Phoma betae

A, E A, E
Page 206 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Phoma herbarum

Use A, E C

Restrictions Approved for topical use only. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. Approved for topical use only. Concentration must not exceed 20%. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. Concentration in liquid preparations must not exceed 15%.

Phosphatidyl choline Phosphatidyl inositol Phospholipids Phosphorus Phosphoric acid

E, C

E E C

Photinia serrulata

Phragmites communis Phyllanthus amarus Phyllostachys nigra Physalis alkekengi Physalis pubescens

Phycomyces blakesleeanus Phyllanthus emblica

A, E A, E A, E A, E A, E A, E A, E A, E A

May be a native species if exporting this product please contact the DSEWPC. May be a native species if exporting this product please contact the DSEWPC.

Substances that may be used in Listed medicines in Australia December 2007

Physostigma venenosum

Physostigmine is a mandatory component of this ingredient (see separate entry).

Page 207 of 305

Therapeutic Goods Administration

Ingredient Phytantriol

Physostigmine

Use C E

Restrictions

Phytolacca decandra Phytomenadione Phytosphingosine

A E E E

Concentration from all ingredients must not exceed 10 mg/kg or 10 mg/L or 0.001%. Approved for topical use only. Concentration imust not exceed 0.5%. MRDD must contain 1 mg or less of the equivalent dry herbal material. PRV may only be used as an excipient in topical preparations.

Phytosterol complex - conifer Phytosteryl macadamiate Picea excelsea Picea mariana

A, E A

When used as an active in oral or sublingual products, the label must include the statement VIT.

Phytosteryl/octyldodecyl lauroyl glutamate

PRV may only be used as an excipient in topical preparations.

Picrasma excelsa

A, E A, E A, E A, E A, E C

Approved for topical use only. Concentration must not exceed 0.1%.

Picrorrhiza kurroa Picrotoxin

Picrorrhiza scrophulariflora

Species listed on CITES only whole and sliced roots and part of roots, excluding manufactured parts or derivatives such as powders, pills, extracts, tonics, teas and confectionary, are subject to the Convention if exporting or importing this product please contact the DSEWPC. Concentration from all ingredients must not exceed 10 mg/kg or 10 mg/L or 0.001%.

Substances that may be used in Listed medicines in Australia December 2007

Page 208 of 305

Therapeutic Goods Administration

Ingredient

Pigment blue 15

Use E E E E E E E E E C

Restrictions

Pigment green 18 Pigment green 7 Pigment red 4 Pigment red 53 Pigment red 57 Pigment red 63

Colour permitted only in topical preparations.

PRV may only be used as an excipient in topical preparations. Colour permitted only in topical preparations. Colour permitted only in topical preparations. Colour permitted only in topical preparations. Colour permitted only in topical preparations.

PRV may only be used as an excipient in topical preparations. Colour permitted only in topical preparations.

Pigment white 26 Pilocarpine

Pigment yellow 12

Pilocarpus jaborandi

Pilocarpus microphyllus Pilocarpus pinnatifolius Pimenta fruit oil Pimenta leaf oil

A A A

Colour permitted only in topical preparations.

Concentration of pilocarpine from all ingredients must not exceed 0.025%.

Pilocarpine is a mandatory component of this ingredient (see separate entry). Pilocarpine is a mandatory component of this ingredient (see separate entry).

Substances that may be used in Listed medicines in Australia December 2007

Pimenta officinalis

A, E A, E A, E

Pilocarpine is a mandatory component of this ingredient (see separate entry).

Page 209 of 305

Therapeutic Goods Administration

Ingredient

Pimenta racemosa

Use A, E

Restrictions

Pimpinella anisum Pimpinella saxifraga Pine oil aromatic Pine oil pumilio Pineapple Pinellia ternata Pinus contorta

A, E A, E A, E A, E A, E E A, E A, E A, E A, E A, E

Permitted without restriction in preparations containing 25% or less of bay oil. When the concentration of bay oil is greater than 25% and the nominal capacity of the container is 15 mL or less, a RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. When the concentration of bay oil is greater than 25% and the nominal capacity of the container is greater than 15 mL but less than or equal to 25 mL, a CRC and RFI must be fitted on the container and the product label must include the statements CHILD and NTAKEN. Permitted without restriction in preparations containing 50% or less of anise oil. When the concentration of anise oil is greater than 50%, the nominal capacity of the container must be 50 mL or less, a RFI must be fitted on the container and the product label must include the statement CHILD.

Pine needle oil scotch

Only Ananas sativus fruit flesh or fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Pinus massoniana Pinus monticola Pinus mugo

Substances that may be used in Listed medicines in Australia December 2007

Page 210 of 305

Therapeutic Goods Administration

Ingredient

Pinus pinaster Pinus radiata

Use A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E

Restrictions

Pinus ponderosa Pinus strobus

Pinus sylvestris Piper chaba

Pinus tabulaeformis Piper cubeba

Piper futokadsura Piper longum

Piper methysticum

Piper nigrum

Piper sarmentosum

A, E A, E

When the container type is tea bag the maximum quantity per tea bag is 3 grams of dried rhizomes. Approved in topical preparations for use on the rectum, vagina or throat only when containing dried whole or peeled rhizome or containing aqueous dispersions or aqueous extracts of whole or peeled rhizome. Kavalactones (of Piper methysticum) is a mandatory component of this ingredient (see separate entry). Customs Prohibited Import requires an import permit/licence.

Substances that may be used in Listed medicines in Australia December 2007

Page 211 of 305

Therapeutic Goods Administration

Ingredient Piperonal

Piperine_(of piper nigrum) Piperonyl butoxide Piroctone olamine Piscidia piscipula Pistacia lentiscus Pisum sativum Plantago afra

Use C E E E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E

Restrictions PRV may only be used as an excipient in topical preparations.

Approved only in topical preparations for localised effect. Topical products require the label statement PIPBUT.

Approved for topical use only. Concentration must not exceed 0.5% in leave-on products and 1% in wash-on/wash-off products.

Plantago asiatica Plantago indica Plantago major Plantago ovata

If a dose for children is stated, it must be followed by the label statement PSYLL. If a dose for children is stated, it must be followed by the label statement PSYLL.

Plantago lanceolata

Plantago seed dry

Substances that may be used in Listed medicines in Australia December 2007

Platanus occidentalis

If a dose for children is stated, it must be followed by the label statement PSYLL. If a dose for children is stated, it must be followed by the label statement PSYLL.
Page 212 of 305

Therapeutic Goods Administration

Ingredient

Platanus racemosa

Use A, E A, E A, E E A, E A, E A, E A, E A, E A, E C C

Restrictions

Platanus X acerifolia Plum

Platycodon grandiflorum Plumbago europaea Plumeria alba Plumeria lancifolia Plumeria rubra Poa nemoralis Poa pratensis Podophyllin

Only Prunus cerasifera, P. domestica, P. instititia, P. salicina, P. spinosa and hybrids fruit flesh is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Podophyllotoxin

Podophyllum dry

Concentration from all ingredients must not exceed 1 mg/kg or 1 mg/L or 0.0001%.

Concentration from all ingredients must not exceed 10 mg/kg or 10 mg/L or 0.001%.

Podphyllin and Podophyllotoxin are mandatory components of this ingredient (see separate entries). Species may be listed on CITES if exporting or importing this product please contact the DSEWPC.

Substances that may be used in Listed medicines in Australia December 2007

Page 213 of 305

Therapeutic Goods Administration

Ingredient

Podophyllum emodi

Use A A A A E E E E E E

Restrictions

Podophyllum peltatum Podophyllum powder Podophyllum resin Pogostemon cablin Polacrilin

Podphyllin and Podophyllotoxin are mandatory components of this ingredient (see separate entries). Species may be listed on CITES if exporting or importing this product please contact the DSEWPC. Podphyllin and Podophyllotoxin are mandatory components of this ingredient (see separate entries). Podphyllin and Podophyllotoxin are mandatory components of this ingredient (see separate entries). Species may be listed on CITES if exporting or importing this product please contact the DSEWPC. Podphyllin and Podophyllotoxin are mandatory components of this ingredient (see separate entries). Species may be listed on CITES if exporting or importing this product please contact the DSEWPC.

Polacrilin potassium Pollack-liver oil Pollen Poloxamer

A, E

A, E

Poly C10-30 alkyl acrylate Polyacrylamide

If the ingredient is collected by bees then the product requires the label statement POLLEN. Approved for topical use only. Approved for topical use only. Concentration must not exceed 1%.

Substances that may be used in Listed medicines in Australia December 2007

Approved only in topical preparations for localised effect. Acrylamide is a mandatory component of this ingredient in topical products.

Page 214 of 305

Therapeutic Goods Administration

Ingredient

Polyacrylic acid

Use E E E E E E E E E

Restrictions Approved for topical use only. Approved for topical use only.

Polyamino sugar condensate Polyaminopropyl biguanide Polybutene

Polybutylene glycol/PPG-9/1 copolymer Polycaprolactone Polydecene Polydextrose Polyethylene

Approved for topical use only. Concentration must not exceed 0.02%. PRV may only be used as an excipient in topical preparations.

Approved for topical use only. Concentration must not exceed 0.1%. Approved for topical use only. Concentration must not exceed 6%.

Polygala chinensis Polygala senega Polygala sibirica

A, E A, E A, E E E E

Polyglyceryl-10 oleate

Polyglyceryl-10 pentastearate Polyglyceryl-2-PEG-4 stearate

PRV may only be used as an excipient in topical preparations. PRV may only be used as an excipient in topical preparations. Approved for topical use only.
Page 215 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Polyglyceryl-2 dipolyhydroxystearate Polyglyceryl-2 diisostearate Polyglyceryl-3 diisostearate Polyglyceryl-3 oleate Polyglyceryl-2 triisostearate

Use E E E E E E E E E E E E

Restrictions

Approved for topical use only. Concentration must not exceed 5%. PRV may only be used as an excipient in topical preparations. PRV may only be used as an excipient in topical preparations. Approved for topical use only.

Polyglyceryl-3 methylglucose distearate Polyglyceryl-3 polydimethylsiloxyethyl dimethicone Polyglyceryl-3 polyricinoleate Polyglyceryl-4 isostearate Polyglyceryl-4 oleate

Approved for topical use only. Concentration must not exceed 3%. PRV may only be used as an excipient in topical preparations.

Polyglyceryl-3 polydimethylsiloxyethyl dimethicone is for dermal use only. The concentration of Polyglyceryl-3 polydimethylsiloxyethyl dimethicone is not to exceed 3%. Approved for topical use only. Concentration must not exceed 5%. Approved for topical use only. Approved for topical use only. Approved for topical use only. Concentration must not exceed 1%.

Polyglyceryl-6 polyricinoleate Polyglyceryl-6 ricinoleate Polygonatum officinale Polygonatum multiflorum Polygonatum sibiricum

A, E A, E A, E

Substances that may be used in Listed medicines in Australia December 2007

Page 216 of 305

Therapeutic Goods Administration

Ingredient

Polygonum aviculare Polygonum bistorta Polygonum chinense

Use A, E A, E A, E A, E A, E A, E A, E E E E E E E C E

Restrictions

Polygonum cuspidatum Polygonum odoratum

Polygonum multiflorum Polygonum tinctorium

Polyhydroxysteraric acid Polyisoprene

Polyisobutene - hydrogenated Polymethacrylic acid

Approved for topical use only. Approved for topical use only.

Approved only in topical preparations for localised effect.

Polymethyl methacrylate

Polymethylsilsesquioxane

Polyphenols calculated as catechin (of Oenothera biennis)

Approved only in topical preparations for localised effect.

Approved for topical use only. Concentration must not exceed 1%. PRV may only be used as an excipient in topical preparations.

Substances that may be used in Listed medicines in Australia December 2007

Polyphosphorylcholine glycol acrylate

Page 217 of 305

Therapeutic Goods Administration

Ingredient

Polyporus umbellatus Polypropylene Polyquaternium-10 Polyquaternium-11 Polyquaternium-24 Polyquaternium-28 Polyquaternium-44 Polyquaternium-51 Polyquaternium-7 Polysilicone-11 Polysilicone-14 Polysilicone-15 Polysilicone-2

Use A, E E E E E E E E E E E E E E E

Restrictions Approved for topical use only.

Approved for topical use only. Approved for topical use only. Approved for topical use only.

Approved only in topical preparations for localised effect.

Approved for topical use only. Concentration must not exceed 0.3%. Approved for topical use only. Concentration must not exceed 5%. Approved for topical use only. PRV may only be used as an excipient in topical preparations.

Approved for topical use only. Concentration must not exceed 1%. PRV may only be used as an excipient in topical preparations.

Polysiphonia lanosa cell extract 1:3.1 in 100% W ICID 2004 Polysorbate 20

Approved for topical use only. Concentration must not exceed 10%. (?) PRV may only be used as an excipient in topical preparations.

Substances that may be used in Listed medicines in Australia December 2007

Page 218 of 305

Therapeutic Goods Administration

Ingredient

Polysorbate 40 Polysorbate 60 Polysorbate 65 Polysorbate 80 Polysorbate 85 Polytef

Use E E E E E E E E E E E E A, E A, E A, E

Restrictions

Polyvinyl acetate

Approved for topical use only.

Polyvinyl acetate phthalate Polyvinyl alcohol Pomegranate Ponceau SX Polyvinyl chloride

Approved for topical use only. Concentration must not exceed 0.5%.

Approved for topical use only.

Poncirus trifoliata Populus alba Populus balsamiifera

Only Punica granatum fruit flesh is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Colour permitted only in topical preparations.

Oxedrine is a mandatory component of this ingredient when used for internal use (see separate entry).

Substances that may be used in Listed medicines in Australia December 2007

Page 219 of 305

Therapeutic Goods Administration

Ingredient

Populus candicans Populus deltoides Populus nigra Populus tremula Poria cocos

Use A, E A, E A, E A, E A, E A, E E E C

Restrictions

Populus tremuloides

Porphyra yezoensis cytoplasm extract ICID 2004 Porphyridium purpureum cytoplasm extract ICID 2004 Portulaca oleracea Potassium Potassium acetate

PRV may only be used as an excipient in topical preparations. PRV may only be used as an excipient in topical preparations. May be a native species if exporting this product please contact the DSEWPC.

A, E E

Potassium ascorbate

Potassium ascorbate dihydrate Potassium ascorbyl tocopheryl phosphate

A, E A, E E

When used as an active in oral or sublingual products, the label must include the statement VIT. When used as an active in oral or sublingual products, the label must include the statement VIT. Approved for topical use only.

Substances that may be used in Listed medicines in Australia December 2007

Page 220 of 305

Therapeutic Goods Administration

Ingredient

Potassium aspartate

Use A, E A, E A, E E E E E E, C E E

Restrictions

Potassium aspartate dihydrate Potassium bicarbonate Potassium carbomer Potassium carbonate Potassium chloride Potassium citrate

Potassium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of potassium is required on the product label. Potassium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of potassium is required on the product label. Potassium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of potassium is required on the product label. PRV may only be used as an excipient in topical preparations. Approved for topical use only.

Potassium aspartate monohydrate

Potassium cetyl phosphate

In solid preparations, the pH of a 10 gm/L aqueous solution must not be more than 11.5. In liquid or semi-solid preparations, the pH of the preparation must not exceed 11.5.

Potassium cocoyl hydrolysed collagen Potassium cocoyl hydrolysed soy protein Potassium gluconate

A, E

Potassium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of potassium is required on the product label. Approved for topical use only. Concentration must not exceed 0.15%.

Approved for topical use only. Concentration must not exceed 10%. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. Potassium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of potassium is required on the product label.

A, E

Substances that may be used in Listed medicines in Australia December 2007

Page 221 of 305

Therapeutic Goods Administration

Ingredient

Potassium glycerophosphate Potassium hydroxide Potassium iodide

Use A, E E

Restrictions

Potassium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of potassium is required on the product label.

Potassium hydroxycitrate

Potassium metaphosphate Potassium orotate Potassium phosphate - dibasic Potassium phosphate - dibasic trihydrate

A E

A, E A, E A, E A, E A, E

Concentration must not exceed 5%. In solid preparations, the pH of a 10 gm/L aqueous solution must not be more than 11.5. In liquid or semi-solid preparations, the pH of the preparation must not exceed 11.5. Iodine is a mandatory component of this ingredient (see separate entry). Approved for topical use only. Concentration must not exceed 0.5%.

Potassium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of potassium is required on the product label.

Potassium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of potassium is required on the product label. In solid preparations, the pH of a 10 gm/L aqueous solution must not exceed 11.5. In liquid or semisolid preparations, the pH of the preparation must not exceed 11.5.

Potassium phosphate - monobasic

Potassium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of potassium is required on the product label. In solid preparations, the pH of a 10 gm/L aqueous solution must not exceed 11.5. In liquid or semisolid preparations, the pH of the preparation must not exceed 11.5. Potassium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of potassium is required on the product label. In solid preparations, the pH of a 10 gm/L aqueous solution must not exceed 11.5. In liquid or semisolid preparations, the pH of the preparation must not exceed 11.5.

Substances that may be used in Listed medicines in Australia December 2007

Page 222 of 305

Therapeutic Goods Administration

Ingredient

Potassium phosphate - tribasic Potassium pyrophosphate Potassium sorbate Potassium sulfate Potato Potassium stearate

Use A, E E E E E

Restrictions

Potassium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of potassium is required on the product label. In solid preparations, the pH of a 10 gm/L aqueous solution must not exceed 11.5. In liquid or semisolid preparations, the pH of the preparation must not exceed 11.5. Approved for dental, oral, and topical use only. Not to be used in products intended for use in the eye. Concentration must not exceed 3%. Requires the label statement SORB8. Approved for topical use only.

A, E

Potassium is a mandatory component of this ingredient. If used as an active AND intended as a mineral supplementation, the equivalent quantity of potassium is required on the product label.

Potentilla anserina Potentilla discolor Potentilla erecta Potentilla reptans

Potentilla chinensis

A, E A, E A, E A, E A, E A, E

Only Solanum tuberosum tuber is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Steroidal alkaloids calculated as solanine is a mandatory component of this ingredient (see separate entry).

Poterium officinale

Substances that may be used in Listed medicines in Australia December 2007

Page 223 of 305

Therapeutic Goods Administration

Ingredient Povidone

Poterium sanguisorba

Use A, E E E E E E E E E E E E E E E

Restrictions

PPG-12/SMDI copolymer PPG-15 stearyl ether

PPG-15 stearyl ether benzoate PPG-2 lanolin alcohol ether

Approved for topical use only. Concentration must not exceed 2%. Approved for topical use only.

PPG-17/IPDI/DMPA Copolymer

Approved for topical use only. Concentration must not exceed 0.3%. PRV may only be used as an excipient in topical preparations. Approved for topical use only. Approved for topical use only.

PPG-2 myristyl ether propionate PPG-20 lanolin alcohol ether PPG-20 methyl glucose ether PPG-20 methyl glucose ether distearate PPG-3 myristyl ether PPG-5-ceteth-20 PPG-5-laureth-5

Approved for topical use only. Concentration must not exceed 5%.

Approved only in topical preparations for localised effect. Concentration must not exceed 0.5%. Approved only in topical preparations for localised effect. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved only in topical preparations for localised effect. Concentration must not exceed 6%.

PPG-3 hydrogenated castor oil

Substances that may be used in Listed medicines in Australia December 2007

Page 224 of 305

Therapeutic Goods Administration

Ingredient

PPG-51/SMDI copolymer Prickly ash bark dry Primula veris Prickly ash bark powder Primula vulgaris

Use E A, E A, E A, E A, E A, E C C C C

Restrictions

PRV may only be used as an excipient in topical preparations.

Prinsepia unifloria

Proanthocyanidins calculated as procyanidine B1 (of Vaccinium macrocarpon) procyanidins (of Pinus pinaster) procyanidins (of Pinus radiata) procyanidins (of Vitis vinifera) Proline Propane

Propan-1-ol

A, E E E

Propionyllevocarnitine hydrochloride

A
Page 225 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient Propolis

Use

Propolis balsam

A, E, C A, E, C A, E, C A, E, C A, E, C A, E, C E E E E E E

Restrictions

Lead is a mandatory component of this ingredient (see separate entry). Topical products require the label statement PROP1. Products other than for topical use require the label statement PROP2. Lead is a mandatory component of this ingredient (see separate entry). Topical products require the label statement PROP1. Products other than for topical use require the label statement PROP2. Lead is a mandatory component of this ingredient (see separate entry). Topical products require the label statement PROP1. Products other than for topical use require the label statement PROP2. Lead is a mandatory component of this ingredient (see separate entry). Topical products require the label statement PROP1. Products other than for topical use require the label statement PROP2. Lead is a mandatory component of this ingredient (see separate entry). Topical products require the label statement PROP1. Products other than for topical use require the label statement PROP2.

Propolis dry extract Propolis resin Propyl gallate

Propolis liquid extract Propolis tincture Propyl hydroxybenzoate Propylene carbonate Propylene glycol

Lead is a mandatory component of this ingredient (see separate entry). Topical products require the label statement PROP1. Products other than for topical use require the label statement PROP2. Topical products require the label statement TOTBNZ. Approved for topical use only.

Propylene glycol dicaprate

Propylene glycol dicaprylate

Approved for topical use only. Concentration must not exceed 1%. PRV may only be used as an excipient in topical preparations.

Substances that may be used in Listed medicines in Australia December 2007

Page 226 of 305

Therapeutic Goods Administration

Ingredient

Propylene glycol dicaprylate/dicaprate

Use E E E E E E E A, E A, C E C C

Restrictions

Propylene glycol dioctanoate Propylene glycol isostearate

Approved for topical use only. Approved for topical use only. Approved for topical use only.

Propylene glycol dipelargonate Propylene glycol monolaurate

Approved only in topical preparations for localised effect.

Propylene glycol monostearate Prosopis juliflora Protease

Approved only in topical preparations for localised effect. Approved for topical use only. Approved for topical use only. Permitted only when derived from Aspergillus oryzae.

Propylene glycol myristyl ether acetate

Protein hydrolysate Protopine

Protodioscin (of Tribulus terrestris) Prunella vulgaris

If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL.

A, E

Substances that may be used in Listed medicines in Australia December 2007

Page 227 of 305

Therapeutic Goods Administration

Ingredient

Prunus africana

Use A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E

Restrictions

Prunus armeniaca Prunus avium Prunus cerasifera Prunus cerasus Prunus dulcis Prunus domestica Prunus humilis

Amygdalin and Hydrocyanic acid are mandatory components of this ingredient (see separate entries). Species listed on CITES if exporting or importing this product please contact the DSEWPC. Amygdalin and Hydrocyanic acid are mandatory components of this ingredient (see separate entries). Amygdalin and Hydrocyanic acid are mandatory components of this ingredient (see separate entries). Amygdalin and Hydrocyanic acid are mandatory components of this ingredient (see separate entries). Amygdalin and Hydrocyanic acid are mandatory components of this ingredient (see separate entries). Amygdalin and Hydrocyanic acid are mandatory components of this ingredient (see separate entries). Amygdalin and Hydrocyanic acid are mandatory components of this ingredient (see separate entries). Amygdalin and Hydrocyanic acid are mandatory components of this ingredient (see separate entries).
Page 228 of 305

Amygdalin and Hydrocyanic acid are mandatory components of this ingredient (see separate entries). Amygdalin and Hydrocyanic acid are mandatory components of this ingredient (see separate entries).

Prunus insititia

Prunus japonica

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Prunus laurocerasus Prunus mume Prunus persica

Use A, E A, E A, E A, E A, E E A, E A, E A, E A, E A, E A, E

Restrictions

Amygdalin and Hydrocyanic acid are mandatory components of this ingredient (see separate entries). Amygdalin and Hydrocyanic acid are mandatory components of this ingredient (see separate entries). Amygdalin and Hydrocyanic acid are mandatory components of this ingredient (see separate entries). Amygdalin and Hydrocyanic acid are mandatory components of this ingredient (see separate entries). Amygdalin and Hydrocyanic acid are mandatory components of this ingredient (see separate entries). Amygdalin and Hydrocyanic acid are mandatory components of this ingredient (see separate entries). Colour permitted only in topical preparations.

Prunus salicina

Prunus serotina Prunus spinosa Prussian blue

Pseudolarix kaempferi Pseudostellaria heterophylla Pseudotsuga menziesi Psidium guajava Pseudowintera colorata

If the plant part is stem bark or root and the preparation is for internal use, the MRDD must contain 1 mg or less of the equivalent dry stem bark or root. The stem bark and root used topically is listable without restriction. Plant parts other than stem bark or root are permitted only if the MRDD contains 1 mg or less of the dry herbal material.

Permitted only if the plant part is leaf.


Page 229 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Psoralea corylifolia Psyllium husk dry Psyllium seed dry Ptelea trifoliata

Use A, E A, E A, E A, E A, E A, E A, E A, E A, E C E E E E

Restrictions If a dose for children is stated, it must be followed by the label statement PSYLL. If a dose for children is stated, it must be followed by the label statement PSYLL. If a dose for children is stated, it must be followed by the label statement PSYLL.

Psyllium husk powder

Pterocarpus marsupium Pterocarpus santalinus Pueraria lobata Pulegone Pullulan Pumice

Pueraria pseudohirsuta

Pulsatilla vulgaris Pumpkin

A, E

Concentration must not exceed 4%.

Substances that may be used in Listed medicines in Australia December 2007

Pumpkin seed

Only Cucurbita maxima, C. moschata and C. pepo fruit flesh orange and high in starch is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Only Cucurbita pepo seed is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Page 230 of 305

Therapeutic Goods Administration

Ingredient

Pumpkin seed oil Punica granatum Punicalagins (of Punica granatum) PVM/MA copolymer

Use E C C

Restrictions

Purine alkaloids calculated as caffeine (of Paullinia cupana) PVM/MA decadiene crosspolymer PVP/eicosene copolymer PVP/VA copolymer Pyrethrins PVP/hexadecene copolymer

A, E

Only Cucurbita pepo seed oil fixed is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

E E E E E

Approved only in topical preparations for localised effect. Approved for topical use only. Approved for topical use only.

Pyridoxal 5-phosphate Pyridoxine

E, C C

A, E

Approved only in topical preparations for localised effect. Concentration must not exceed 10%. Requires the label statement PYRTH3. Pyridoxine is a mandatory component of this ingredient (see separate entry). When used as an active in oral or sublingual products, the label must include the statement VIT. RDD must not contain more than 200 mg. If the preparation contains more than 50 mg and less than 200 mg of pyridoxine per RDD the product requires the label statement VITB6.

Substances that may be used in Listed medicines in Australia December 2007

Page 231 of 305

Therapeutic Goods Administration

Ingredient

Pyridoxine hydrochloride Pyroglutamic acid Pyrola decorata Pyrrosia lingua

Use A, E E A, E A, E A, E A, E A, E A, E A, E A, E A, E E E E

Restrictions

Pyridoxine is a mandatory component of this ingredient unless present as an active homoeopathic (see separate entry). When used as an active in oral or sublingual products, the label must include the statement VIT.

Pyrrosia petilosa Pyrus communis Pyrus pyrifolia Quassia amara

Pyrrosia sheareri

Quassia wood jamaican dry Quaternium-15 Quaternium-18 Quaternium 52

Quassia wood jamaican powder

Approved only in topical preparations for localised effect. Requires the label statement QUAT15. PRV may only be used as an excipient in topical preparations. Approved for topical use onlyin wash on/wash off products. Concentration must not exceed 1%. Should not be used in products in which N-nitroso compounds may be formed.

Substances that may be used in Listed medicines in Australia December 2007

Page 232 of 305

Therapeutic Goods Administration

Ingredient

Quaternium-18 bentonite Quaternium-18 hectorite Quercetin Quercus acutissima Quercus alba Quercus palustris Quercus robur Quercus rubra Quillaia dry

Use E E

Restrictions

Approved for topical use only. Approved for topical use only.

A, E A, E A, E A, E A, E A, E A, E A, E A, E E C C

Quercus virginiana Quillaia powder Quince

Quillaja saponaria Quinic acid Quinidine

Only Cydonia oblonga fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Concentration must not exceed 10 mg/kg or 10 mg/L or 0.001%.

Substances that may be used in Listed medicines in Australia December 2007

Page 233 of 305

Therapeutic Goods Administration

Ingredient Quinine Quinoline yellow

Use C E E

Restrictions

Quinoline yellow aluminium lake Quisqualis indica R-alpha lipoic acid Radish

MRDD must not exceed 50 mg.

R,S-alpha lipoic acid Ranunculus bulbosus Ranunculus ficaria Ranunculus ternatus

A, E A A E

A, E A, E A, E A, E E A, E A, E E

Only Raphanus sativus root is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Ranunculus zuccarini Rape seed oil Raspberry

Rape oil/tung oil copolymer Raphanus sativus

Approved for topical use only. Concentration must not exceed 1%.

Allyl isothiocyanate is a mandatory component of this ingredient (see separate entry).

Substances that may be used in Listed medicines in Australia December 2007

Only Rubus idaeus, R. occidentalis, R. parvifolius and hybrids fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Page 234 of 305

Therapeutic Goods Administration

Ingredient

Rauwolfia serpentina

Use A A A

Restrictions

Rauwolfia serpentina dry

Concentration of equivalent dry herbal material must not exceed 10 mg/Kg or 10 mg/L or 0.001%. Species listed on CITES if exporting or importing this product please contact the DSEWPC excluding chemical derivatives and finished pharmaceutical products. Concentration must not exceed 10 mg/Kg or 10 mg/L or 0.001%. Species listed on CITES if exporting or importing this product please contact the DSEWPC excluding chemical derivatives and finished pharmaceutical products. Concentration must not exceed 10 mg/Kg or 10 mg/L or 0.001%. Species listed on CITES if exporting or importing this product please contact the DSEWPC excluding chemical derivatives and finished pharmaceutical products.

Rauwolfia serpentina powder Red clover flower dry Rehmannia glutinosa Red clover flower powder

A, E A, E A, E C C

Resveratrol (of Polygonum cupidatum) Retinol

Resveratrol (of Vitis vinifera) Retinyl acetate

A, E A, E E

Vitamin A is a mandatory component of this ingredient (see separate entry). When used as an active in oral or sublingual products, the label must include the statement VIT. PRV may only be used as an excipient in topical preparations.

Retinyl linoleate

Vitamin A is a mandatory component of this ingredient (see separate entry). When used as an active in oral or sublingual products, the label must include the statement VIT.

Substances that may be used in Listed medicines in Australia December 2007

Page 235 of 305

Therapeutic Goods Administration

Ingredient

Retinyl palmitate

Use A, E A A A A A C

Restrictions

Rhamnus catharticus Rhamnus frangula Rhatany root dry Rhein Rhamnus purshianus Rhatany root powder Rheum officinale

Vitamin A is a mandatory component of this ingredient (see separate entry). When used as an active in oral or sublingual products, the label must include the statement VIT.

Hydroxyanthracene derivatives is a mandatory component of this ingredient in oral preparations (see separate entry). Glucofrangulins calculated as glucofrangulin A is a mandatory component of this ingredient (see separate entry). Hydroxyanthracene derivatives calculated as cascaroside A is a mandatory component of this ingredient in oral preparations (see separate entry).

Rheum palmatum

A, E A, E A, E

Not permitted if the plant part contains leaf. Hydroxyanthracene derivatives calculated as rhein is a mandatory component of this ingredient in oral preparations when the plant part is not leaf (see separate entry). Not permitted if the plant part contains leaf. Hydroxyanthracene derivatives is a mandatory component of this ingredient in oral preparations when the plant part is not leaf (see separate entry).

Rheum rhaponticum

Not permitted if the plant part contains leaf. Hydroxyanthracene derivatives calculated as rhein is a mandatory component of this ingredient in oral preparations when the plant part is not leaf (see separate entry).

Substances that may be used in Listed medicines in Australia December 2007

Page 236 of 305

Therapeutic Goods Administration

Ingredient

Rheum tanguticum Rhizopus oryzae Rhodamine B Rhizopus stolonifer

Use A, E A, E A, E E A, E A, E A, E A, E A, E E A, E A, E A, E

Restrictions

Not permitted if the plant part contains leaf. Hydroxyanthracene derivatives is a mandatory component of this ingredient in oral preparations when the plant part is not leaf (see separate entry).

Rhododendron chrysantheum Rhododendron ferrugineum Rhododendron molle Rhodotorula glutinus Rhubarb

Colour permitted only in topical preparations.

Rhodymenia palmata Rhubarb root dry Rhus aromatica

MRDD must contain 1 mg or less of the equivalent dry herbal material.

Only Rheum rhaponticum leaf stalk (petiole) is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Hydroxyanthracene derivatives is a mandatory component of this ingredient in oral preparations (see separate entry).

Rhubarb root powder

Hydroxyanthracene derivatives calculated as rhein is a mandatory component of this ingredient in oral preparations (see separate entry). Hydroxyanthracene derivatives calculated as rhein is a mandatory component of this ingredient in oral preparations (see separate entry).
Page 237 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Rhus diversiloba Rhus glabra Rhus radicans

Use A, E A, E A, E A, E A, E A, E A, E A, E A, E E

Restrictions

Rhus semialata Rhus venenata Ribes nigrum Riboflavin

Rhus succedanea

Ribes grossularia

Riboflavin sodium phosphate Riboflavin tetraacetate Riboflavine

A, E, C

When used as an active in oral or sublingual products, the label must include the statement VIT. Approved for topical use only.

Riboflavine sodium phosphate Ribonucleic acid

A, E, C A, E E

When used as an active in oral or sublingual products, the label must include the statement VIT. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. When used as an active in oral or sublingual products, the label must include the statement VIT. Approved for topical use only.

When used as an active in oral or sublingual products, the label must include the statement VIT. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.
Page 238 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient Rice

Use E E E E E E A, E A, E A A, E

Restrictions

Rice - hydrolysed Rice bran Rice bran oil Rice vinegar Rice wine

A, E

Only Oryza sativa seed (grain) is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Only Oryza sativa seed (grain) husk or seed coat (bran) is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Rice bran wax

A, E

Only Oryza sativa seed (grain) husk or seed coat (bran) with/out seed embryo (germ) oil fixed is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Only Oryza sativa seed (grain) vinegar is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Approved for topical use only.

Ricinoleic acid

Ricinus communis Rohdea japonica Rosa alba

Only Oryza sativa seed (grain) fermented (wine) is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Ethanol is a mandatory component of this ingredient (see separate entry). Approved only when the plant part is seed and the plant preparation is oil fixed. MRDD must contain 1 mg or less of the equivalent dry herbal material.

Robinia pseudoacacia

If the plant part is other than leaf or flower, the MRDD must contain 1 mg or less of the equivalent dry herbal material. If the plant part is leaf or flower, it is listable without restriction.

Substances that may be used in Listed medicines in Australia December 2007

Page 239 of 305

Therapeutic Goods Administration

Ingredient

Rosa arvensis Rosa canina

Use A, E A, E A, E A, E A, E A, E A, E A, E A, E E A, E A, E A, E E A, E

Restrictions

Rosa centifolia

Rosa damascena Rosa eglanteria Rosa gallica Rosa indica

Rosa laevigata

Rosa multiflora Rosa rugosa Rosa villosa Rose hip Rose oil

Rosa roxburghii extract ICID97

PRV may only be used as an excipient in topical preparations.

Rose fruit fresh

Only Rosa arvensis, R. canina and R. villosa fruit flesh (hip) is permitted. May only be used as a food excipient refer to introduction for permitted preparations.
Page 240 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Rosemary oil Royal jelly

Use A, E A, E

Restrictions

Rosmarinus officinalis Royal jelly fresh Rubber natural

A, E, C A, E, C A, E, C E A, E A, E A, E A, E A, E A, E A, E A, E

Safrole is a mandatory component of this ingredient (see separate entry).

Camphor, Cineole and Safrole are mandatory components of this ingredient (see separate entries). Requires the label statements CHILD2 and ROYJ. 10-Hydroxy-2-decenoic acid is a mandatory component of this ingredient. Requires the label statements CHILD2 and ROYJ. 10-Hydroxy-2-decenoic acid is a mandatory component of this ingredient. Requires the label statements CHILD2 and ROYJ. 10-Hydroxy-2-decenoic acid is a mandatory component of this ingredient. Approved for topical use only.

Royal jelly lyophilised Rubia cordifolia Rubus chingii

Rubia tinctorum Rubus coreanus Rubus idaeus

Rubus fruticosus

Rubus occidentalis Rubus parvifolius

May be a native species if exporting this product please contact the DSEWPC.
Page 241 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Rubus rosifolius Rubus tokkura Rubus villosus Rue oil

Use A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E C A, E A, E A, E A, E

Restrictions

May be a native species if exporting this product please contact the DSEWPC.

Rudbeckia hirta Rumex acetosa Rumex acutus

Rumex acetosella Rumex crispus

Rumex pulcher Ruscogenin

Rumex scutatus

Ruscus aculeatus Ruta chalepensis Ruta graveolens Ruta montana

Substances that may be used in Listed medicines in Australia December 2007

Page 242 of 305

Therapeutic Goods Administration

Ingredient Rutin Rye

Use A, E E E C C

Restrictions Only Secale cereale seed (grain) is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Gluten is a mandatory component of this ingredient when the route of administration is other than topical and mucosal (see separate entry). Only Secale cereale seed (grain) husk or seed coat (bran) is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Gluten is a mandatory component of this ingredient when the route of administration is other than topical and mucosal (see separate entry). Requires the label statement SAME.

Rye bran S-Allyl-Cysteine (of Allium sativum) (S)-S-Adenosylmethionine (S)-S-Adenosylmethionine disulfate ditosylate dihydrate (S)-S-Adenosylmethionine disulfate tosylate (S)-S-Adenosylmethionine disulfate tritosylate dihydrate (S)-S-Adenosylmethionine hexatosylate dihydrate (S)-S-Adenosylmethionine pentasulfate dihydrate (S)-S-Adenosylmethionine hexasulfate dihydrate

A, C A, C A, C A, C A, C A, C

(S)-S-Adenosylmethionine is a mandatory component of this ingredient (see separate entry). (S)-S-Adenosylmethionine is a mandatory component of this ingredient (see separate entry). (S)-S-Adenosylmethionine is a mandatory component of this ingredient (see separate entry). (S)-S-Adenosylmethionine is a mandatory component of this ingredient (see separate entry). (S)-S-Adenosylmethionine is a mandatory component of this ingredient (see separate entry). (S)-S-Adenosylmethionine is a mandatory component of this ingredient (see separate entry).

Substances that may be used in Listed medicines in Australia December 2007

Page 243 of 305

Therapeutic Goods Administration

Ingredient

(S)-S-Adenosylmethionine pentatosylate dihydrate (S)-S-Adenosylmethionine tetratosylate dihydrate Saccharin

Use A, C A, C A, C A, C E E

Restrictions

(S)-S-Adenosylmethionine tetrasulfate dihydrate (S)-S-Adenosylmethionine trisulfate ditosylate dihydrate Saccharin sodium

(S)-S-Adenosylmethionine is a mandatory component of this ingredient (see separate entry). (S)-S-Adenosylmethionine is a mandatory component of this ingredient (see separate entry). (S)-S-Adenosylmethionine is a mandatory component of this ingredient (see separate entry). Requires the label statement SACCH. (S)-S-Adenosylmethionine is a mandatory component of this ingredient (see separate entry).

Saccharomyces cerevisiae Saccharomyces cervisiae polysaccharides

Saccharomyces cerevisiae (Boulardii) Saccharomyces/magnesium ferment Saccharomyces/zinc ferment Saccharum officinarum

A, E A E E E

Requires the label statement SACCHS. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.

Approved for topical use only. Concentration must not exceed 1%. PRV may only be used as an excipient in topical preparations. Approved for topical use only.

A, E

Substances that may be used in Listed medicines in Australia December 2007

Page 244 of 305

Therapeutic Goods Administration

Ingredient Saffron Safrole

Safflower oil

Use A, E E C

Restrictions

Sage leaf dry

Sage leaf powder Sage oil spanish Salicin Salicylic acid Salix alba

Sage oil dalmation

A, E A, E A, E A, E C E

If the preparation is for internal use, the concentration from all ingredients must not exceed 0.1%. If the preparation is for topical use, the concentration from all ingredients must not exceed 1%. Customs Prohibited Import requires an import permit/licence. Thujone is a mandatory component of this ingredient (see separate entry). Thujone is a mandatory component of this ingredient (see separate entry). Thujone is a mandatory component of this ingredient (see separate entry).

Salix daphnoides Salix discolor Salix fragilis Salix nigra

A, E A, E A, E A, E A, E A, E

Approved only in topical preparations for localised effect.

Substances that may be used in Listed medicines in Australia December 2007

Salix purpurea

Page 245 of 305

Therapeutic Goods Administration

Ingredient Salsola kali

Salix purpurea MIS Salvia chinensis Salvia fruticosa

Use A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E

Restrictions

Salvia hispanica

Salvia hispanorium Salvia miltiorrhiza Salvia officinalis Salvia sclarea

Salvia lavandulaefolia

Sambucus canadensis Sambucus ebulus Sambucus nigra

Thujone is a mandatory component of this ingredient (see separate entry).

Sandalwood oil east indian Sanguinaria canadensis Sanicula europaea

Substances that may be used in Listed medicines in Australia December 2007

Page 246 of 305

Therapeutic Goods Administration

Ingredient

Santalum album

Use A, E A, E A, E A, E A, E E A, E A, E A A, E A, E A, E A, E A, E A, E

Restrictions Permitted only if the plant part is root or stem wood, the plant preparation is oil, and the route of administration is topical or inhalation.

Santalum spicatum Sapium sebiferum Sarcosine

Sapindus mukorossi

Saponaria officinalis

Sargassum fusiforme Sargassum tortile

Approved for topical use only. Concentration must not exceed 0.5%.

Sarothamnus scoparius Sassafras albidum Satureia montana Satureia hortensis

Iodine is a mandatory component of this ingredient (see separate entry). Iodine is a mandatory component of this ingredient (see separate entry).

Sparteine is a mandatory component of this ingredient (see separate entry). Safrole is a mandatory component of this ingredient (see separate entry).

Sauropus changianus Saururus chinensis Saussurea costus

Substances that may be used in Listed medicines in Australia December 2007

Sponsors must confirm the absence of aristolochic acids or herbal species known to contain these acids. Species listed on CITES if exporting or importing this product please contact the DSEWPC.

Page 247 of 305

Therapeutic Goods Administration

Ingredient

Savory oil summer Scabiosa arvensis

Use A, E A, E A, E A, E A, E A, E A, E A, E A E C A, E A, E A

Restrictions

Saxifraga granulata

Schefflera octophylla Schinopsis lorentzii Schinus molle

Schizandra chinensis

Schizonepeta tenuifolia Scleranthus annuus Sclerotium gum

Schoenocaulon officinale

MRDD must contain 1 mg or less of the equivalent dry herbal material. Approved only in topical preparations for localised effect.

Scolopendrium vulgare Scopolia carniolica

Scopoletin (of Urtica dioica) Scrophularia ningpoensis Scrophularia nodosa

A, E A, E

Concentration of equivalent dry herbal material must not exceed 10 mg/Kg or 10 mg/L or 0.001%.

Substances that may be used in Listed medicines in Australia December 2007

Page 248 of 305

Therapeutic Goods Administration

Ingredient

Scurrula gracilifolia Scutellaria barbata

Use A, E A, E A, E A, E C E

Restrictions

Scutellaria baicalensis Scutellaria lateriflora Sea whip extract Secale cereale Sedum acre Selenium

Scutellarin (of Scutellaria lateriflora)

A, E A, E A, E C

PRV may only be used as an excipient in topical preparations.

Selaginella tamarisciana

Gluten is a mandatory component of this ingredient when the plant part is seed and the route of administration is other than topical and mucosal (see separate entry).

Selenocysteine

Selenomethionine

A A

When the product is intended for oral use and contains organic selenium sources only, the MRDD must not provide more than 26 micrograms of selenium. When the product contains inorganic selenium sources only, the MRDD must not provide more than 52 micrograms of selenium. When the product contains both inorganic and organic selenium materials, the sum of the organic selenium expressed as micrograms and half of the inorganic selenium expressed in micrograms contained in the RDD must be 26 micrograms or less. Other than oral use, selenium is listable without restrictions. Requires the label statement SELE. Selenium is a mandatory component of this ingredient (see separate entry). Selenium is a mandatory component of this ingredient (see separate entry).

Substances that may be used in Listed medicines in Australia December 2007

Page 249 of 305

Therapeutic Goods Administration

Ingredient

Semecarpus anacardium Semolina

Use A, E E

Restrictions

If the plant part is other than seed, the MRDD must contain 1 mg or less of the equivalent dry herbal material. If the plant part is seed, it is listable without restriction. May be a native species if exporting this product please contact the DSEWPC.

Sempervivum tectorum Senega root dry Senega root powder

A, E A, E A, E A A A A A A C

Only Triticum aestivum and T. durum seed endosperm (grain starch) middlings dry or powder is permitted. May only be used as a food excipient refer to introduction for permitted preparations. May be a native species if exporting this product please contact the DSEWPC. May be a native species if exporting this product please contact the DSEWPC.

Senna fruit alexandrian dry Senna fruit tinnevelly dry Senna leaf dry Sennoside A

Senna fruit alexandrian powder Senna fruit tinnevelly powder Senna leaf powder

Hydroxyanthracene glycosides calculated as sennoside B is a mandatory component of this ingredient in oral preparations (see separate entry). Hydroxyanthracene glycosides calculated as sennoside B is a mandatory component of this ingredient in oral preparations (see separate entry). Hydroxyanthracene glycosides calculated as sennoside B is a mandatory component of this ingredient in oral preparations (see separate entry). Hydroxyanthracene glycosides calculated as sennoside B is a mandatory component of this ingredient in oral preparations (see separate entry). Hydroxyanthracene glycosides calculated as sennoside B is a mandatory component of this ingredient in oral preparations (see separate entry).
Page 250 of 305

Hydroxyanthracene glycosides calculated as sennoside B is a mandatory component of this ingredient in oral preparations (see separate entry).

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Sennosides A and B

Use C C

Restrictions

Sennosides calculated as sennoside B (of Cassia) Sequoia sempervirens Serenoa repens Serine Sesame oil Sequoiadendron giganteum

A, E A, E A, E A, E A, E E C C A, E

Serenoa repens is the correct AAN and replaces the name Serenoa serrulata.

Sesame seed

Sesamum indicum

Sesquiterpene lactones calculated as alantolactone Sesquiterpene lactones calculated as parthenolide Setaria italica Shark-liver oil

Only Sesamum indicum seed is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

A, E A, E

May be a native species if exporting this product please contact the DSEWPC.
Page 251 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Shark cartilage Shea butter Shellac Shea butter unsaponifiables Shepherd's purse herb dry Sigesbeckia orientalis Siler divaricatum

Use A, E E E E

Restrictions

Requires the label statement SHARK. May be a native species if exporting this product please contact the DSEWPC. Approved only in topical preparations for localised effect.

Only Butyrospermum parkii seed fat is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Shepherd's purse herb powder

A, E A, E A, E A, E A, E E E E C C

Silica - colloidal anhydrous Silica dimethyl silylate Silica silylate Silicon Silver

Not permitted if the route of administration is inhalation. Approved for topical use only.

Siliceous earth - purified Silicon dioxide

Approved for topical use only. Concentration must not exceed 4%.

A, E, C

Not permitted if the route of administration is inhalation. Concentration from all ingredients must not exceed 1%.
Page 252 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient Silver beet Silybin

Use E E C C A, E A, E E A, E A, E A, E A, E A, E A, E A, E

Restrictions

Silver borosilicate Silybum marianum Silymarin Simaba cedron Simethicone Sinapis alba

Only Beta vulgaris leaf blade or leaf is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Approved for topical use only. Concentration must not exceed 0.6%. Silver is a mandatory component of this ingredient in topical preparations (see separate entry).

Simmondsia chinensis Sinapis arvensis

Sinomenium acutum Siratia grosvenorii

Allyl isothiocyanate is a mandatory component of this ingredient alba when the plant part is seed (see separate entry).

Siphonestegia chinensis Sisymbrium officinale

Sponsors must confirm the absence of aristolochic acids or herbal species known to contain these acids.

Substances that may be used in Listed medicines in Australia December 2007

Page 253 of 305

Therapeutic Goods Administration

Ingredient Sitosterol

Sisymbrium sophia

Use A, E C C

Restrictions

Sitosterol and sitosterol glycosides calculated as sitosterol (of Prunus Africana) Skipjack-liver oil Slippery elm bark dry

Slippery elm bark powder Smilax aristolochiifolia Smilax china Smilax glabra

A, E A, E A, E A, E A, E A, E A, E A, E A, E C E

Smilax medica Smilax ornata Sodium

Smilax officinalis

Sodium acetate

When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.
Page 254 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Sodium acetylated hyaluronate Sodium acid citrate Sodium acrylates copolymer

Use E E E E E E A, E E E E

Restrictions

Approved for topical use only. Concentration must not exceed 1%.

Sodium acrylates/C10-30 alkyl acrylates crosspolymer Sodium alginate

When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. Approved for topical use only. Concentration must not exceed 0.8%. PRV may only be used as an excipient in topical preparations. PRV may only be used as an excipient in topical preparations.

Sodium acrylate/acryloyldimethyl taurate copolymer Sodium ascorbate Sodium ascorbyl phosphate Sodium benzoate

When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.

When used as an active in oral or sublingual products, the label must include the statement VIT. If used as an active AND intended as a mineral supplementation, the equivalent quantity of sodium is required on the product label. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. Approved for topical use only. Concentration must not exceed 5%.

Sodium ascorbyl/cholesteryl phosphate

Approved for topical use only. Concentration must not exceed 0.1% in primary sunscreen products and 0.5% in other products. Requires the label statement TBNZO8. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.
Page 255 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Sodium beta-hydroxy-betamethylbutyrate

Use A A E E E E E E E E E E

Restrictions

Sodium beta-hydroxy-betamethylbutyrate monohydrate Sodium bicarbonate Sodium bisulfite

Sodium beta-sitosterol sulfate

PRV may only be used as an excipient in topical preparations.

When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. Approved for topical use only. Topical products require the label statement TOTBNZ. Approved for topical use only.

Sodium butyl hydroxybenzoate Sodium carbonate anhydrous

Sodium C14-16 olefin sulfonate Sodium carbonate monohydrate Sodium carboxymethyl dextran Sodium carrageenan

Requires the label statement SULF. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.

When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. Approved for topical use only. Concentration must not exceed 0.005%. PRV may only be used as an excipient in topical preparations.

Sodium carboxymethyl betaglucan

Substances that may be used in Listed medicines in Australia December 2007

When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.

Page 256 of 305

Therapeutic Goods Administration

Ingredient

Sodium cetostearyl sulfate Sodium chloride

Use E

Restrictions

A, E E E E E E E E E E

Approved for topical use only. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.

Sodium chondroitin sulfate Sodium citrate

If used as an active AND intended as a mineral supplementation, the equivalent quantity of sodium is required in the application and also on the product label. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. Approved for topical use only. Concentration must not exceed 0.001%. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. Approved for topical use only. Concentration must not exceed 0.05%. Approved for topical use only. Approved only in topical preparations for localised effect.

Sodium citrate anhydrous

Sodium coco PG-dimonium chloride phosphate Sodium cocoamphoacetate Sodium cocoyl sarcosinate Sodium cyclamate Sodium DNA Sodium dehydroacetate

When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. Approved only in topical preparations for localised effect. Requires the label statement SDACET. Approved for topical use only. Concentration must not exceed 0.1%.

Substances that may be used in Listed medicines in Australia December 2007

Page 257 of 305

Therapeutic Goods Administration

Ingredient

Sodium dodecylbenzenesulfonate Sodium erythorbate Sodium ethyl hydroxybenzoate Sodium fumarate

Use E E E E

Restrictions

Approved for topical use only. Concentration must not exceed 30%.

When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. Topical products require the label statement TOTBNZ. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.

Sodium glycerophosphate Sodium hyaluronate Sodium hydroxide

A, E E E E A

If used as an active AND intended as a mineral supplementation, the equivalent quantity of sodium is required on the product label. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. Approved for topical use only. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. Approved for topical use only.

Sodium hydrogenated tallow glutamate

Sodium hydroxycitrate

Concentration must not exceed 5%. In solid preparations, the pH of a 10 gm/L aqueous solution must not be more than 11.5. In liquid or semi-solid preparations, the pH of the preparation must not exceed 11.5. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.

Substances that may be used in Listed medicines in Australia December 2007

Page 258 of 305

Therapeutic Goods Administration

Ingredient

Sodium hydroxyethyl acrylate/acryloyldimethyl taurate copolymer Sodium hydroxymethylglycinate Sodium hypochlorite Sodium lactate Sodium isostearoyl lactylate Sodium laureth sulfate

Use E E E E E E E E E E E E

Restrictions Approved for topical use only. The concentration of Sodium hydroxyethyl acrylate/acryloyldimethyl taurate copolymer is not to exceed 1.5%. Approved only in topical preparations for localised effect. Approved for topical use only.

Chlorine is a mandatory component of this ingredient (see separate entry). When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. PRV may only be used as an excipient in topical preparations. Approved for topical use only.

Sodium lauroyl lactylate

Sodium lauroyl sarcosinate Sodium lauryl phosphate Sodium lauryl sulfate

When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.

Sodium lauryl sulfoacetate

When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. Approved for topical use only.
Page 259 of 305

Substances that may be used in Listed medicines in Australia December 2007

Sodium magnesium silicate

Therapeutic Goods Administration

Ingredient

Sodium mannose phosphate Sodium metabisulfite Sodium methyl hydroxybenzoate Sodium monofluorophosphate Sodium myreth sulfate

Use E E E

Restrictions

PRV may only be used as an excipient in topical preparations.

Requires the label statement SULF. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. Topical products require the label statement TOTBNZ. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. Fluoride is a mandatory component of this ingredient (see separate entry). Approved only in pastes, powders or gels for the cleaning of teeth that contain at least one other Listable therapeutically active ingredient. Any claims in relation to the fluoride content from this ingredient are restricted to those relating to improvements in oral hygiene or the use of fluoride for the prevention of tooth decay.

A E E

Sodium myristoyl glutamate Sodium pantothenate Sodium PCA Sodium perborate

PRV may only be used as an excipient in topical preparations. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. When used as an active in oral or sublingual products, the label must include the statement VIT. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. Approved for topical use only. Boron is a mandatory component of this ingredient (see separate entry).

A, E E A

Approved for topical use only. Concentration must not exceed 0.0164%. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.

Substances that may be used in Listed medicines in Australia December 2007

Page 260 of 305

Therapeutic Goods Administration

Ingredient

Sodium percarbonate

Use E A, E

Restrictions

Sodium phosphate - dibasic

Approved for topical use only. Concentration must not exceed 15%.

Sodium phosphate - dibasic anhydrous

A, E

In solid preparations, the pH of a 10 gm/L aqueous solution must not be more than 11.5. In liquid or semi-solid preparations, the pH of the preparation must not exceed 11.5. If used as an active AND intended as a mineral supplementation, the equivalent quantity of sodium is required on the product label. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. In solid preparations, the pH of a 10 gm/L aqueous solution must not be more than 11.5. In liquid or semi-solid preparations, the pH of the preparation must not exceed 11.5. If used as an active AND intended as a mineral supplementation, the equivalent quantity of sodium is required on the product label. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. In solid preparations, the pH of a 10 gm/L aqueous solution must not be more than 11.5. In liquid or semi-solid preparations, the pH of the preparation must not exceed 11.5. If used as an active AND intended as a mineral supplementation, the equivalent quantity of sodium is required on the product label. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.

Sodium phosphate dibasic dihydrate

A, E

Sodium phosphate - dibasic dodecahydrate

A, E

In solid preparations, the pH of a 10 gm/L aqueous solution must not be more than 11.5. In liquid or semi-solid preparations, the pH of the preparation must not exceed 11.5. If used as an active AND intended as a mineral supplementation, the equivalent quantity of sodium is required on the product label. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.

Substances that may be used in Listed medicines in Australia December 2007

Page 261 of 305

Therapeutic Goods Administration

Ingredient

Sodium phosphate - dibasic monohydrate Sodium phosphate - monobasic

Use A, E

Restrictions

A, E

In solid preparations, the pH of a 10 gm/L aqueous solution must not be more than 11.5. In liquid or semi-solid preparations, the pH of the preparation must not exceed 11.5. If used as an active AND intended as a mineral supplementation, the equivalent quantity of sodium is required on the product label. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.

Sodium phosphate - monobasic dihydrate Sodium phosphate - tribasic Sodium polyacrylate

E E E E E

In solid preparations, the pH of a 10 gm/L aqueous solution must not be more than 11.5. In liquid or semi-solid preparations, the pH of the preparation must not exceed 11.5. If used as an active AND intended as a mineral supplementation, the equivalent quantity of sodium is required on the product label. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.

In solid preparations, the pH of a 10 gm/L aqueous solution must not be more than 11.5. In liquid or semi-solid preparations, the pH of the preparation must not exceed 11.5. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.

Sodium polyaspartate

In solid preparations, the pH of a 10 gm/L aqueous solution must not be more than 11.5. In liquid or semi-solid preparations, the pH of the preparation must not exceed 11.5. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. Approved for topical use only. PRV may only be used as an excipient in topical preparations.

Sodium polymetaphosphate

When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.
Page 262 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Sodium propionate

Use E E E E A A A E E E E

Restrictions

Sodium propyl hydroxybenzoate Sodium riboflavin phosphate Sodium RNA Sodium selenate Sodium selenite Sodium silicate

Topical preparations require the label statement SPROP. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. Topical preparations require the label statement TOTBNZ. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. Approved for topical use only. Concentration must not exceed 0.1%. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. Selenium is a mandatory component of this ingredient (see separate entry). Selenium is a mandatory component of this ingredient (see separate entry).

Sodium selenite pentahydrate

Selenium is a mandatory component of this ingredient (see separate entry).

Sodium starch glycollate Sodium stearate

In solid preparations, the pH of a 10 gm/L aqueous solution must not be more than 11.5. In liquid or semi-solid preparations, the pH of the preparation must not exceed 11.5. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. Approved for topical use only. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM.
Page 263 of 305

Sodium starch glycollate type A

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Sodium stearoyl glutamate Sodium stearyl 2-lactylate Sodium succinate Sodium sulfate

Use E E E E

Restrictions

Sodium stearyl phthalamate

PRV may only be used as an excipient in topical preparations. Approved for topical use only. Approved for topical use only.

Sodium sulfate anhydrous Sodium sulfite anhydrous Sodium tripolyphosphate Solanidine Solanine

Approved for topical use only. Concentration must not exceed 1.5%.

A, E E E E C C

If used as an active AND intended as a mineral supplementation, the equivalent quantity of sodium is required on the product label. When included in a product that is not intended to be a laxative the product requires the label statement LAX4. If used as an active AND intended as a mineral supplementation, the equivalent quantity of sodium is required on the product label. When included in a product that is not intended to be a laxative the product requires the label statement LAX4. Requires the label statement SULF. When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. Approved for topical use only. Requires the label statement SULF. Approved for topical and buccal use only. Concentration must not exceed 5%.

Sodium sulfite heptahydrate

Solanum dulcamara

Steroidal alkaloids calculated as solanine is a mandatory component of this ingredient in products for internal use (see separate entry).
Page 264 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Solanum ferox

Use A, E E A, E A, E A, E A, E A, E A, E E E E E E

Restrictions

Solanum lycocarpum ICID2000 fruit ext.1:5 in 50% butylene glycol : water Solanum melongena Solanum nigrum Solanum tuberosum Solidago gigantea Solidago gigantea MIS Solidago virgaurea Solvent green 3 Solvent red 1

Steroidal alkaloids calculated as solanine is a mandatory component of this ingredient in products for internal use (see separate entry). Approved for topical use only. Concentration must not exceed 0.02%. Steroidal alkaloids calculated as solanine is a mandatory component of this ingredient in products for internal use (see separate entry). Steroidal alkaloids calculated as solanine is a mandatory component of this ingredient in products for internal use (see separate entry). Steroidal alkaloids calculated as solanine is a mandatory component of this ingredient in products for internal use (see separate entry).

Solvent violet 13

Colour permitted only in topical preparations. Colour permitted only in topical preparations. Colour permitted only in topical preparations. Colour permitted only in topical preparations.

Solvent yellow 172 Solvent yellow 33

PRV may only be used as an excipient in topical preparations.

Substances that may be used in Listed medicines in Australia December 2007

Page 265 of 305

Therapeutic Goods Administration

Ingredient

Sophora angustifolia Sophora japonica Sorbic acid

Use A, E A, E A, E E E E E E E E E E E E E

Restrictions

Sophora subprostrata Sorbitan isostearate

Sorbitan mono-oleate

Requires the label statement SORB8. Approved for topical use only.

Sorbitan monolaurate Sorbitan oleate

Sorbitan monostearate Sorbitan olivate

Sorbitan palmitate

PRV may only be used as an excipient in topical preparations. Approved for topical use only. Approved for topical use only.

Sorbitan sesquiisostearate Sorbitan sesquioleate Sorbitan stearate Sorbitan tristearate

Approved for topical use only. Concentration must not exceed 10%. Approved only in topical preparations for localised effect.

Approved for topical use only.


Page 266 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient Sorbitol

Use

Sorbitol solution (70 per cent) (crystallising) Sorbus aucuparia Sorghum

A, E, C A, E A, E A, E A, E E A, E A, E A, E C E E E

Restrictions

When used as an active, this ingredient is only listable as an uncompounded BP substance. When the quantity of sugar alcohols per RDD exceeds 2 g, the quantity of the sugar alcohols must be declared on the label in addition to the label statement SUGOLS.

Sorbitol solution (70 per cent) (noncrystallising) Sorbus domestica

When used as an active, this ingredient is only listable as an uncompounded BP substance. Sorbitol is a mandatory component ot this ingredient (see separate entry). When used as an active, this ingredient is only listable as an uncompounded BP substance. Sorbitol is a mandatory component ot this ingredient (see separate entry).

Sorghum halepense Sorghum vulgare

Sorghum sudanense

Only Sorghum vulgare seed (grain) is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Soy phosphatidylserine Soy polysaccharide Soy protein

Concentration must not exceed 15%.

Soy protein-hydrolysed

Approved for topical use only. Concentration must not exceed 0.5%.
Page 267 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient Soy sterol Soya bean Soya bran Soya oil

Use E E E E C A, E A, E A, E A, E A, E E A, E A A, E

Restrictions Only Glycine max seed (bean) is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Soya oil - hydrogenated Sparteine

Only Glycine max seed (bean) husk or seed coat (bran) is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Sparganium stoloniferum Spartium junceum Spearmint oil

Spatholobus suberectus Sphingolipids

Concentration must not exceed 0.001%.

Spigelia anthelmia Spike lavender oil

Spigelia marilandica

Approved for topical use only. Concentration must not exceed 0.1%. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. MRDD must contain 1 mg or less of the equivalent dry herbal material.

Camphor is a mandatory component of this ingredient (see separate entry).


Page 268 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient Spinach

Spilanthes acmella Spinacia oleracea Spirulina

Use A, E E A, E A, E E E

Restrictions Only Spinacia oleracea leaf blade or leaf is permitted. May only be used as a food excipient refer to introduction for permitted preparations. May be a native species if exporting this product please contact the DSEWPC.

Spirodela polyrrhiza

Squalane Squalene

Squill dry

Squill indian dry Squill powder

A, E, C A, E A, E A, E A, E A A

Only Arthrospira maxima and A. platensis cell (filament) is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Iodine is a mandatory component of this ingredient (see separate entry). May be a native species if exporting this product please contact the DSEWPC. Spirulina maxima is not a valid name. Approved for topical use only.

Squill indian powder

St John's Wort herb dry

St John's Wort herb powder

Preparations for oral ingestion containing this ingredient as a herbal ingredient or a mother tincture require the label statement STJOHN. Preparations for oral ingestion containing this ingredient as a herbal ingredient or a mother tincture require the label statement STJOHN.

Substances that may be used in Listed medicines in Australia December 2007

Page 269 of 305

Therapeutic Goods Administration

Ingredient

Stachybotrys chartarum Stachys palustris Stannic oxide Stachyurus himalaicus

Use A, E A, E A, E E E E E

Restrictions

Starch - acid treated waxy maize Starch - gluten-free wheat Starch - hydrolysed maize Starch - maize

Approved for topical use only. Concentration must not exceed 0.005%.

Starch - maize high amylose Starch - oxidised tapioca Starch - potato

A, E A, E E E E E E E E
Page 270 of 305

Starch - pregelatinised maize

Starch - pregelatinised potato Starch - pregelatinised wheat Starch - rice Starch - soluble maize

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Starch - soluble potato Starch - tapioca Starch - wheat

Use E E E E E E E E E E E E E E E

Restrictions

Starch modified - potato Stearalkonium chloride Stearamide

Starch sodium octenyl succinate Stearalkonium hectorite

Gluten is a mandatory component of this ingredient when the route of administration is other than topical and mucosal (see separate entry). PRV may only be used as an excipient in topical preparations. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only. Approved for topical use only.

Stearamidoethyl diethylamine

Stearamidopropyl dimethylamine Stearamidopropyl PG-dimonium chloride phosphate Steareth-10 Steareth-2 Steareth-100 Steareth-20

Approved only in topical preparations for localised effect. Concentration must not exceed 2%. Requires the label statement EYE2. Approved for topical use only. Concentration must not exceed 1.5%. Approved for topical use only.

Substances that may be used in Listed medicines in Australia December 2007

Page 271 of 305

Therapeutic Goods Administration

Ingredient Steareth-5

Steareth-21 Stearic acid

Use E E E E E E E E E E E E

Restrictions

Approved for topical use only. Approved for topical use only.

Stearoxy dimethicone

Stearoxytrimethylsilane Stearyl acetate

Stearoyl macrogolglycerides Stearyl alcohol

Approved for topical use only. Concentration must not exceed 4%. Approved only in topical preparations for localised effect. Approved for topical use only.

Can only be used as an excipient in oral products. Concentration must not exceed 0.6%.

Stearyl dimethicone Stearyl heptanoate Stearyl stearate

Stearyl glycyrrhetinate

Approved only in topical preparations for localised effect. Concentration must not exceed 4.5%. Requires the label statements EYE and EYE2. Approved for topical use only. Approved for topical use only. Approved for topical use only.

Stellaria chamaejasme Stellaria dichotoma Stellaria media

A, E A, E A, E

Substances that may be used in Listed medicines in Australia December 2007

Page 272 of 305

Therapeutic Goods Administration

Ingredient

Stemona japonica

Use A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E C C A, E

Restrictions

Stemona sessilifolia (sessifolia is invalid) Stemphylium botryosum Stemphylium solani Stephania tetranda Sterculia

Stenotaphrum secundum

Sterculia platanifolia Sterculia scaphigera Sterculia urens

Sponsors must confirm the absence of aristolochic acids or herbal species known to contain these acids.

Sterculia tragacantha

Steroidal alkaloids calculated as solanine Stevia rebaudiana

Stevioside (of Stevia rebaudiana

Can only be used as a component and is not listable in its own right. MRDD must provide 10 mg or less.

Substances that may be used in Listed medicines in Australia December 2007

Page 273 of 305

Therapeutic Goods Administration

Ingredient

Stillingia sylvatica Storax prepared

Use A, E A, E A A E A A A

Restrictions

Stramonium leaf dry Strawberry

Stramonium leaf powder Streptococcus thermophilus Strophanthus hispidus Strychnos nux-vomica Styrax benzoin

Alkaloids calculated as hyoscyamine is a mandatory component of this ingredient (see separate entry). Alkaloids calculated as hyoscyamine is a mandatory component of this ingredient (see separate entry). Only Fragaria X ananassa, F. chiloensis, F. vesca, F. virginiana and hybrids fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Styrax paralleloneurus Styrax tonkinensis Succinic acid Sucralose

A, E A, E A, E E E E

Concentration of equivalent dry herbal material must not exceed 10 mg/Kg or 10 mg/L or 0.001%.

Concentration of equivalent dry herbal material must not exceed 10 mg/Kg or 10 mg/L or 0.001%.

Styrene/acrylates copolymer

Approved for topical use only.

Substances that may be used in Listed medicines in Australia December 2007

Page 274 of 305

Therapeutic Goods Administration

Ingredient Sucrose

Use E, C E E E E E E E E E E

Restrictions

Sucrose cocoate Sucrose laurate

Sucrose distearate Sucrose octaacetate Sucrose palmitate Sucrose stearate Sudan III Sucrose polycottonseedate

When used as an excipient in oral products and the total amount of all sugars (glucose, invert sugar, lactose, maltose, and sucrose) exceeds 100 mg in the MDD of the product, the label requires the statement SUGARS. If one of the sugars is lactose the label also requires the statement LACT. Approved for topical use only. Concentration must not exceed 2%. Approved for topical use only. Sucrose is a mandatory component of this ingredient in oral and sublingual products (see separate entry).

Sucrose is a mandatory component of this ingredient in oral and sublingual products (see separate entry). Approved for topical use only. Sucrose is a mandatory component of this ingredient in oral and sublingual products (see separate entry). Approved for topical use only. Concentration must not exceed 0.25%. Colour permitted only in topical preparations.

Sucrose is a mandatory component of this ingredient in oral and sublingual products (see separate entry). Approved for topical use only. Concentration must not exceed 1%. Requires the label statements EYE and EYE2.

Sugar cane wax alcohols Sugarcane Sulfan blue

MRDD must not contain more than 12 mg. Requires the label statement PREGNT. Colour permitted only in topical preparations.

Only Saccharum officinarum stem (canes) is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Sucrose is a mandatory component of this ingredient when used in oral and sublingual products (see separate entry).
Page 275 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Sulfur dioxide

Use E A A E E E E E E C A, E A, E A, E

Restrictions

Sulisobenzone Sunflower oil

Sulisobenzone sodium Sunflower seed

Requires the label statement SULF.

A, E

Sunscreen active permitted only in topical products. Concentration must not exceed 10%. Sunscreen active permitted only in topical products.

Sunset yellow FCF

Sunset yellow FCF aluminium lake Superoxide dismutase Swede Sweet potato

Only Helianthus annuus seed is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Approved for topical use only.

Only Brassica napus var. napobrassica root is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Swertia chirata Swertiamarin

Only Ipomoea batatas tuberous root is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Swietenia mahogani

Symplocarpus foetidus

Substances that may be used in Listed medicines in Australia December 2007

Page 276 of 305

Therapeutic Goods Administration

Ingredient

Syncephalastrum racemosum Syringa reticulata Syringa vulgaris

Use A, E A, E A, E C C C

Restrictions

Syringaresinol diglucoside Syringin

Syringaresinol diglucosides (of Eleutherococcus senticosus) Syzygium aromaticum

A, E

Tabebuia avellanedae

Tabebuia heptophylla Tabebuia ipe

Tabebuia impetiginosa Tabebuia serratifolia Tagetes erecta

A, E A, E A, E A, E A, E A, E

Permitted without restriction in preparations containing 25% or less of clove oil. When the concentration of clove oil is greater than 25% and the nominal capacity of the container is 15 mL or less, a RFI must be fitted on the container and the label must include the statements CHILD and NTAKEN. When the concentration of clove oil is greater than 25% and the nominal capacity of the container is greater than 15 mL but less than or equal to 25 mL, a CRC and RFI must be fitted on the container and the label must include the statements CHILD and NTAKEN.

Substances that may be used in Listed medicines in Australia December 2007

Page 277 of 305

Therapeutic Goods Administration

Ingredient

Tagetes minuta Talc - purified Tallow

Use A, E E E E E

Restrictions

Tallow glycerides Tamarix aphylla Tamarix gallica

Tallow glycerides-hydrogenated Tamarix chinensis Tamus communis

Approved for topical use only, If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. Approved for topical use only. Concentration must not to exceed 3%.

A, E A, E A, E A, E A, E A, E A, E A, E E A, E

Tanacetum cineriifolium Tanacetum parthenium Tanacetum vulgare Tannic acid

If the plant part is fruit and root, the MRDD must contain 1 mg or less of the equivalent dry fruit and dry root. Plant parts other than root or fruit are listable without restriction.

Tangerine oil coldpressed Taraxacum mongolicum

Oil (of Tanacetum vulgare) is a mandatory component of this ingredient (see separate entry). Approved for topical use only as an excipient.

Substances that may be used in Listed medicines in Australia December 2007

Page 278 of 305

Therapeutic Goods Administration

Ingredient Taro

Taraxacum officinale Tarragon oil Tartrazine Taurine

Use A, E E E E C A, E

Restrictions Only Colocasia esculenta corm and tubers is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Tartaric acid

Taxifolin (of Pinus pinaster) Taxodium distichum TEA-lauryl sulfate TEA-stearate

A, E A, E E E

Approved for topical use only. Requires the label statement TART.

Terminalia catappa Terminalia chebula

Terminalia ferdinandiana Terpene resin - synthetic Terpineol

A, E A, E A E

Approved for topical use only. Approved for topical use only.

Substances that may be used in Listed medicines in Australia December 2007

A, E

Permitted only when the ingredient is the fruit flesh dry or aqueous extractions of the fruit flesh. Approved for topical use only.

Page 279 of 305

Therapeutic Goods Administration

Ingredient

Tert-Butyl alcohol

Use E A, E A, E C E E E E E

Restrictions

Tetraclinis articulata

Tetracoccosporium paxianum Tetrahexyldecyl ascorbate

Approved for topical use only.

Tetracyclic oxindole alkaloids (of Uncaria tomentosa) Tetrahydrodiferuloylmethane Tetrapanax papyrifera

Tetrahydroxypropyl ethylenediamine Tetrasodium etidronate Teucrium chamaedrys Teucrium marum Teucrium scorodonia Thapsia garganica Thaumatin

Approved for topical use only. Concentration must not exceed 1%. Approved for topical use only. Approved for topical use only.

Tetrasodium pyrophosphate

A, E

Approved for topical use only. Concentration must not exceed 0.1%.

A A A E

When used as an excipient in oral or sublingual products and the total amount of sodium from all ingredients in the MDD exceeds 120 mg, the product requires the label statement SODIUM. MRDD must contain 1 mg or less of the equivalent dry herbal material. MRDD must contain 1 mg or less of the equivalent dry herbal material. MRDD must contain 1 mg or less of the equivalent dry herbal material.

A, E

Substances that may be used in Listed medicines in Australia December 2007

Page 280 of 305

Therapeutic Goods Administration

Ingredient

Theanine (of Camellia sinensis) Themeda australis Theobroma cacao Theobroma oil

Use C A, E A, E A, E A, E E

Restrictions May be a native species if exporting this product please contact the DSEWPC.

Theobroma prepared Thiamine

Thermus thermophilyus concentrate Thiamine hydrochloride Thiamine nitrate

A, E, C A, E A, E A A E A, E A, E A, E

PRV may only be used as an excipient in topical preparations.

When used as an active in oral or sublingual products, the label must include the statement VIT. When used as an active in oral or sublingual products, the label must include the statement VIT. When used as an active in oral or sublingual products, the label must include the statement VIT. When used as an active in oral or sublingual products, the label must include the statement VIT. When used as an active in oral or sublingual products, the label must include the statement VIT. Approved for topical use only. Concentration must not exceed 0.02%.

Thiamine phosphate acid ester chloride dihydrate Thiotaurine Threonine

Thiamine phosphoric acid ester chloride Thlaspi arvense

Substances that may be used in Listed medicines in Australia December 2007

Thuja occidentalis

Page 281 of 305

Therapeutic Goods Administration

Ingredient Thujone

Thuja plicata

Use A, E C

Restrictions Can only be used as a component and it is not listable in its own right. Permitted without restriction in preparations containing 4% or less. When the concentration is greater than 4%, the nominal capacity of the container must be 15 mL or less, a CRC and RFI must be fitted on the container and the label must include the statements CHILD and NTAKEN.

Thyme herb dry Thyme oil Thymol

A, E A, E A, E A, E A, E A, E A, E A, E A, E A, C

Permitted without restriction in preparations containing 50% or less. When the concentration is greater than 50%, the nominal capacity of the container must be 25 mL or less, a RFI must be fitted on the container and the label must include the statement CHILD. When used as an active, permitted only in Medicated Space Sprays or Medicated Throat Lozenges. Topical products containing thymol as an excipient require the label statement THYMOL. As per Thymus capitatus (see above). As per Thymus capitatus (see above). As per Thymus capitatus (see above). As per Thymus capitatus (see above). As per Thymus capitatus (see above). Permitted without restriction in preparations containing 50% or less of thyme oil. When the concentration of thyme oil is more than 50%, the nominal capacity of the container must be 25 mL or less, a RFI must be fitted on the container and the label must include the statement CHILD.

Thymus capitatus

Thymus mastichina Thymus serpyllum Thymus vulgaris Thymus zygis Tilactase

Thymus vulgaris mis

Substances that may be used in Listed medicines in Australia December 2007

Permitted only when derived from Aspergillus oryzae.

Page 282 of 305

Therapeutic Goods Administration

Ingredient

Tilia cordata

Use A, E A, E A, E A, E A, E A, E A, E E E

Restrictions

Tilia platyphyllos Tilia tomentosa Tilia x vulgaris

Tinospora cagillipes Tinospora sinensis Titanium dioxide Tococysteamide Tocofersolan

Not to be used in topical products intended for use in the eye. Concentration in topical products must not exceed 25%. For Sunscreen products only. Approved for topical use only. Concentration must not exceed 0.01%. Approved for topical use only. Concentration must not exceed 0.1%.

Tocopherols concentrate - mixed (high-alpha type) Tocopheryl linoleate Tocoquinone

Tocopherols concentrate - mixed (lowalpha type) Tocopheryl nicotinate

A, E A, E E E E

When used as an active in oral or sublingual products, the label must include the statement VIT. When used as an active in oral or sublingual products, the label must include the statement VIT. Approved for topical use only. Approved for topical use only. Concentration must not exceed 0.1%. PRV may only be used as an excipient in topical preparations.

Substances that may be used in Listed medicines in Australia December 2007

Page 283 of 305

Therapeutic Goods Administration

Ingredient

Tocotrienols complex - palm Tolu balsam Toluene Tomato

Use A E E E A, E

Restrictions

Concentration must not exceed 0.089%. Residual solvent limit is 8.9 mg per MDD. PRV may only be used as an excipient in topical preparations.

Tourmaline

Toxicodendron radicans Tragacanth

Trachelospermum jasminoides Trametes versicolor Transglutaminase Treacle

Only Solanum lycopersicum fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations. RDD must contain 10 mg or less of steroidal alkaloids including solanine, solaneine and solanidine. MRDD must contain 1 mg or less of the equivalent dry herbal material.

A, E A, E A A E E E A, E

Trametes versicolor proteoglycan concentrate

Trametes versicolor hyphae dry extract must only be prepared using water. May only be used in oral preparations. PRV may only be used as an excipient in topical preparations. Approved for topical use only.

Trehalose dihydrate Tremella fuciformis

Sucrose is a mandatory component of this ingredient in oral and sublingual products (see separate entry).

Substances that may be used in Listed medicines in Australia December 2007

Page 284 of 305

Therapeutic Goods Administration

Ingredient Tribehenin Tribehenin PEG-20 esters Tribulus terrestris Tricaprylin Tricaprylyl citrate

Use E E E E E

Restrictions

A, E

Approved for topical use only. Concentration must not exceed 6%.

Approved for topical use only. Concentration must not exceed 6%. Approved for topical use only. Concentration must not exceed 5%. Approved for topical use only. Concentration must not exceed 7%. Approved for topical use only.

Triceteareth-4 phosphate Trichoderma viride Trichosanthes kirilowii Trichothecium roseum Triclosan Tricontanyl PVP

A, E A, E A, E E E E E E E

Trideceth-4 phosphate Tridecyl behenate Tridecyl neopentanoate Tridecyl salicylate

Approved only in topical preparations for localised effect. Concentration must not exceed 1%. Requires the label statement TRICLO. Approved for topical use only. Approved for topical use only.

Approved for topical use only. Behenic acid is a mandatory component of this ingredient (see separate entry). Approved for topical use only. Concentration must not exceed 23%. Approved for topical use only. Concentration must not exceed 5%.

Substances that may be used in Listed medicines in Australia December 2007

Page 285 of 305

Therapeutic Goods Administration

Ingredient

Tridecyl stearate Triethanolamine

Use E E E E E E E E E A, E A, E A, E E E

Restrictions

Tridecyl trimellitate

Approved only in topical preparations for localised effect. Approved only in topical preparations for localised effect.

Triethanolamine carbomer Triethanolamine salicylate Triethoxycaprylylsilane Triethyl citrate Triethylene glycol

Triethanolamine lauryl sulfate

Approved for topical use only. Concentration must not exceed 5%. PRV may only be used as an excipient in topical preparations. Approved for topical use only.

Sunscreen active permitted only in topical products. Concentration must not exceed 12%. Approved for topical use only. Concentration must not exceed 0.22%.

Trifluoromethyl c1-4 alkyl dimethicone Trifolium pratense Trifolium repens

PRV may only be used as an excipient in topical preparations.

Trigonella foenum-graecum Trihydroxystearin

Trihydroxypalmitamidohydroxypropyl myristyl ether

Approved for topical use only. Concentration must not exceed 0.02%. Approved for topical use only.
Page 286 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Triisocetyl citrate Triisononanoin Triisostearin Trilaurin

Use E E E E E E E E E E E E E

Restrictions

Triisodecyl trimellitate

Approved only in topical preparations for localised effect.

Approved for topical use only. Concentration must not exceed 5%. Approved for topical use only. Concentration must not exceed 5%. Approved only in topical preparations for localised effect. Approved for topical use only. PRV may only be used as an excipient in topical preparations.

Trilaureth-4 phosphate Trillium erectum

Trimethoxycaprylyl silane Trimethylolpropane tricaprylate/tricaprate Trimethylopropane trioctanoate Trimethylpentanediol/adipic acid/glycerin crosspolymer Trimethylsiloxysilicate Trioctanoin Trioctyldodecyl citrate

A, E

Approved for topical use only. Concentration must not exceed 0.25%. PRV may only be used as an excipient in topical preparations. Approved for topical use only. Approved for topical use only. Approved for topical use only.

Approved for topical use only. Concentration must not exceed 5%.

Substances that may be used in Listed medicines in Australia December 2007

Triosteum perfoliatum

A, E

Approved for topical use only. Concentration must not exceed 12%.
Page 287 of 305

Therapeutic Goods Administration

Ingredient

Trioxaundecanedioic acid Trisodium edetate Trisodium NTA Tristearin

Use E E E E E C C

Restrictions

Trisodium ethylenediamine disuccinate

Approved for topical use only. Concentration must not exceed 5%. Approved for topical use only.

Approved for topical use only. Concentration must not exceed 0.2%.

Triterpene glycosides calc 27desoxyactein (of Cimicifugia racemosa) Triticum aestivum Triticum durum Triundecanoin Trometamol

Approved for topical use only. Concentration must not exceed 0.005%.

Triterpenes: asiaticoside, asiatic acid and madecassic acid (of Centella asiatica)

A, E A, E E E A, E

Gluten is a mandatory component of this ingredient when plant part is seed and the route of administration is other than topical and mucosal (see separate entry). Gluten is a mandatory component of this ingredient when plant part is seed and the route of administration is other than topical and mucosal (see separate entry). PRV may only be used as an excipient in topical preparations.

Trollius chinensis

Substances that may be used in Listed medicines in Australia December 2007

Page 288 of 305

Therapeutic Goods Administration

Ingredient

Trometamol hydrochloride Tropaeolum majus Troxerutin Tsuga canadensis Tulipa edulis Turnip Turnera diffusa Turpentine oil

Use E C A, E A, E A, E A, E E A, E A, E A, E A, E A, E A, E A, E

Restrictions

Colchicine is a mandatory component of this ingredient (see separate entry).

Typha angustifolia Typha latifolia Tyrosine

Only Brassica rapa root is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Concentration must not exceed 25%.

Typhonium giganteum Ubidecarenone

Ulex europaeus

Approved for topical use only when present as an excipient. Must not be used in topical products intended for use in the eye. MRDD must not contain more than 150 mg. Concentration must not exceed 0.05%. Requires the label statement WARF.

Substances that may be used in Listed medicines in Australia December 2007

Page 289 of 305

Therapeutic Goods Administration

Ingredient

Ulmus americana Ulmus glabra

Use A, E A, E A, E A, E A, E A, E A, E E A, E A, E A, E A, E A, E A E

Restrictions

Ulmus campestris Ulmus parvifolia Ulmus procera Ulmus pumila Ulmus rubra Ulva lactuca

Ultramarine blue Uncaria gambir

Colour permitted only in topical preparations.

Uncaria rhyncophylla Uncaria sinensis Uncaria tomentosa Undecenoic acid

Approved for topical use only (blade of plant/liquid extract concentration). Concentration must not exceed 0.1%. Iodine is a mandatory component of this ingredient (see separate entry). May be a native species if exporting this product please contact the DSEWPC.

Undaria pinnatifida

Permitted only in oral products. The plant part must not contain the holdfast. Approved for topical use only.
Page 290 of 305

Substances that may be used in Listed medicines in Australia December 2007

Therapeutic Goods Administration

Ingredient

Undecylenamide dea Urea

Use E E E

Restrictions

Undecylenoyl peg-5 paraben Urtica dioica Urtica urens

Approved for topical use only. Approved for topical use only.

Usnea barbata

A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E C

Uva ursi leaf dry

Uva ursi leaf powder Vaccaria segatalis

May be a native species if exporting this product please contact the DSEWPC.

Vaccinium bracteatum

Vaccinium macrocarpon Vaccinium myrtilloides Vaccinium myrtillus Vaccinium oxycoccus Valerenic acid

Vaccinium vitis-idaea

Substances that may be used in Listed medicines in Australia December 2007

Page 291 of 305

Therapeutic Goods Administration

Ingredient

Valerenic acids calc hydroxy/acetoxyvalerenic acid & valerenic acid Valerian dry Valerian powder Valeriana edulis

Use C

Restrictions

A, E A, E A, E A, E A, E C A, E A, E A, E A, E A, E E E E

Valeriana officinalis Valeriana sorbifolia Valeric acid Valine Vanilla dry

Vanilla planifolia Vanilla powder Vanillin

Vanilla tahitensis Vat red 1 Vat red 5

Species listed on CITES if exporting or importing this product please contact the DSEWPC. Species listed on CITES if exporting or importing this product please contact the DSEWPC. Colour permitted only in topical preparations. Colour permitted only in topical preparations.

Substances that may be used in Listed medicines in Australia December 2007

Page 292 of 305

Therapeutic Goods Administration

Ingredient

Vegetable oil

Use E E E C

Restrictions

Vegetable oil - hydrogenated Veratrum album

Vegetable protein - hydrolysed

Verbascoside (of Olea europaea) Verbascum densiflorum Verbascum thapsus Verbena officinalis

A, E A A, E A, E A, E A, E A, E A, E A, E A, E A, E

Concentration of equivalent dry herbal material must not exceed 10 mg/Kg or 10 mg/L or 0.001%.

Veronica chamaedrys Veronica officinalis

Veronicastrum virginicum Verticillium albo-atrum Vetiveria zizanioides Viburnum opulus Vicia faba

Viburnum prunifolium

Substances that may be used in Listed medicines in Australia December 2007

Page 293 of 305

Therapeutic Goods Administration

Ingredient Vinblastine

Vigna radiata Vinca major Vincamine

Use A, E C A, E A, E C C C C C A, E

Restrictions Concentration must not exceed 10 mg/kg or 10 mg/L or 0.001%.

Vinca minor

Vincamine is a mandatory component of this ingredient (see separate entry). Concentration must not exceed 10 mg/kg or 10 mg/L or 0.001%.

Vincetoxicum officinale Vincristine Vindesine

Vincamine and Vincristine are mandatory components of this ingredient (see separate entries).

Vinorelbine

Vinyl acetate

Vinyldithiins (of Allium sativum) Viola odorata Viola tricolor

Concentration must not exceed 10 mg/kg or 10 mg/L or 0.001%. Concentration must not exceed 10 mg/kg or 10 mg/L or 0.001%. Approved for topical use only.

Viola yedoensis Viscum album

A, E A, E A, E A, E A, E

Substances that may be used in Listed medicines in Australia December 2007

Viscum coloratum

Page 294 of 305

Therapeutic Goods Administration

Ingredient Vitamin A

Viscum flavescens

Use A, E C

Restrictions Permitted as a component only. Listable as an active as Retinol, Retinyl acetate and Retinyl palmitate (see separate entries). Concentration in topical products must not exceed 1%. Products for internal use must not exceed 5000 IU in the MRDD and require the coded label statement VIT (see introduction). Products for internal use containing between 100 IU and 5000 IU in the MRDD and that are labelled for adult use require the coded label statements VITA1 and VITA2 (see introduction).

Vitex agnus-castus Vitex negundo Vitex trifolia Vitex rotundifolia

A, E A, E A, E A, E C A, E E E C C

Vitexin-2-rhamnoside Vitis vinifera

Vitreoscilla concentrate

Voandenzeia subterranea seed aqueous extract ICID 2004 Volatile oil components (of Chenopodium ambrosioides)

Approved for topical use only. Concentration must not exceed 1.0%.

Volatile oil components (of Armoracia rusticana)

Approved for topical use only. Concentration must not exceed 0.05%.

Can only be used as a component and it is not listable in its own right. MRDD must provide 20 mg or less. Can only be used as a component and it is not listable in its own right. MRDD must provide 10 mg or less.

Substances that may be used in Listed medicines in Australia December 2007

Page 295 of 305

Therapeutic Goods Administration

Ingredient

Volatile oil components (of Mentha pulegium) Wahlenbergia gracilis Walnut Walnut oil

Use C C

Restrictions

Volatile oil components (of Peumus boldus)

In topical products, the MRDD may only provide 150 mg or less of pennyroyal oil. In products other than topical, the MRDD may only provide 50 mg or less of pennyroyal oil.

A, E E E E E E E E E E

Can only be used as a component and it is not listable in its own right. MRDD must provide 100 mg or less. Only Juglans cinerea, J. nigra and J. regia seed (nut kernel) is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Only Juglans cinerea, J. nigra and J. regia seed (nut kernel) oil fixed is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Water - potable Water melon

Water - purified Wax - emulsifying Wax - synthetic Wheat

Wax - microcrystalline

Only Citrullus vulgaris fruit or fruit flesh is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Approved for topical use only. Approved for topical use only.

Substances that may be used in Listed medicines in Australia December 2007

Only Triticum aestivum and T. durum seed (grain) is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Gluten is a mandatory component of this ingredient when the route of administration is other than topical and mucosal (see separate entry).

Page 296 of 305

Therapeutic Goods Administration

Ingredient

Wheat bran Wheat germ Wheat germ glycerides Wheat germ protein Wheat leaf Wheat protein Wheat sprout

Use E E E E E E E E A, E

Restrictions

Only Triticum aestivum and T. durum seed (grain) husk or seed coat (bran) is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Gluten is a mandatory component of this ingredient when the route of administration is other than topical and mucosal (see separate entry). Only Triticum aestivum and T. durum seed (grain) embryo (germ) is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Gluten is a mandatory component of this ingredient when the route of administration is other than topical and mucosal (see separate entry). PRV may only be used as an excipient in topical preparations. PRV may only be used as an excipient in topical preparations.

Gluten is a mandatory component of this ingredient when the route of administration is other than topical and mucosal (see separate entry). Only Triticum aestivum and T. durum leaf or herb is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Wheat protein - hydrolysed

Gluten is a mandatory component of this ingredient when the route of administration is other than topical and mucosal (see separate entry). Only Triticum aestivum and T. durum seed (grain) sprout is permitted. May only be used as a food excipient refer to introduction for permitted preparations. Gluten is a mandatory component of this ingredient when the route of administration is other than topical and mucosal (see separate entry).

Wheatgerm oil

Substances that may be used in Listed medicines in Australia December 2007

Page 297 of 305

Therapeutic Goods Administration

Ingredient

Whey powder Whey protein

Use E E

Restrictions

Lactose is a mandatory component of this ingredient in oral products (see separate entry). If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. Lactose is a mandatory component of this ingredient in oral products (see separate entry). If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL.

White horehound herb dry Wikstroemia viridifolia Wild carrot herb dry

White horehound herb powder

A, E A, E A, E A, E A, E A A A A E

Wild carrot herb powder Wild cherry bark dry Wild lettuce leaf dry Wine - fortified

May be a native species if exporting this product please contact the DSEWPC.

Wild cherry bark powder Wild lettuce leaf powder Wintergreen oil

Substances that may be used in Listed medicines in Australia December 2007

Withania somnifera

A, E A, E

Ethanol is a mandatory component of this ingredient (see separate entry).

Methyl salicylate is a mandatory component of this ingredient (see separate entry).


Page 298 of 305

Therapeutic Goods Administration

Ingredient

Withanolides (of Withania somnifera) Wool alcohols Wool fat

Use C E

Restrictions Approved for topical use only. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL.

Wool fat - hydrous Xanthan gum Xanthium sibiricum

A, E A, E E A, E A, E A, E C A, E E E E

If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. For Uncompounded BP Substances. If derived from Bovine, Deer, Goat, or Sheep from BSE High Risk Countries, this ingredient requires pre-clearance from TGAL. For Uncompounded BP Substances.

Xanthium strumarium Xanthophyll Xylene Xylitol Xylose

Xanthomona campestris

Xerophyllum asphodeloides

Concentration must not exceed 0.217%. Residual solvent limit is 21.7 mg per MDD. Approved for topical use only.

When the quantity of sugar alcohols per recommended daily dose exceeds 2 g, the quantity of the sugar alcohols must be declared on the label in addition to the label statement SUGOLS. Customs Prohibited Import requires an import permit/licence.

Substances that may be used in Listed medicines in Australia December 2007

Page 299 of 305

Therapeutic Goods Administration

Ingredient Yam

Use E

Restrictions

Yarrow herb dry

Yarrow herb powder

Yeast - high chromium Yeast - high selenium Yeast - hydrolysed Yeast dried Yellow 2G

A, E A, E A, E A, E A E E C

Only Dioscorea japonica and D. opposita tuber/tuberous root is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Yeast - high molybdenum

Chromium is a mandatory component of this ingredient (see separate entry). Selenium is a mandatory component of this ingredient (see separate entry). PRV may only be used as an excipient in topical preparations. Colour permitted only in topical preparations.

Molybdenum is a mandatory component of this ingredient. The MDD of molybdenum from yeast high molybdenum must not exceed 62.5 micrograms.

Ylang ylang oil Yohimbine Yucca baccata Yucca elata

A, E A, E A, E A, E A, E

May be a native species if exporting this product please contact the DSEWPC.

Concentration must not exceed 10 mg/kg or 10 mg/L or 0.001%. Customs Prohibited Import requires an import permit/licence.

Yucca filamentosa

Substances that may be used in Listed medicines in Australia December 2007

Page 300 of 305

Therapeutic Goods Administration

Ingredient

Yucca gloriosa

Use A, E A, E A, E A, E A, E A, E A, E A, E A, E A, E E C

Restrictions

Yucca whipplei

Zanthoxylum americanum Zanthoxylum bungeanum Zanthoxylum nitidum

Zanthoxylum clava-herculis Zanthoxylum piperitum Zanthoxylum simulans Zea mays Zein Zinc Zeaxanthin

Zanthoxylum schinifolium

A, E, C

Zinc amino acid chelate Zinc ascorbate

A, E A, E

For internal use, the MRDD must not provide more than 50 mg. For internal use, if the MRDD provides more than 25 mg but less than or equal to 50 mg of zinc, the product requires the label statement ZINC. When used internally, zinc is a mandatory component of this ingredient (see separate entry). Zinc is a mandatory component of this ingredient (see separate entry).

Substances that may be used in Listed medicines in Australia December 2007

Page 301 of 305

Therapeutic Goods Administration

Ingredient

Zinc chloride Zinc citrate Zinc citrate dihydrate Zinc gluconate Zinc lactate Zinc oxide Zinc myristate

Use A, E A, E A, E A, E A, E E E E E E

Restrictions

Concentration must not exceed 5%. Zinc is a mandatory component of this ingredient (see separate entry). Zinc is a mandatory component of this ingredient (see separate entry). Zinc is a mandatory component of this ingredient (see separate entry). Zinc is a mandatory component of this ingredient (see separate entry). Approved for topical use only. Concentration must not exceed 2%. Approved for topical use only. Concentration must not exceed 0.1%. Zinc is a mandatory component of this ingredient (see separate entry).

Zinc citrate trihydrate

Zinc para-phenolsulfonate Zinc ricinoleate Zinc stearate Zinc sulfate Zinc succinate

A, E

Zinc is a mandatory component of this ingredient (see separate entry). PRV may only be used as an excipient in topical preparations. Approved for topical use only.

Approved for topical use only. Concentration must not exceed 5%. Zinc is a mandatory component of this ingredient (see separate entry).

A, E A, E A, E

Zinc is a mandatory component of this ingredient (see separate entry). Zinc is a mandatory component of this ingredient (see separate entry).

Zinc sulfate hexahydrate

Concentration must not exceed 5%. Zinc is a mandatory component of this ingredient (see separate entry).

Substances that may be used in Listed medicines in Australia December 2007

Page 302 of 305

Therapeutic Goods Administration

Ingredient

Zinc sulfate monohydrate Zingiber officinale Zizyphus jujuba Zizyphus sativa Zostera marina Zucchini

Use A, E A, E A, E A, E A, E A, E E

Restrictions

Concentration must not exceed 5%. Zinc is a mandatory component of this ingredient (see separate entry).

When the extraction ratio is 25:1 or higher AND the equivalent dry weight per dosage unit is 2 g or higher this ingredient requires the label statement GINGER.

Zizyphus spinosa

Ingredient Use: A = active; E = excipient; C = component.

Only Cucurbita pepo var. melopepo cv. zucchini fruit is permitted. May only be used as a food excipient refer to introduction for permitted preparations.

Substances that may be used in Listed medicines in Australia December 2007

Page 303 of 305

Therapeutic Goods Administration

Abbreviations:
BP British Pharmacopoeia

BSE

CITES CRC

Bovine Spongiform Encephalopathy Child Resistant Closure Maximum Daily Dose

DSEWPC MDD PRV RFI MRDD RDD

Convention on International Trade in Endangered Species of Wild Flora and Fauna Department of Sustainability, Environment, Water, Population and Communities: http://www.environment.gov.au/biodiversity/trade-use/cites/index.html Maximum Recommended Daily Dose Recommended Daily Dose Restricted Flow Insert

Provisional Ingredient For further information on conditions related to PRVs, refer to the Australian Regulatory Guidelines for OTC Medicines: http://www.tga.gov.au/industry/otc-argom.htm

SUSMP TGAL

Standard for the Uniform Scheduling of Medicines and Poisons Therapeutic Goods Administration Laboratories

Substances that may be used in Listed medicines in Australia December 2007

Page 304 of 305

PO Box 100 Woden ACT 2606 Australia Email: info@tga.gov.au Phone: 02 6232 8444 Fax: 02 6232 8605 www.tga.gov.au

Therapeutic Goods Administration


Reference/Publication #

Vous aimerez peut-être aussi